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Abstract
Dietary components have been known for many years to have a variable effect 
on non-haem iron uptake in humans. Since it is impractical and expensive to employ in 
vivo methods for iron uptake, in this study, a human intestinal Caco-2 cell line was 
utilised for investigation of the effect of dietary components on non-haem iron uptake.
Using a radioactive iron isotope ^^Fe, it is possible to observe iron uptake activity 
in Caco-2 cell whether or not the dietary components are present in the media. Several 
dietary components including ascorbate, (3-carotene, amino acids, organic acids and two 
types of polyphenols (rutin dihydrate and catechin dihydrate) increased iron uptake in 
Caco-2 TC7 cells. In contrast, phytate and zinc reduced iron uptake, and vitamin E 
showed no effect on iron uptake. Interestingly, effects of ascorbate, zinc and phytate on 
iron uptake were found to follow Michaelis-Menten equation.
Fe(III) reduction was measured by analysing the formation of Fe(II) via the 
spectrophotometric measurement of Fe(II)-bathophenanthrolinedisulfonic acid. 
Ascorbate and p-carotene had a significant effect on the reduction of Fe(III) to Fe(II), 
thereby increasing the aqueous solubility of iron. This study model also sheds some light 
on the potential capability of p-carotene to reduce Fe(III) before Fe(II) is taken up by the 
cells.
Western blotting was used to study the effect of dietary components on the 
transporter proteins (DMTl and Iregl) levels. Western blotting demonstrated that most 
of the amino acids and organic acids tested were able to reduce the expression of 
membrane DMTl levels. On the contrary, zinc and phytate caused a significant increase 
effect in membrane DMTl levels (p<0.05) but ascorbate had no effect in membrane
DMTl levels. Iregl was significantly increased in the presence of phytate in the medium 
but there was no effect of ascorbate, p-carotene and zinc on Iregl. These findings 
provide evidence that although membrane DMTl levels responded to the addition of 
selected dietary components in the medium, most if not all had no effect on Iregl 
expression. The results suggest that the effect of dietary components on iron transporters 
is merely a mucosal block phenomenon, where the first step of iron uptake is regulated 
by DMTl. In addition, the effects of ascorbate are not simply on the reduction and 
chelation of iron, but also on the transporter protein DMTl itself.
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1.0 Introduction
Iron is indispensable and crucial for life serving as a metal cofactor for many 
enzymes, including both non-haem and haem proteins. Despite the fact that iron is the 
most abundant metal, both in terms of cosmic abundance and in the earth’s crust 
(Carpinteri & Manuello, 2010), iron deficiency is the commonest cause of anaemia 
especially in developing countries. There is an estimate that 25% of the world 
population is affected by iron deficiency and over 90% of affected individuals live in 
developing countries (Monajemzadeh & Zarkesh, 2009). In fact, iron deficiency anaemia 
(IDA) is a common condition known to the medical profession for several centuries. 
Therefore, there is a need for an inexpensive and accurate method for determining trace 
mineral availability from foods particularly iron and zinc to reduce “hidden hunger” in 
the global micronutrient crisis (Ferraz et a l, 2005; Thavarajah et ah, 2009). Iron 
deficiency can be caused by food deficient in iron or poor availability of dietary iron 
(Puyfoulhoux et al., 2001; Grillenberger et al., 2008), excessive loss or a combination of 
these factors. National and international studies have highlighted that iron is particularly 
important during the growing period of infants and women of reproductive age (Ferraz 
et al., 2005).
Iron is a vital micronutrient for the formation of red blood cell and mostly stored 
in the haemoglobin (Bolanle, 2005). Haemoglobin functions as an oxygen carrier in the 
body. Persistent low levels of haemoglobin is a risk factor for postpartum depression in 
new mothers (Corwin et al., 2003) and can lead to cardiac arrest in patients with kidney 
diseases (Fort g/ a/., 2010)
Clinical manifestation of iron deficiency includes anaemia, angular stomatis, 
glossitis, dysphagia, hypochlorhydria, koilonychias (spoon nail), and pagophagia (ice 
eating) (Waldo, 2002). Iron deficiency has also been linked to loss of energy, tiredness, 
anorexia, increased susceptibility to infection, behavioral abnormalities and reduction in 
intellectual performance and work capacity (Lozoff et a l, 2000; Semba & Bloem 2002; 
Ho et aL, 2008; Gautam et al., 2010). In children, iron deficiency can also cause 
psychomotor retardation and slow mental development (Hurrel et ah, 2003). In adults, 
iron deficiency is associated with weakness and fatigue which reduce capacity for 
physical work and productivity. In pregnant women, it contributes to serious 
consequences for both mother and baby, which includes maternal morbidity and 
mortality, and increases the risk of foetal morbidity, mortality and low birth weight 
(Andersen et ah, 2006; Paesano et ah, 2010).
An important consideration with respect to an adequate intake of iron for human 
consumption is the feasibility of iron-containing foods. Although iron is widely 
distributed in foods, inappropriate food combinations can compromise its absorption.
1.1 Sources of Iron (Haem and Non-haem Iron)
There are two main types of iron available in foods: haem iron which is present 
in meat and its products and around 20 to 30% being absorbed; non-haem iron is 
obtained from vegetables sources and generally has much lower bioavailability, ranging 
from 1 -  8% (Philip & Greenwood, 2000; Krishnamurthy et ah, 2007; Yokoi et ah, 
2008).
1.1.1 Haem Iron
Haem is liberated by the proteolytic digestion o f haemoglobin and myoglobin in 
the lumen of the proximal small intestine (Cau et ah, 2010). Dietary haem iron is
considered to be nutritionally important as it is more easily absorbed than non-haem iron 
(D'evoli et ah, 2008). In animal cells, haem biosynthesis and intracellular transport of 
haem are essential because it plays a role as a component of many enzymes and 
metabolites, and as a signalling molecule for diverse regulatory processes (Latunde- 
Dada et a l ,  2006).
Haem is absorbed as a porphyrin-iron complex, a separate pathway from non- 
haem iron absorption and is generally not influenced by dietary factors of iron 
absorption (Yanatori et a l,  2010), which affect the bioavailability of non-haem iron 
(Morgan & Oates, 2002).
In 2005, a haem uptake transporter, haem carrier protein 1 (HCPl) has been 
cloned and characterized as a putative transporter in the apical region of the duodenum 
and is responsible for uptake of haem by enterocytes and cultured cells (Shayeghi et al., 
2005; Rouault, 2005). Within the mucosal cell, the iron is released from the porphyrin 
molecule by a specific enzyme, haem-oxygenase (Follet et a l, 2002; Latunde-Dada et 
a l, 2006). Haem oxygenase catalyzes the release of Fe(III) from haem to release a- 
biliverdin IX (which is rapidly converted to bilirubin ) (Fig. l.I).
Heme
otrbîliverdin
COOH COOH COOH COOH
Fig. 1.1: Haem oxygenase catalyzes a multistep reaction that breaks open haem to 
release Fe(III) and a-biliverdin IX. (Zhu & Silverman, 2007). See comments in text.
1.1.2 Non-haem Iron
Dietary components influence bioavailability of non-haem iron (Navas-Carretero 
et ah, 2008). The iron status of an individual along with the balance between absorption 
facilitators and inhibitors determines the bioavailability of iron from individual foods or 
from meals (Lynch, 2005). In developing countries, non-haem iron is the most important 
source of dietary iron, where a vegetarian diet is an economic necessity (Chiplonkar & 
Agte, 2006). Unlike haem iron, non-haem iron uptake is regulated and it needs to 
compete with many complexing ligands in the intestinal lumen to be absorbed. Although 
some studies have shown that vegetarians and vegans have similar iron intakes or higher 
than those o f omnivores, their iron body stores are usually lower, especially in female 
vegetarians (Hunt, 2003; Craig, 2010). The absorption of non-haem iron is highly 
variable and depends on the nature of meal (Table 1.1). The Reference Nutrient Intake 
(RNI) for iron is 8.7 mg/day for vegetarian men and for women afl;er menopause and
14.8 mg/day for menstruating women (Geissler & Singh, 2011).
Table 1.1: Factors influencing dietary iron absorption
• Haem iron absorption
1. Amount of haem iron, especially as meat
2. Content o f calcium in meal 
______ 3. Food preparation (time, temperature)
• Non-haem iron absorption
1. Iron status of subjects
2. Amount of potentially available non-haem iron
3. Balance between enhancers and inhibitors factors 
Enhancers Inhibitors
Ascorbate 
Meat/fish 
Fermented foods
Phytate 
Iron-binding 
Soy protein 
Calcium 
Polyphenols
(Rossander-Hulthen et aL, 1995)
1.2 Iron Status in the Human Body
The quantity of iron of the body is controlled by absorption from the intestines, 
which depend on individuaPsdron status, iron intake and bioavailability, and by factors 
influencing the absorption of iron (Bayraktar & Bayraktar, 2010). Such factors may 
include high intakes of phytate, dietary fibers, and tannins, ascorbate, flesh food and 
acidic pH (Teucher et aL, 2004; Mendes et ah, 2009). There is no specific physiological 
mechanism for iron excretion so its loss from the body is limited to non-specific 
processes such as desquamation of mature enterocytes and blood loss. In a normal 
individual, iron levels are maintained by controlling the amount o f dietary iron that is 
absorbed, with a normal human adult containing 50-65 mg of iron/kg of body weight 
(Conrad & Umbreit, 2002). The distribution o f iron in the body is summarized in Table 
1.2. The main component of iron in the body include haemoglobin in the red blood cells
(70%), myoglobin in muscle (4%), and the enzymes such as cytochromes, catalases and 
peroxidases (less than 1%) (Pradeep et aL, 2010). An average adult produces 2 x lO'* 
red blood cells daily, with a red blood cell renewal rate of 0.8 percent per day, and each 
ml of packed red cell volume contains 1 mg of iron (Conrad & Umbreit, 2002; 
Nagababu et aL, 2008). Some proteins involved in iron transport and storage are 
summarized in Table 1.3.
Normal iron status implies both the presence of erythropoiesis (the process by 
which red blood cells are produced) and a reserve of storage iron in normal subjects. 
Apart from too much or too little iron, there is also maldistribution (de Mast et aL, 
2010). This can occur in anaemia associated with inflammation or infection, where there 
is a partial failure of erythropoiesis and of iron release from the phagocytic cells in liver, 
spleen and bone marrow which results in accumulation of ferritin and haemosiderin (two 
forms of storage iron) in these cells (Papanikolaou et al., 2005; Prentice et aL, 2007). 
Thus, determination o f body iron status requires an estimate of the amount of haem iron 
and the level of storage iron. Methods o f the assessment o f body iron status are 
summarized in Table 1.4. The three major aspects of assessment are functional iron, 
tissue iron supply and iron stores (Brittenham & Badman, 2003). The functional iron 
measurement focuses on haemoglobin concentration, red cell indices, red cell zinc 
protoporphyrin, red cell ferritin (basic) and serum transferrin receptor. The tissue iron 
supply measurement focuses on serum iron levels, serum total iron binding capacity 
(TIBC) and saturation o f transferrin. Whereas, the iron store measurement focuses on 
quantitative phlebotomy, tissue biopsy of iron and serum ferritin.
Table 1.2: Distribution of iron in the body (70 kg man)
Protein Location Iron content (mg)
Haemoglobin Red blood cells 3000
Myoglobin Muscle 400
Cytochromes, other haem 
and iron sulphur proteins
All tissues 50
Transferrin Plasma and extravascular 
fluid
5
Ferritin and haemosiderin Liver, spleen and bone 
marrow
0-1000
{Source: Conrad & Umbreit, 2002)
Stored iron represents the 25% of the body iron, predominantly in the liver. 
Smaller amounts are found in the reticulo-endothelial cells of the bone marrow, liver and 
spleen (Nadadur et aL, 2008). Average iron levels in adult male and female are 1 g and 
2 g, respectively (Conrad & Umbreit, 2000). Of this, approximately two-thirds consist of 
ferritin, the soluble fraction of the non-haem iron stores. The adult male and female 
require approximately 1 mg/day and 2 mg/day, respectively. That amount is just enough 
to cover normal iron loss and menstruation (for female). Pregnant females require 
approximately 3 mg/day, enough for normal, ongoing loss and fetal requirements. 
Whereas, children of both sexes require approximately 2 mg/day, enough for normal 
loss and extra to produce some residual iron stores and allow for increasing red cell mass 
(Luther, 2008)
Table 1.3: Mammalian proteins containing iron
Proteins Function Location
Haem-containing proteins
Haemoglobin
Myoglobin
Cytochromes (b,c,a) 
cytochromes oxidase
Catalase, peroxidase
Di oxygenase, mono-oxygenases 
(several, some without haem, 
cytochrome P450
Transport of oxygen
Binding of oxygen
Electron transfer in 
respiratory chain
Enzymatic cleavage of 
peroxidase
Hydroxylations, 
detoxification, steroid 
synthesis
Erythrocyte
Muscle
Mitochondrion
Peroxisome
Several tissues 
Liver microsomes 
Adrenal gland
Iron sulfur-containing proteins 
Dehydrogenases 
Aconitase
Electron transfer chain 
Citric acid cycle
Mitochondrion
Mitochondrion
Iron-binding proteins
Ribonucleotide-reductase
Transferrin
Lactoferrin
Deoxynucleotide synthesis 
Iron transport 
Iron transport
Cytoplasm 
Serum 
Mucosal secretion
Iron-storage proteins
Ferritin Iron storage Cytoplasm
{Source: Conrad & Umbreit, 2002)
1.3 Regulation of Iron Uptake
The regulation and acquisition of dietary iron by the small intestine is strongly 
linked to the body’s iron needs (Ganz & Nemeth, 2006). Although iron is present in 
wide range of forms in the diet, the most important forms are either inorganic ferrous 
[Fe(II)] or ferric [Fe(III)] iron (Yanatori et al., 2010), or as haem iron (McKie, 2008). 
The process o f intestinal iron absorption is affected by several factors which can be
divided into intraluminal, mucosal and corporeal factors (Zimmermann & Hurrell, 
2007).
1.3.1 Intraluminal Factors in Iron Absorption
The intraluminal factors include dietary iron (quantity and chemical form), pH, 
and chelation and precipitation processes that occur at intraluminal sites (the interior of 
the gastrointestinal tract)(Zimmermann & Hurrell, 2007).
1.3.2 Mucosal Factors
Several factors at the mucosal site (linings of mostly endodermal origin, covered 
in epithelium, which are involved in absorption and secretion) affect iron uptake, and 
these include anatomic factors (diminished absorptive surface, defective epithelial cells 
and mucosal life span), intestinal motility, mucosal iron (quantity and chemical form), 
inhibition by other metal ions, and drugs affecting protein synthesis (Mena et aL, 2006).
For two decades it was believed that ferritin (a protein that stores iron) regulates 
iron absorption and that apoferritin (ferritin that is not combined with iron) enhanced 
iron uptake and holoferritin (ferritin that is saturated with iron) blocked iron uptake. 
Transferrin was postulated to be secreted into the intestinal lumen to bind iron and enter 
the absorptive cell as a transferrin (Kolachala et aL, 2007) iron complex. But, the 
inability to demonstrate transferrin receptors on the intestinal microvilli and 
observations that patient with atransferrinemia became iron-overloaded made this 
postulate less likely (Pietrangelo et aL, 1992). This postulate leads to the identification 
of pathways of non-transferrin-dependent iron transfer into enterocytes and the divalent 
metal transporter 1 (DMTl) and intergrin-mobilferrin pathways (IMP) (Conrad & 
Umbreit, 2002).
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1.3.3 Corporeal Factors
Two major “corporeal” factors related to the regulation of iron absorption are the 
status of body iron stores and the rate of erythropoiesis (Naugler, 2008).
Body iron stores are the most important corporeal factor to enhance iron 
absorption (Apinan et aL, 2010). Body iron store plays an important part in regulating 
iron absorption in accordance with the body’s needs, increasing absorption when body 
iron stores are low and decreasing it when they are high. This effect is thought to act on 
progenitor cells in the Crypts of Lieberkuhn by affecting the amount of iron taken up by 
these cells, thereby programming them for the appropriate absorptive activity when they 
mature (Barisani et aL, 2004; Orino & Watanabe, 2008).
Increased erythropoiesis and rapid plasma iron turnover seem related to 
enhanced iron absorption whether the cause be haemorrhage, hemolysis or hypoxia 
(Bergmans et aL, 2007).
1.4 Mechanism of Iron Absorption and Transport
Eukaryotes have evolved unique mechanisms for cellular iron uptake and 
transport, including the regulation of intestinal absorption of dietary iron by body iron 
status to combat the inherent toxicity of iron in the promotion of oxidation (Mladenka et 
aL, 2005). Iron absorption is high when body iron stores are low and vice versa (Rolfs & 
Hediger, 1999; Thompson & Yoon, 2006).
Iron absorption occurs predominantly in the duodenum and upper jejunum 
(Morgan & Oates, 2002). Most dietary inorganic iron is in the Fe(III) form, which has 
low bioavailability. When iron enters the stomach from the esophagus, Fe(III) needs to 
be reduced to Fe(II) before it can transverse the intestinal brush border and it is thought 
that a membrane-bound ferric reductase, namely duodenal cytochrome B (DcytB),
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mediates the process of Fe(III) conversion to Fe(II) in the brush border membrane (Fig. 
1.2) (MacKenzie & Garric, 2005). Intestinal uptake of Fe(II) into the enterocytes is then 
mediated by DMTl in the brush border of the intestinal cells (Zerounian & Linder 
2002). Newly absorbed iron may be re-oxidised to Fe(III) and stored in ferritin if the 
body iron levels are high (Ravet et aL, 2008). If the body iron levels are low, it may be 
transported out of the cell via the iron regulatory 1 protein (Iregl) at the basolateral 
membrane (MacKenzie et aL, 2006). Strong circumstantial evidence suggests that 
hephaestin (a ferro-oxidase) that is thought to work closely with Iregl to convert Fe(II) 
to Fe(III) (Hadziahmetovic et aL, 2008), and once in this form the iron is loaded onto 
transferrin for transport in the plasma (McKie et aL, 2000).
H em e
L u m e n
H ep h a estin
mW
D cytB
D M T l
FezTT
B lo o d
Fig. 1.2: Intestinal iron uptake. Fe(III) is reduced to Fe(II) by apical membrane 
ferrireductase that include Dcyt B. The acid microclimate at the brush border 
provides electrochemical potential gradient to drive transport of Fe(II) via DMTl 
into the enterocyte. DMTl may also contribute to the absorption of other 
nutritionally important metal ions (e.g. Mn^^). Haem can be taken up by 
endocytosis, and Fe(ll) is liberated within the endosome/lysosome, but the 
molecular identity of proteins involved is yet to be reported. Basolateral export of 
Fe(II) may be mediated by Iregl in association with hephaestin. Haem oxygenase 
(HO); FeiTf, diferric transferrin (McKie et aL, 2000).
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1.4.1 Divalent Metal Transporter (DMTl)
DMTl, previously known as the natural resistance-associated macrophage 
protein 2 (NRAMP2), was first identified in 1995 in a screen for homologs of Nrampl, a 
protein involved in host defense (Grunheid et aL, 1995). The human DMTl, consists of 
17 exons spread over more than 36 kb (Lee et aL, 1998) with 12 putative transmembrane 
domains. There are two isoforms of first exon, lA and IB. The lA  isoform is tissue- 
specific, found predominantly in the duodenum and kidney, whereas the IB isoform is 
ubiquitous (MacKenzie et aL, 2007). DMTl isoforms are the result of splice variants 
that lead to two different NH2-terminal (exon lA and exon IB) and two different 
COOH-terminal amino acid sequences (exon 16/16A or exon 16/17).
The identification of DMTl as probably the major brush border iron transporter 
has provided considerable insight into the regulation of iron uptake. It was identified by 
functional cloning in Xenopus laevis oocytes as an electrogenic metal transporter o f 
broad substrate specificity, transporting Fe(ll), Zn(II), Mn(II), and other ions 
(MacKenzie et aL, 2007). The protein expression of this transporter and its deployment 
are inversely related to levels of iron within the enterocyte. Together, changes in brush 
border concentration of DMTl and the DcytB would thus relate to the rate of intestinal 
iron uptake and absorption (Zerounian & Linder, 2002). DMTl-mediated Fe(II) 
transport was also shown to be pH dependent.
DMTl is highly expressed at the lumenal surface brush border of the mature 
upper small intestine enterocytes found along the villus and modestly expressed in the 
cytoplasm of the same cells. It is not found at the basolateral membrane of enterocytes, 
or in detectable amounts in immature enterocytes from the crypts (Tandy et aL, 2000). 
DMTl is highly expressed also in the renal proximal tubules and collecting ducts, testes,
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medullary thymocytes of the thymus, macrophages, hepatocytes and in neurons 
(Veuthey et aL, 2008; Nevo & Nelson, 2004). In duodenal enterocytes DMTl transports 
Fe(II) across the apical membrane from the duodenal lumen into the enterocytes (Nunez 
et aL, 2010). Under conditions of iron deficiency DMTl in enterocytes is localised 
mainly in the apical membrane, with some found in the cytoplasm (Nevo & Nelson, 
2004). Similarly, hepatocytes express DMTl on the plasma membrane after iron loading 
but not after iron depletion (Trinder et aL, 2000). The DMTl expressed on the surface 
cells is pH dependant. DMTl is active at pH < 6  and inactive at pH > 7 (Tandy et aL, 
2000).
1.4.1.2 DM Tl Mutations and Polymorphisms
At least eight genetic polymorphisms, resulting in defective DMTl expression, 
have been found, with four in animal models and four in humans (Lee et aL, 2002). In 
patients suffering from severe iron disorders (microcytic anaemia and hepatic overload), 
mutations were discovered that altered DMTl functional expression. The mutations 
caused high serum iron and transferrin saturation as well as increased hepatic iron stores 
(lolascon et aL, 2008). Genetic studies in rat and mouse models (due to missense 
mutation G185R in TMS4 of DMTl) have shown that DMTl is required for life, and 
that a drastic reduction in level of functional protein results in severe anaemia that 
cannot be corrected with oral or intravenous iron supplements (Fleming et aL, 1997; Su 
et aL, 1998; Lam-Yuk-Tseung et aL, 2003; Gunshin et aL, 2005).
The DMTl studies in the Belgrade rat and microcytic mouse due to mutation 
with a Gly*^  ^ ->Arg substitution exhibit a severe hypochromic, microcytic anaemia with 
diminished erythrocyte survival. In this case, DMTl does not allowing iron to enter
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enterocytes to eliminate the iron-deficient appearance. However, how critical DMTl is 
depends on the effect of the mutation (Garrick & Garrick, 2004).
1.4.2 Iron- regulated Transporter 1 (Iregl)
Iron cannot pass through cellular membranes unassisted (Donovan et aL, 2005). 
In addition to iron uptake by DMTl and storage (ferritin), cellular iron balance in the 
body also depends on the amount of iron exported from the cells. Iregl or ferroportinl 
(Fpnl) is required for iron export from cells across the basolateral membrane which 
requires oxidation of the Fe(II) via hephaestin (Heph), a multi copper oxidase (Vulpe et 
al., 1999; Kuo et aL, 2004). Accordingly, in polarized epithelial cells, DMTl is found on 
the apical membrane, and Iregl is found on the basolateral membrane (Canonne- 
Hergaux et aL, 1999; Donovan et aL, 2000). Increased expression of Iregl has been 
found in patients with iron deficiency and in patients with hereditary haemochromatosis 
(iron overload in the organs, particularly in liver, heart and endocrine gland) (Zoller et 
aL, 2001). Iregl was also found to increase in both hypotransferrinemia (deficiency of 
transferrin in the blood which causes elevated body iron stores) (Ponka, 2002). This 
phenomenon indicates that Iregl can be regulated independently of iron stores.
Evidence implicating Iregl in the efflux of Fe(III) is provided by several 
observations. (1) Over-expression of Iregl in Xenopus oocytes resulted in iron efflux 
(Donovan et aL, 2000; McKie et aL, 2000). (2) Mutations to Iregl resulted in a 
haemachromatosis, suggesting that iron release from stores is impaired (De Domenico et 
aL, 2005 & 2007). These data support the hyphothesis that Iregl is involved in non 
haem iron transport.
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1.4.3 Ferritin
Ferritins are iron-storage proteins present in all cells of vertebrates, invertebrates, 
plants and bacteria. The liver, bone marrow and spleen are the major organs for 
synthesis of ferritin (Harrison & Arosio, 1996). In animals, ferritin is found inside cells 
as well as circulating in plasma, and plasma levels o f ferritin are directly related to the 
level of body iron and have been used as an index of iron storage deficiency (Lenga et 
al., 2007). It has been suggested that a difference of 1 pg/L in serum ferritin is 
equivalent to approximately 7-8 mg of storage iron in a normal adult (Milman et a l, 
2002). Normally, serum ferritin concentrations are within the range 15-300 pg/1; values 
are lower in children than adults, and from puberty to middle age mean concentrations 
are higher in men than in women. The iron status appears to have relatively little 
influence on cord serum concentrations, mean values for which are in the range 
100-200 pg/1 in pregnant women (Paiva et al., 2007; Killip et al., 2007). Mutations in 
the ferritin light chain are responsible for a disease called the hyperferritinemia-cataract 
syndrome characterized by cataracts (opacities in the lens of the eye) and high levels of 
ferritin in the blood (Zandman-Goddard & Shoenfeld, 2007).
The ferritins are globular quaternary proteins consisting of 24 heavy (H) or light 
(L) subunits that can encapsulate up to 4500 iron atoms in hydrous ferric oxide mineral 
core (Shi et al., 2008). Iron is deposited in the centre of the ferritin, via channels that 
transport the iron in and out, in the form of Fe(III) hydroxyphosphate (Fe0 (H2P0 4 ), 
which is attached to the inner wall of the sphere. When the body requires iron, the iron 
must be changed from the Fe(III) to the Fe(II) oxidation state. Then, the iron leaves 
through channels in the spherical structure.
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1.5 Dietary Factors Affecting Iron Uptake
1.5.1 Ascorbate
Intake of ascorbate is rarely low enough to cause overt deficiency diseases 
especially in “Western” countries. Low intakes of ascorbate, however, increase the risk 
of certain chronic diseases (Gaziano et aL, 2009). Many studies suggest that 
supplements of ascorbate may contribute to lowering the risk of specific chronic 
diseases such as Alzheimer’s (Bowman et aL, 2009), cataracts and ischemic heart 
disease (IHD) despite the fact that several clinical trials failed to prove an effect in 
humans (Middleton et aL, 2000). In the USA, an estimated of 70% of the population 
uses dietary supplements at least occasionally, and approximately 40% use dietary 
supplements on a regular basis (Clifford, 2000). Daily intakes of ascorbate from dietary 
sources could be as high as 210-280 mg/d (Levine et aL, 1999), which could lead to 
intestinal lumen concentration as high as 500 pM (MacDonald et aL, 2002). However, 
the RDA for USA^and Canada is 90mg/d and the RNI for UK is 40 mg/d (MacDonald et 
al., 2002). It is generally agreed that ascorbate is safe at intakes of less than 2000 mg/d 
(Levine et aL, 1999).
There are two types of ascorbate which are reduced ascorbate and 
dehydroascorbate (oxidised) (Fig. 1.3). Ascorbate is transported into cells by the 
sodium-ascorbate co-transporters (SVCT-1 and SVCT-2), which are present in the small 
intestine, renal epithelial cells, osteoblasts, adrenomedullary chromaffin cells, and 
fibroblasts (Savini et aL, 2008; Cahill & El-Sohemy, 2010). SVCTl contains up to 12 
transmembrane domains, two possible sites for N-glycosylation and multiple 
phosphorylation sites and is largely expressed in epithelial surfaces involved in bulk 
transport such as intestine, liver and kidney. SVCT2 accounts for tissue specific uptake
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of ascorbate, expression is widespread occurring in neurons, bone and other tissues. 
However, dehydroascorbate uptake is through the glucose transporters, GLUT-1, GLUT- 
3 and GLUT-4 (Agus et aL, 1997; Rivas et aL, 2008). Once inside the cell, 
dehydroascorbate is rapidly reduced to ascorbate by both enzymatic and non-enzymatic 
mechanisms with the production o f reactive oxygen species (ROS).
HOHQ
HOHO
HO OH
Fig. 1.3: The (A) reduced and (B) oxidized forms of ascorbate. (Bode et aL, 1990)
1.5.1.2 SVCTl and SVCT2
Ascorbate is imported by an active mechanism, requiring two sodium-dependent 
vitamin C transporters SVCTl and SVCT2. Homology among transcripts from different 
species (mouse, rat, pig and human) is about 86-95 and 89-95% for SVCTl and SVCT2 
mRNAs, respectively (Savini et aL, 2008). The two isoforms have also different 
capacity for ascorbate as, in all heterologous expression studies, human SVCTl exhibits 
a higher Vmax value than SVCT2. Thus, SVCT2 is a high affinity/low capacity 
transporter, whereas SVCTl is a high capacity/low affinity carrier.
1.5.1.3 GLUT-1, GLUT-3 and GLUT-4
Another mechanism is based on oxidation of external ascorbate to 
dehydroascorbate. Dehydroascorbate is transported into cells by sodium independent
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glucose transporters GLUT 1, GLUTS and GLUT4 and then immediately reduced to 
ascorbate by intracellular proteins such as glutaredoxin (Park & Levine, 2000).
1.5.1.4 Ascorbate and Interaction with Minerals
Ascorbate has significant interactions with several key minerals in the body. 
Ascorbate is not only one of the most widely used antioxidants but has been quoted as 
the most potent enhancer of iron absorption (Fidler et aL, 2004). Some studies have 
shown the influence o f ascorbate on iron absorption was most pronounced in meals that 
contain high levels o f phytates and polyphenols (Hallberg et aL, 1986; Lopez & Martos,
2004). In a study done by Hallberg and colleagues (1986), when iron absorption was 
measured in different meals served with and without ascorbate, absorption increase 
varied and most significant when cauliflower was added to the meal (Hallberg et al., 
1986). In a comprehensive study of infant cereals it was found that iron absorption is 
increased by dietary ascorbate (Moretti et aL, 2006; Teucer, 2004), while a separate 
study showed that dietary fiber and phytate inhibited iron uptake (Hallberg et aL, 1987). 
The mechanism of action of ascorbate has been proposed to be a reduction of Fe(III) to 
Fe(II) (Conrad & Umbreit, 2000).
1.5.2 Beta carotene (p-Carotene)
P-carotene belongs to a family of natural chemicals known as carotenes or 
carotenoids. p-carotene is a fat-soluble pigment widely found in plants and is the 
pigment that gives a lot of fruits and vegetable their orange or yellow colours (Guzman 
et aL, 2010). p-carotene contains a cyclic structure at each end of a conjugated chain. It 
occurs naturally as all-trans P-carotene (Fig. 1.4) and 9-cis p-carotene (Fig. 1.5). 
P-carotene is not as active biologically as vitamin A but a source of vitamin A (Strobel 
et aL, 2007). Where vitamin A is essential for growth and differentiation of a number of
19
cells and tissues, p-carotene reacts as provitamin A. For the part o f the population unable 
to meet vitamin A requirements according to the RDA recommendations, sufficient 
intake of P-carotene may be crucial to help improve and maintain adequate vitamin A 
status of the individual. It is estimated that 2.6 pg P-carotene in oil can be converted to 
1 pg retinol (Van Lieshout et aL, 2003) and only 14% of dietary p-carotene is absorbed 
in the gut. However, the bioavailability of p-carotene from fruit and vegetables is much 
lower than previously thought. The US Institute of Medicine revised the conversion 
factor for a mixed diet from 6  pg to 12 pg P-carotene to supply 1 pg retinol (Grusak,
2005).
CHj
Fig 1.4: Structure of p-carotene (Tschimer et aL, 2008)
Fig 1.5: Structure of 9-cis p-carotene
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p-carotene is believed to be an antioxidant because it appears to protect the body 
from free radicals (Walczyk et aL, 2003). However, its mechanism is not clearly 
understood. Results from some human studies have shown improvement of measures of 
antioxidant activities including decreased copper-induced low density lipoprotein (LDL) 
oxidation (Shaish et aL, 2008), decreased deoxyribonucleic acid (DNA) strand breaks 
and oxidized pyrimidine bases in peripheral (Glei et aL, 2002), decreased serum 
malondialdehyde in patients with major a-thalasemia (Mahjoub et aL, 2007), and 
increased red blood cell copper/zinc-superoxide dismutase activity (Palozza et aL,
2006). It has also been shown to increase the numbers of white blood cells including T 
cells, monocytes, and natural killer cells (Ashfaq et aL, 2000). Some studies have found 
that high doses of p-carotene were able to increase CD4 cells after only two weeks of 
supplementation (Ashfaq et aL, 2000). It was also shown that p-carotene could improve 
iron absorption from cereals and overcome the inhibition of iron uptake by phytates and 
polyphenols infusions (Layrisse et al. 2000).
1.5.3 Dietary Minerals and Their Physiological Functions
1.5.3.1 Zinc and Its Functions
Zinc is an essential dietary trace metal required by the human body for a number 
of physiological and biochemical functions. Zinc is essential for growth and 
development, proliferation, differentiation and apoptosis, neurogenesis, synaptogenesis, 
neuronal growth and neurotransmission (Fraker & King, 2004). The best sources of zinc 
are oysters (richest source), red meats, poultry, cheese, shrimp, crab, and other shellfish. 
The body absorbs 20% to 40% of the zinc present in food. Zinc from animal foods like 
red meat, fish, and poultry is more readily absorbed by the body than zinc from plant 
foods (Walingo, 2009). Recommendations for dietary zinc intake are based on average
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daily intake of populations from several countries and range from 4.7 to 18.6 mg/day 
(Nishiyama et aL, 1999). Bioavailability of zinc is influenced by other food constituents. 
Dietary fibre, particularly phytates, calcium, Fe(II) and pharmacological intakes of folic 
acid can interfere with zinc absorption (Hunt, 2003; Oberleas, 1996; Viadel et aL, 2006; 
Simmer et aL, 1987). The amount of zinc needed daily is about 2 -3 mg in adults, i.e. 
only 0 .1% of the total zinc pool is renewed daily, in agreement with a biological half-life 
of approximately 280 days for zinc (Wastney et aL, 1996).
1.5.3.2 Magnesium and Its Functions
Magnesium is the eighth most abundant element in the Earth’s crust, but does not 
occur uncombined (Dobrzahski et aL, 2009). Magnesium plays an important role in a 
wide range of biochemical and physiological processes, particularly the body’s 
metabolism, including muscle tension, the regulation of blood pressure and bone cell 
function (Touyz, 2004). There is no recorded evidence that magnesium inhibits iron 
uptake.
1.5.3.3 Manganese and Its Functions
Manganese is a trace element found in a variety of food includes cereals, 
vegetables and nuts (Gow et aL, 2010). In the body, manganese functions as an enzyme 
activator (responsible for the utilization of several key nutrients including biotin, 
thiamin, ascorbate, and choline) and a component o f metalloenzymes (an enzyme that 
contains a metal ion in its structure) (Aschner & Aschner, 2005). It was recorded in a 
study done by Rossander-Hulten et aL, 1991 that manganese inhibited iron absorption 
both in solutions and in a hamburger meal.
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1.5.3.4 Sodium and Its Functions
Sodium chloride is vital for human health. Sodium ions regulate blood pressure 
and blood volume. Sodium ions are responsible facilitating transmission o f electrical 
signals in the nervous system and regulate the water balance between body cells and 
body fluids (Doyle & Glass, 2010). Absorbability of iron from foods are varies widely 
depending on the type of sodium compounds presence in the meals. A study conducted 
by Fisher and colleagues on the effect o f high sodium ions on iron uptake by the 
halotolerant alga Dunaliella showed that high salt affects neither the affinity nor the rate 
of iron uptake (Pick, 2004).
1.5.3.5 Potassium and Its Functions
Potassium can be found in many plants and is essential for proper function of all 
cells, tissues, and organs in the human body (Soetan et aL, 2010). Potassium is required 
for maintaining a normal water balance between the cells and body fluids. Potassium is 
crucial to heart function and plays a key role in skeletal and smooth muscle contraction, 
making it important for normal digestive and muscular function (Haddy et aL, 2006). A 
study conducted by Musilkova and Kova (2001) has shown increases iron uptake by 
HeLa and K562 cells when calcium and potassium were added into the medium.
1.5.4 The Effects of Toxic Metals on Human Health
1.5.4.1 Lead Toxicity
Lead is a chemical element that can damage nervous connections (especially in 
young children) and cause blood and brain disorders (Nirmal Kumar et aL, 2009). 
Symptoms of lead poisoning include weakness, excessive tiredness, irritability, 
constipation, anorexia, abdominal discomfort (colic), fine tremors, and wrist drop 
(Garcia & Snodgrass, 2007). Iron deficiency increases the absorption o f lead (Nadadur
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et aL, 2008). It has been suggested that that iron and lead absorption may be mediated by 
common transporters and that ingested iron decreases the absorption of lead in a dose- 
related manner, presumably by competitive inhibition of the carrier protein (Bannon et 
al, 2002). However, no effect of iron levels and iron supplementation on lead absorption 
was found in humans (Watson et aL, 1986; Flanagan et aL, 1982).
1.5.4.2 Cadmium Toxicity
Cadmium is a natural element in the earth’s crust and is usually found in 
combination with other elements such as oxygen (cadmium oxide), chlorine (cadmium 
chloride), or sulphur (cadmium sulphate, cadmium sulphide) (Cuypers et aL, 2010). 
Intake of cadmium can cause lung and kidney damage, and stomach irritation, leading to 
vomiting and diarrhoea (Jiang et aL, 2008; Garcon et aL, 2007).
The intestinal absorption of cadmium is influenced by body iron status in animal 
and human models (Ryu et aL, 2004). The depletion of body iron concentrations 
markedly up-regulated DMTl expression in the duodenum and increased the cadmium 
body burden in rats, suggesting that the absorption of cadmium is associated with DMTl 
(Park et aL, 2002).
1.5.4.3 Mercury Toxicity
Mercury is a natural element in the environment. Some bacterias can produce 
organic mercury, particularly methylmercury and can accumulate in living organisms 
such as fish and mammals via a process called biomagnification (Munthe et aL, 2007). 
In children, extreme exposure to mercury affects the brain that includes a decrease in 
intelligence quotient (IQ), delays in walking and talking, lack of coordination, blindness 
and seizures (Jill et al., 2002). In adults, extreme exposure can lead to health effects such
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as personality changes, tremors, changes in vision, deafness, loss o f muscle coordination 
and sensation, memory loss, intellectual impairment, and even death (Satoh, 2000).
No inhibition on iron absorption by mercury was found in an in vitro study (Iturri 
& Nunez, 1998). However, af Geijerstam and colleagues had reported an inverse 
correlation between plasma-mercury and serum ferritin after a single dose of mercury 
amalgam (af Geijerstam et aL, 2001), and the authors suggested a competition at the 
absorption level (Barany et aL, 2005).
1.5.4.4 Arsenic Toxicity
Arsenic is an element that is present naturally and due to human activities. Plants 
on land can accumulate arsenic compounds via uptake from soil and humans are 
exposed through contaminated foods and drinks (Zhao et aL, 2010). Foods contain both 
organic and inorganic arsenic and water contains primarily inorganic arsenic. Inorganic 
arsenic is toxic to our bodies. If swallowed in a form that is readily absorbed, arsenic can 
cause rapid poisoning and death. Long-term exposure to high levels o f arsenic in 
drinking water can cause thickening and pigment spots in the skin, and cancer of the 
skin, lungs, bladder or kidney (Gensheimer et aL, 2010). However, no information is 
available on the effects of arsenic on non-haem iron uptake.
1.5.5 Other Dietary Components that Influence Dietary Iron Uptake
Proteins are about 50% of the dry weight o f most cells, and are the most 
structurally complex macromolecules known (Gaur, 2009). Intake of protein in our diet 
contributes essential amino acids for normal body functions. Amino acids are used by 
cells to build hormones, antibodies and the enzymes that regulate the chemical reactions 
within the body. Besides, several amino acids have been reported to increase iron 
uptake. Amino acids can be classified based on polarity of the functional groups a)
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nonpolar R groups b) polar unchanged R groups c) positively charged R groups 
d) negatively charged R group, or according to chemical nature a) monoamino 
monocarboxylic b) diamino monocarboxylic c) monoamino dicarboxylic d) sulfur 
containing e) aromatic f) heterocyclic, or according to essential and nonessential amino 
acids for adult mammals (Reeds, 2000). Proline was found to moderate the inhibitory 
effect of tea on iron absorption in rats (Kim & Miller 2005) while cysteine enhanced 
iron uptake from a concentrated haemoglobin hydrolysate in rats (Vaghefi et a l  2005). 
In contrast, histidine had no effect on iron absorption in humans (Layrisse et a l 1984), 
while methionine, alanine and lysine reduced the uptake of iron from Fe(II)-ascorbate 
media in Caco-2 cells (Glahn & Van Campen, 1997).
Several organic acids have been shown to influence the availability and 
absorption of non-haem iron (Salovaara et a l, 2002). The effect obtained was dose- 
dependent where citric acid, tartaric, malic, succinic, oxalic acid and fiimaric acids 
enhanced Fe(III) uptake but propionic and acetic acid had no effect on Fe(III) uptake 
(Salovaara et a l,  2002). Hazel 1 and Johnson (1987) showed that 300 mg of ascorbate, 
citric and malic acid increased the diffusible (spreading of) iron in white wheat flour due 
to increase solubilisation of iron in the presence of organic acids from 4.5% to 17%, 
18.6% and 10.6%, respectively. A separate study by Gillooly and co-workers (1984) 
observed a significant increase in intestinal iron absorption from a rice meal 
supplemented with 1 g o f ascorbate, citric, tartaric or malic acids. In contrast, a study by 
Hallberg and Rossander, (1984) has shown that citric acid had a negative impact on iron 
absorption.
Phytate facilitates the storage of phosphates and minerals in grains, seeds, nuts, 
vegetables and fruits (Chan et a l, 2007). Phytate can be considered as the most effective
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inhibitor that can severely impair iron absorption as it contained in many plant foods 
(Engle-Stone et ah, 2005). In developing countries, cereal porridges, based on rice, 
maize, wheat, oat or sorghum grains, are common complementary foods for infants 
during the weaning period and, due to the high phytate content o f these cereal porridges, 
iron absorption may be very low (Hurrel et ah, 2003; Chan et ah, 2007). Phytate can be 
degraded completely by phytase to reduce iron binding by phytate, and phytases can be 
introduced exogenously to cereal preparations or native phytases can be activated 
(Kincaid et a l, 2005; Marero et a l, 1991). In contrast to cereals, some legumes have 
high phytate degradation at neutral or alkaline pH. Certainly, once phytate is degraded, 
legumes and cereals are good sources of iron as the content of these minerals are high 
(Sandberg, 2002).
Polyphenol is a group of chemical substances found in plants, characterized by 
the presence of more than one phenol unit and commonly present in many vegetables 
such as tea, coffee, cocoa products and red wine (Ramirez-Coronel et a l, 2004; 
Kuehnau, 1979). Consumption of total polyphenols is estimated at I g/day in adults 
(Ovaskainen et ah, 2008). Whether polyphenols can induce physiological effects in 
humans has been a subject of study and controversy for several decades. Studies using 
animal and in vitro models that try to identify the mechanisms of action of polyphenols 
in for example cardiovascular heart diseases (CHD), cancer, inflammation and 
neurodegenerative diseases, have led to a plethora of possible explanations of both 
beneficial and adverse effects of polyphenols (Stang et a l,  2007). However most o f the 
time, these studies do not give a conclusive answer on whether and how dietary 
polyphenols decrease disease risk and affect human health.
27
Ma et ah, (2006) has found that polyphenols bind to iron in the intestinal cells, 
forming a non-transportable complex in human Caco-2 cells suggesting that these 
compounds form insoluble complexes with iron and may exist as “iron-polyphenols 
complex” in the intestinal lumen and to prevent iron absorption (Beecher, 2003). The 
consumption of black tea and coffee has been shown to strongly inhibit iron absorption 
from composite meals (Morck et ah, 1983; Thankachan et ah, 2008), with coffee having 
about half the inhibitory effect of tea. Other beverages such as cocoa (Gillooly et ah, 
1984) and red wine (Cook et ah, 1995) have also been reported to inhibit iron 
absorption. Red wine polyphenols would appear to be less inhibitory than the phenolics 
of tea and coffee. The relative order of polyphenol content per cup of beverage follows 
the following order: black tea>coffee>cocoa>herbal teas. There is a reason to believe 
that in iron deficient individuals, drinking polyphenol-containing cocoa, tea or coffee 
beverages along with phytate-containing wheat-, rice- or maize-based meal may further 
compromise iron status. Iron absorption from other vegetables rich in polyphenols, such 
as spinach and aubergine, in man has also been shown to be low and a significant 
negative correlation between total polyphenol content of vegetable foods and absorption 
o f their iron content (Gillooly et a/., 1984; Akdogan et ah, 2004). Furthermore, 
consumption of polyphenols inhibits non-haem iron absorption and may lead to iron 
depletion in populations with marginal iron stores (Mennen et al, 2005).
1.6 The Formation of Free Radicals by Iron
As a chemical component of haem in haemoglobin, iron is capable o f carrying 
oxygen throughout the body. In healthy cells, iron ions are never found in a naked state, 
but are always tightly chelated, usually by proteins (McCord, 2004). If iron is being 
transported or stored it must be chelated in very specific ways that discourage redox
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cycling (e.g., by transferrin or ferritin). When iron is allowed to redox cycle (e.g., as in 
cytochromes or peroxidases), it is tightly held in the context of the protein’s active site 
(McCord, 2004). Free iron is a loose cannon, chemically. The levels of iron in the cell 
must be delicately balanced, and one of the most devastating actions of free redox-active 
iron within the cell is the initiation of lipid peroxidation (Balia et aL, 2003; McCord, 
2004), a free radical chain reaction between polyunsaturated fatty acyl groups in cell 
membranes and molecular oxygen. The unbound iron can result in an increase of free 
radicals, e.g. (Asare et aL, 2009). The most common disease o f free iron overload is 
haemochromatosis.
Eukaryotic cells continuously produce reactive oxygen intermediates (ROIs), a 
side product o f electron transfer. There are several major ROI species, including H2O2, 
superoxide and hydroxyl radicals (Liszkay et aL, 2004). The most dangerous among all 
ROI species is hydroxyl radical and it arises as a product of the reaction between 
superoxide and H2O2. The reaction is catalysed by Fe(II) and is named after the famous 
chemist as Fenton reaction (Crichton et a l, 2002).
In the first step o f the Fenton reaction hydrogen peroxide (H2O2) oxidises Fe(II) 
to Fe(III).
H2O2 + Fe(II) ► Fe(III) + HO ‘ + HO “ (Fenton Reaction)
This ferrous ion promotes the fission of the 0 -0  bond in peroxide to generate a 
hydroxyl anion and hydroxyl radical (Duesterberg et aL, 2008; Jia et aL, 2008).
The iron storage protein ferritin is responsible to protect cells from the 
potentially toxic effects of free iron by sequestering iron in a mineralized form within 
the protein for later use by the cell in the synthesis of haem (Eisendle et ah, 2006).
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1.7 Methods of Estimating Iron Bioavailability
The term “bioavailability” is defined as the proportion of an ingested food that is 
absorbed and utilized for normal physiological function or storage (Manach et al, 2004). 
Determination of mineral bioavailability is complicated in the fact that once a food is 
consumed, it mixes with other foods and minerals present in the gastrointestinal tract 
(Yun e/ a l,  2004). There are two ways o f estimating iron bioavailability, non-isotopic 
and isotopic methods which can be divided to several approaches.
1.7.1 Non-Isotopic Methods for Investigating Iron Bioavailability: Chemical 
Balance
This technique involved consumption of the test meal by the subjects for two 
weeks with a fecal marker to ensure that previous meals have been excreted from the 
gut, and then intake and excretion are measured for at least a week. The differences 
between the intake and the excretion of iron (from the intestine and urinary tract) will 
determine the actual iron being absorbed by the body. This method is insensitive, 
imprecise and time consuming because it cannot provide information on iron absorption 
from more than one diet at one time. This method was widely used prior to the 
introduction of radioisotope and stable isotopes for iron determination (Allen & 
Ahluwalia, 1997).
1.7.2 Non-Isotopic Methods for Investigating Iron Bioavailability: Haemoglobin 
and Ferritin Concentration
This technique requires the anaemic subject to consume an experimental diet 
containing iron. Any changes in body iron stores for more than 2-3 days, will give 
reflect in changes in haemoglobin and serum ferritin concentrations. Serum ferritin is 
more responsive to changes in iron body stores. This technique is suitable if the
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effectiveness of different simultaneous interventions is to be compared among 
population groups (Allen & Ahluwalia, 1997).
1.7.3 Isotopic Methods for Investigating Iron Bioavailability:
There are a number of isotopic methods that can be used to study iron 
bioavailability. Techniques currently used to assessing the bioavailability are 
summarized in Table 1.5. All the techniques listed involve radio- or stable-isotope labels 
to monitor the absorption and possibly to assess bioavailability of iron. The two most 
common radioisotopes of iron (^^Fe and ^^Fe) have been used extensively for human 
studies by intrinsically and extrinsically labelling of individual foods.
Table 1.5: Methods for assessing iron uptake (Fairweather-Tait, 2001).
Haemoglobin incorporation (radio- and stable-isotopes) 
Fecal monitoring (radio- and stable isotopes) 
Whole-body counting (^^Fe)
Plasma appearance/disappearance 
Caco-2 cell systems {in vitro)
Haemoglobin incorporation:
This method requires the test compound to be labeled with a radioisotope (eg. 
^^Fe or ^^Fe), fed to fasting individuals on one or more occasions and percentage 
incorporation into red blood cells measured 14 days after the last oral dose (Brise and 
Hallberg 1962). A comparison can be measured between two different sources of iron 
(^^Fe or ^^Fe) or between the test compounds (Fairweather-Tait, 2001).
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Faecal monitoring:
Iron in the meal that is not absorbed by the body will be excreted through faeces 
and the amount of iron can be monitored by this technique. The main problem with this 
technique is incomplete faecal collection due to longer transit time for certain people and 
is expensive because it requires the use of stable isotopes (Fairweather-Tait, 2001).
Whole body counting:
This is a gold standard for iron monitoring but it needs access to a whole-body 
counter and associated specialist techniques. The supplement given to the subjects must 
be labeled with the gamma-isotope, ^^Fe (Fairweather-Tait, 2001).
Plasma appearance/disappearance:
This technique requires information on the rate of removal o f iron from the 
plasma which can be obtained by giving an intravenous dose of a second iron isotope at 
the same time as the oral dose and monitoring its concentration in plasma (Fairweather- 
Tait, 2001).
1.8 The Utilization of Caco-2 TC7 Cells as a Tool to Study Iron Biovailability
It is expensive to do in vivo methods for the bioavailability studies because they 
require recruitment of volunteers who are already anaemic or who are made anaemic, 
which may create logistical and/or ethical problems. Over the past few decades, the cost 
of performing animal and human trials on iron bioavailability has limited progress not 
only for iron nutrition but also for other micronutrients as well. To overcome these 
problems, the development of an in vitro iron bioavailability model that simulates the 
intestinal digestion of humans using commercially available enzymes, coupled with 
culture of human intestinal epithelial cell (Caco-2) shows great promise as a rapid and 
cost-effective tool in addressing iron bioavailability issues (Yun et aL, 2004).
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Caco2 cells have been used for many nutrient uptake studies including cellular 
uptake of lipid metabolites using a differential monolayer of the Caco-2 cells (Tsuzuki,
2007), flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma 
cells (Caco-2) (Salucci et ah, 2002) and uptake of quercetin and quercetin 3-glucoside 
from whole onion and apple peel extracts by Caco-2 cell monolayers (Boyer et aï., 
2004).
The Caco-2 cell-line is derived from human colon adenocarcinoma lines that 
display characteristics of small intestine enterocytes. These cells spontaneously 
differentiate into a polarized monolayer and well-developed brush borders to exhibit 
many of the morphological and biochemical characteristics of enterocytes (Pynaert et 
ah, 2006).
Caco-2 cell is a useful tool for studies of intestinal human iron uptake (Han et ah, 
1995). Caco-2 TC7 cells have recently been shown to express DMTl in the apical 
membrane, with a substrate preference for iron and transport occurring by a proton- 
dependent mechanism (Tandy g/ ah, 2000; Sharp, 2005).
Caco-2 TC7 cell was known to be cloned in 1994 from early and late passage of 
Caco-2 cells. Caco-2 cells from passage 29 and 198 were cloned by the limited dilution 
technique. Cloned from early and late passage were named P (for precoce, i.e. early) and 
T (for tardif, i.e. late) respectively. From 26 clones isolated, only four were selected for 
further analysis on the basis of differences in the level of sucrase activity. Caco-2 TC7 
cell has been shown to outperform other clones in term of sucrase activity in cell 
homogenates and brush border-enriched fractions, dipeptidyl peptidase (DPP-IV) 
activity in cell homogenates, villin, glycogen content in post-confluent (day 2 0 ) and 
glucose consumption in the cell homogenates (day 2 0 ).
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Since several dietary components may limit the uptake of iron, it is important to 
further investigate the strength of this limitation. Although Caco-2 cell has been used to 
determine the effect of dietary components on iron uptake study since the mid 90’s, the 
cell-mediated reduction of iron and the kinetic mechanism involved are still the subject 
of dispute. This study will likely reveal the true character of these mechanisms.
1.9 Hypothesis
There is a significant difference in the effect of dietary components on iron 
uptake and iron reduction in Caco-2 TC7 cells.
Enhancers of iron will significantly increase the amount of iron uptake and iron 
reduction in Caco-2 TC7 cells, and inhibitors of iron will significantly decrease the 
amount of iron uptake and iron reduction in Caco-2 TC7 cells.
1.10 Aims
The aims o f this study are:
• To characterize the influence o f dietary components particularly ascorbate, 
P-carotene, zinc and phytate on iron uptake and their effect on the expression of 
iron transporter DMTl and Iregl by Caco-2 cells.
• This study will also examine whether cell-mediated reduction of Fe(III) to Fe(II) 
is required for acquisition o f iron in the absence o f an exogenous reductant.
• Furthermore, their kinetic mechanisms on iron uptake will also being 
determined.
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2.0 Materials and Methods
2.1 Caco-2 TC7 cells
Caco-2 TC7 cells were obtained from from Drs. Monique Rousset and Edith 
Brot-Laroche, Paris and maintained in 25 cm^ plastic flasks (Fisher Scientific, UK). The 
cells were grown in Dulbecco’s Modified Eagle Medium (DMEM)(Invitrogen Corp., 
UK), supplemented with 20% v/v fetal calf serum (Invitrogen Corp., UK), 1% v/v non- 
essential amino acids (Invitrogen Corp., UK), 1% v/v antibiotic antimycotic (penicillin- 
streptomycin) solution (Invitrogen Corp., UK) and 1% v/v L-glutamine (Invitrogen 
Corp., UK). The cells were maintained at 37°C in an incubator (Galaxy B, Sci. Lab. 
Supplies Ltd, UK) with 5% carbon dioxide (CO2), 95% air atmosphere at constant 95% 
relative humidity, and the medium was changed every 2 days. At 90% confluence the 
cells were rinsed with phosphate-buffered saline solution (PBS) (8  g/L NaCl (BDH, 
England), 0.2 g/L KCl (Fisher Scientific, UK), 0.91 g/L Na2HP0 4  (Fisher Scientific, 
UK), 0.20 g/L H2KPO4 (Fisher Scientific, UK) and dissociated using 2-3 ml o f trypsin- 
EDTA solution (2.5 g/L trypsin (Invitrogen Corp., UK), 0.2 g/L EDTA (Sigma Aldrich, 
UK) at 37°C for 5 minutes. Then, the cells were centrifuged at 830x g for 5 minutes 
using a centrifuge (Sigma 6KI0, Germany). The supernatants were discarded and the 
cell pellet was resuspended in 5-10 mL DMEM. The cells were counted by pipetting 20- 
100 pi onto a haemacytometer slide. The cells were then reseeded at a density of 40,000 
cells/cm^ in collagen-treated six-well cell culture plates (Costar Corp., Cambridge, MA 
USA). The cells were used in the iron uptake experiments at 14-21 days post-seeding. At 
this stage, the amount of cell protein measured in each well was found to be highly
consistent from well to well within each culture plate (Yun et a l, 2004).
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2.2 MTT Cell Proliferation Assay
The MTT (3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay 
is commonly used to measure of cell viability and proliferation (Ahmad et al., 2006). 
Adherent cells were dissociated from their substrate by trypsinization or scraping. Then, 
the cells were centrifuged at 830 x g for 5 minutes. The supernatants were discarded and 
the cell pellet was resuspended in DMEM at a density of 20,000 cells/cm^ into a 96-well 
plate (Costar Corp., Cambridge, MA USA). The cells were then incubated overnight in 
an incubator with 5% carbon dioxide (CO2), 95% air atmosphere, 95% relative humidity 
at 37°C. The next day, the medium was changed to medium-free FBS (Invitrogen Corp., 
UK) following exposure to (or treatment with) the compound at the required 
concentrations, and the cells incubated for 15 minutes or 24 hours, depending on the 
type of experiments needed. MTT reagent (ATCC, USA) at a concentration o f 5 mg/ml 
and a volume of 10 pi added to each well and the plate returned to the incubator for 3-4 
hours. Periodically, the cells were viewed under an inverted microscope for the presence 
of intracellular punctuate purple precipitate. When the purple precipitate was clearly 
visible, a further period of incubation, the medium was aspirated from the wells as 
completely as possible without disturbing the formazan crystals and cells on the plastic 
surface. A 200 pi volume of dimethyl sulfoxide (DMSO) (Sigma Aldrich, UK) was 
added to each well, the plates agitated on a plate shaker for 5 min and the optical density 
then read at 570 nm. The number of surviving cells is directly proportional to the level 
of the formazan product created (Van de Loosdrecht et al., 1994).
The absorbance value for the blanks should be 0.00±0.1 optical density (O.D)
units. The absorbance range for untreated cells should typically be between 0.75 and
1.25 O.D. units. Selection of a cell number (i.e. providing values between the range of
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0.75 and 1.25) allows for the measurement of both stimulation and inhibition of cell 
proliferation. If the absorbance values of the experimental samples are higher than the 
control, this indicates an increase in cell proliferation. Alternatively, if the absorbance 
rates of the experimental samples are lower than the control, this indicates a reduction in 
the rate of cell proliferation or a reduction in overall cell viability.
2.3 Ferric Reduction Assay
Ferric reduction assay was quantified via the spectrophotometric measurement of 
Fe(II)-bathophenanthrolinedisulfonic acid (BPDS) (Sigma Aldrich, UK) production 
(Michelle et aL, 1999). For all assays, samples were compared to a reference blank 
containing all the reaction mixture components except FeClg with the same buffer. 
Blanked absorbance values were compared to a standard curve generated with F ed ]. 
The amount of Fe(II) produced was determined based on the concentration of FeCL 
used.
Approximately 700 pi of assay solution consisted of PBS [8 g/L NaCl, 0.2 g/L 
KCl, 0.91 g/L Na2HP0 4 , 0.20 g/L H2KPO4] and Fe(III) (Sigma Aldrich, UK) with a 
strength in the range of 0-30 pM Fe(III) was added to wells containing 21 day post­
confluent cultures of Caco-2 cells and incubated for 15 minutes at 37°C. The assay 
solution was then collected and placed on ice to stop the reaction. Then, 500 pi of 2 mM 
BPDS was added to the assay solution and incubated in a waterbath (Grant N 14, UK) for 
1 h at 37°C. Cell-mediated reduction of Fe(III) was assessed by measuring the 
concentration of Fe(II)-BPDS complex. It binds Fe(II) and forms Fe(II)-(BPDS), a pink- 
red complex that can be measured spectrophotometrically at 534 nm (Kontrol 
Instrument, Zurich). An aliquot of identical solution from assay medium containing no
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Fe(III) was used as a blank. Results were expressed as Fe(Il) formation (pmol) where the 
average value for the blank was subtracted from the average values from triplicate 
readings. The results were quantified using SPSS version 8 software based on at least 
three independent experiments. All data were shown as mean ± SEM and analysed by 
paired Student’s t test.
2.4 Iron Uptake Studies in Caco-2 TC7 Cells
For the purpose of iron uptake studies, the Caco-2 cells were grown on transwell 
plates for 21 days. The culture medium was removed before adding 2 ml o f uptake 
buffer (140 mM NaCl (BDH, England), 5 mM KCl (Fisher Scientific, UK), 1 mM 
NaH2P0 4  (Fisher Scientific, UK), 10 mM Mes (Sigma Aldrich, UK), 0.5 mM of MgCL 
(Sigma Aldrich, UK), 1.0 mM CaCL (Sigma Aldrich, UK), pH 6.0) and incubated for 
37°C for 2 min. Later, 150 pi of Fe(III) in a strength range of 0-30 pM, 150pl of 
treatment compounds at a different strength range and 60 kBq of radioactive iron ^^Fe 
(REVISS serv., UK) were added into each well before placing the cells for another 15 
min in the incubator at 37°C. Then the buffer was aspirated and cells were rinsed with 
cold buffer for three times before adding 1 ml of 200 mM NaOH (BDH, UK) to 
solubilise the cells and left overnight at 4°C. After an overnight incubation at 4°C, the 
cells were subsequently removed and placed in a scintillation tube before adding liquid 
scintillation cocktail at 5 ml. Then, the intracellular ^^Fe was determined by scintillation 
counting using the standard setting for ^^Fe (Johnson et al., 2005).
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2.5 Isolation of Whole Cell and Membrane Proteins
2.5.1 Whole Cell Protein Isolation
Cells were grown for 21 days post-confluence, then washed with PBS and 
scraped with a sterilized scraper in ice-cold homogenization buffer (50 mM manitol 
(Sigma Aldrich, UK), 10 mM HEPES (Sigma Aldrich, UK), 0.5 mM PMSF (Sigma 
Aldrich, UK), 0.2 mM benzamidine (Sigma Aldrich, UK), 0.02% sodium azide (Sigma 
Aldrich, UK), pH 7.2). After that, the sample was homogenized by passing through 25- 
gauge (orange) needle for 30 times and aliquots of this whole-cell protein sample stored 
at -20°C until required (Johnson et al., 2005).
2.5.2 Membrane Protein Isolation
The whole-cell protein homogenate was used to prepare a membrane protein 
sample. A J2-21 centrifuge (Beckman, US) with JA-17 rotor was used to centrifuge the 
homogenate at 1500 xg (3,400 rpm) for 15 minutes. The supernatant was collected and 
re-centrifuged at 20,000 x g for 30 minutes. The pellet was resuspended in 200 pi 
resuspension buffer (300 mM mannitol, 10 mM HEPES, 0.5 mM PMSF, 0.2 mM 
benzamidine, 0.02% sodium azide, pH 7.2) and stored at -20°C until required.
2.6 Protein Assay
The Bradford method with BioRad dye was used to determine the protein 
concentrations of the whole-cell protein homogenates (Section 2.5.1) and membrane 
protein preparations (Section 2.5.2). The Bradford protein assay is a simple procedure 
for determination of protein concentrations in solutions that depends upon the change in 
absorbance in Coomassie Blue G-250 upon binding of protein (Bradford, 1976).
The ready-to-use dye reagent (BioRad, UK) was diluted 1:5 with reverse osmosis
water.
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The concentrations o f standard were prepared from bovine serum albumin (BSA)
(Sigma Aldrich, UK) from 1 mg/ml stock solution into assigned wells of a 96-well plate.
The samples (whole cell proteins and membrane proteins) were pipetted up to 20 pi into
individual wells. Then, 40 pi of the dye reagent was added and the absorbance was
recorded by using the spectrophotometer at 575 nm. The absorbance of each tube (y-
axis) was plotted against the protein mass in pg (x-axis) and a straight line drawn
through the points. The amount of protein in the unknown wells was determined by its
absorbance and comparison to the standard protein curve. The concentration of the
solution is calculated by the following equation:
Concentration of unknown = mg of protein determined by assay/0.1 ml
2.7 Western Blot Analysis for DMTl, Iregl, Villin and Beta Actin
Western blotting was used to study the effect of dietary components on the
transporter proteins levels. Whole cell protein samples (50 pg total protein) and
membrane protein (20 pg total protein) in sample buffer (2M dithiothreitol (DTT)
(Sigma Aldrich, UK), 250 mM Tris (Sigma Aldrich, UK), 10% sodium dodecyl sulphate
(SDS), 50% glycerol (Sigma Aldrich, UK) and 0.5% bromophenol blue (BDH,
England), pH 7.2) were loaded onto a 10% SDS-PAGE and run at 25 mA for 45
minutes. Then, samples were transferred from the gel onto a pre-soaked nitrocellulose
membrane (Hybond ECL, Amersham, Buckinghamshire, UK), using a wet blotter set at
100 mA per gel overnight. The nitrocellulose was pre-soaked in transfer buffer (40 mM
glycine (Sigma Aldrich, UK), 48 mM Tris, 1.3 mM SDS, 20% methanol (Fisher
Scientific, UK), pH 8.3). Then, the nitrocellulose was blocked in 5% PBS-T [5% fat-free
milk (Marvel milk, UK), 0.1% Tween 20 (Sigma Aldrich, UK) in PBS] for 1 hour. Then,
it was briefly washed twice with PBS-T and incubated with a rabbit antiNramp2 as the
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primary antibody at 1:500 dilution (Santa Cruz Biotechnology, USA) for 1 hour. After 3 
X 15 minute washes in PBS-T the membrane was exposed to the appropriate secondary 
antibody which is goat anti-rabbit Nramp2 conjugated to horseradish peroxidase at a 
1:1000 dilution (Santa Cruz Biotechnology, USA) for 45-60 min. Mouse monoclonal 
antibodies, anti-villin (Santa Cruz Biotechnology, USA) and anti-beta actin (Santa Cruz 
Biotechnology, USA) were used as the primary antibody for villin and beta actin, 
respectively. Goat anti-mouse horseradish peroxidase-conjugated IgG (Santa Cruz 
Biotechnology, USA) was used as the secondary antibody. Both the primary antibody 
and the secondary antibody for villin (Santa Cruz Biotechnology, USA) and p-actin 
(Santa Cruz Biotechnology, USA) were at a 1:1000 dilution.
The samples were then washed 3 x 1 5  min. with PBS-T. Cross reactivity were 
visualized using enhanced chemiluminescence (ECL Plus) (Amersham Bioscience, UK) 
and the detection of protein was performed with the Amersham minicamera.
The relative band intensity was assessed by densitometric analysis o f digitalized 
autoradiographic images using Scion Image software (Scion Corporation, USA) and 
standardized against the amount of p-actin.
2.8 Measurement of pH
A litmus paper was used to measure the pH of the growth medium in the cell 
culture plate. This method employs special strips of paper that change colour based on 
the pH of a sample solution. These strips of paper can measure the difference 0.2-0.3 pH 
in a sample. Litmus paper changes colour based on whether the sample solution is acidic 
or basic, turning red or blue, respectively.
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2.9 Statistical Analysis
Data were analysed with Student’s unpaired t-test using Microsoft Excel and by 
one-way ANOVA using SPSS version or GraphPad PrismS. Values of p<0.05 were 
considered significant.
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3.0 Investigating the Effect of Dietary Components on
Non-Haem Iron
3.1 Introduction
Dietary iron can be classified as either haem or non-haem iron. The distinction 
between non-haem and haem iron is significant because each type of iron is absorbed in 
different ways and to different extents (Yanatori et a l, 2010). Non-haem iron is not as 
well absorbed as haem iron, and its absorption rate is influenced by dietary factors and 
physiological requirements. Dietary components can have a significant effect on iron 
absorption, and several essential nutrients found primarily in fruits and vegetables have a 
pronounced effect on iron absorption studies. The exact nature o f the enhancing and 
inhibiting factors of these dietary components has not been positively identified and, 
since there is a distinction between haem and non-haem dietary iron, it is expected that 
not all dietary components will have the same effect on the absorption rate of these two 
types of iron. In this-chapter the influence of several most common and important 
dietary components on iron uptake will be investigated.
3.2 Aims and Objectives
The purpose of these experiments was to evaluate the effects of different dietary 
components on non-haem iron uptake and on the main non-haem iron transporter, 
DMTl.
The specific objectives for this chapter are to study the effect o f organic acids 
(citric, propionic, tartaric and succinic acid), amino acids (alanine, cysteine, proline, 
arginine, asparagine and histidine), ascorbate, p-carotene, vitamin E, phytate and 
polyphenols (rutin and catechin) on iron uptake. Also, to study the effect o f the 
respective organic acids, amino acids and polyphenols on membrane and whole cell
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DMTL Lastly, to study the effect o f all the selected dietary components on Caco-2 TC7 
cell viability.
3.3 Time Course of Iron Uptake by Caco-2 TC7 Cells Following Addition of 10 
pM  FeC13
Fig. 3.1 shows the rate of iron uptake in Caco-2 TC7 cells. In the absence o f any 
dietary components, iron uptake increased linearly over time in Caco-2 TC7 cells for up 
to 2 hours incubation time.
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Fig. 3.1: Rate of Iron Uptake. Cells were treated with 10 pM FeCl] and 
exposed to ^^FeClg for up to two hours just prior to the uptake study. Iron taken 
into the cell was measured by scintillation counting. Values are given as 
pmol/h/well (Mean ± SEM) for four independent biological determinations.
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3.4 The Influence of FeCb Concentration on Iron Uptake in Caco-2 TC7 Cells 
Rationale:
Iron absorption in the human body takes place most importantly through the 
small intestine. In this study Caco-2 TC7 cells were used because these cells have been 
used as a model system to study intestinal absorption and transportation (Tandy et a/., 
2000; Reboul et al., 2005). It has been reported that iron uptake by Caco-2 TC7 cells 
depends on the amount of iron available under the cell culture conditions. A prior 
selection o f the optimal concentration is necessary before further investigation on iron 
uptake commence.
Result:
In this study, Caco-2 TC7 cells were treated with different concentrations of 
Fe(III) in the form of FeCL before a test dose of radioactive iron was added at 
appropriate intervals. Fig. 3.2 shows the uptake of iron in response to increasing 
concentrations of Fe(III) being added to the system. In the absence of added dietary 
components, iron uptake was maximal at 500 pmol/h (Fig. 3.2A). However, all 
subsequent experiments were performed with 100 pM or less concentration of Fe(III) 
because this is within the range o f the normal iron status in the human body (Fleming & 
Bacon, 2005). Approximately 50% of the iron was taken up by the cells at 10 pM Fe(III) 
concentration (Fig. 3.2B).
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Fig. 3.2C shows that the reciprocal plot reached linearity with increasing 
concentrations of Fe(III) in the media.
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Fig. 3.2C: Effect of adding Fe(III) on the Uptake of ^^Fe into Caco-2 TC7 
cells. Data from the same experiment as in Fig. 3.2B are plotted as 1/V vs. l/[Fe]. 
The data were fitted to a hyperbolic equation (v =[S] x Vmax/(Km + [S]), as 
indicated by the solid lines.
3.5 Villin and DM Tl Protein Expression in Caco-2 TC7 Cells 
Rationale:
Caco-2 cells were defined as a cell population characterized by the ability to 
spontaneously undergo the differentiation process toward a "normal" intestinal 
phenotype in long-term culture after post-confluence (Sambuy et al., 2005). It is well 
known that cell culture conditions such as composition o f the medium and culturing 
systems, as well as passage numbers, have tremendous effects on Caco-2 cells in terms
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of differentiation and transport properties (Sambuy et al., 2005). It has been noted 
elsewhere that the characterization o f the Caco-2 TC7 subclone during the transition 
from a proliferative to a fully differentiated (Yamaji et ai, 2001) is associated with the 
expression of wide range of proteins (Siissalo et al., 2007) and in this study is associated 
with an increase in the expression o f the brush border membrane structural protein, 
villin, and DMTl over a certain period of time.
Result:
Figure 3.3 shows that the intestinal-specific marker protein villin had increased 
throughout the experimental period.
The expression of DMTl protein was low in the proliferating cells (Day 7) and 
was high in the differentiated cells (Day 21) (Fig. 3.4).
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Fig. 3.3: Differentiation of Intestinal Epithelial Cells of the Structural 
Protein, Villin. Whole cell protein samples were taken and subject to Western 
blotting. Band density was measured using Scion Image software. Values are 
expressed as Mean ± SEM of three independent biological determinations.
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Fig. 3.4: Differentiation-Dependent Regulation of D M Tl Expression in Caco- 
2 TC7 Cells. Whole cell protein samples were taken and subject to Western 
blotting. Band density was measured using Scion Image software. Values are 
expressed as Mean ± SEM of three independent biological determinations.
3.6 Expression of DM Tl a t Different Concentrations of Fe(III)
Result:
Using DMTl isoform-specific antibodies, following exposure to iron for 24 
hours, there was a significant decrease in membrane protein DMTl levels at different 
concentrations of Fe(III) compared to the control. Interestingly, whole cell DMTl levels 
were unaltered compared to the control (Fig. 3.5 and Fig. 3.6).
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Fig. 3.5: The Influence of Fe(III) Concentration on Membrane DM Tl Levels.
Cells were treated for 24 hours with three different concentrations of Fe(III). 
Membrane protein samples were taken and subject to Western blotting. Band density 
was measured using Scion Image software. Values are expressed as Mean ± SEM of 
three independent biological determinations. ^Significant difference from control 
p<0.05 (one-way ANOVA).
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Fig. 3.6: The Influence of Fe(III) Concentration on Whole Cell DM Tl 
Levels. Cells were treated for 24 hours with three different concentrations of 
Fe(III). Whole cell protein samples were taken and subject to Western blotting. 
Band density was measured using Scion Image software. Values were expressed 
as Mean ± SEM of three independent biological determinations.
3.7 Time Course Effect of Iron Treatm ent on D M Tl Protein 
Result:
Western blotting determined that there was a significant decrease in DMTl 
expression at the apical surface of Caco-2 cells. The decrease in transporter expression 
was maximal by three hours and remained low in the presence of iron for the remainder
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of the experimental period. In contrast, total cellular DMTl, measured by Western 
blotting of whole-cell homogenates was unaltered by iron-treatment (Fig. 3.7 and Fig. 
3.8).
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Fig. 3.7: Time Course of Iron-induced Changes on Whole-Cell DMTl levels.
Cells were treated for 0 min to 24 hours with 100 piM FeCb. Whole cell protein 
samples were taken and subject to Western blotting. Band density was measured 
using Scion Image software. Values were expressed as Mean ± SEM of three 
independent biological determinations. Statistical analysis was performed using 
one-way ANOVA. p<0.05.
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Fig. 3.8: Time Course of Iron-Induced Changes in Membrane DMTl Levels.
Cells were treated for 0 min to 24 hours with 100 jiM FeCb. Membrane protein 
samples were taken and subject to Western blotting. Band density was measured 
using Scion Image software. Values were expressed as Mean ± SEM of three 
independent biological determinations.
3.8 DMTl Recovery Period Following Exposure to Iron 
Rationale:
As a metal transporter, DMTl function is critical in stabilizing the condition of 
metal available in the medium (Andolfo et ah, 2010). Exposure to iron for a certain 
period of time may result in changes in the expression of DMTl. Several investigators
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had reported this phenomenon (Yeh et aî., 2000; Oates et aL, 2000) and in this study a 
detailed examination of expression of these genes and consider the importance of 
luminal iron was conducted in modulating the response of the intestine to variations in 
systemic iron requirements.
Result:
Fig. 3.9 shows the expression of DMTl following 24 hours of exposure to iron at 
10 pM concentration. Cells were treated with FeClg for three hours before iron-free 
medium was introduced to the cells. The DMTl density decreased rapidly following a 
blocking dose of iron, from control levels of 70 absorbance unit (a.u) to a minimum of 
33 a.u within 3 hours. The DMTl density increased gradually after this time point before 
recovering to near control levels by three hours. This was a transient decrease and 
showed that the DMTl might be recycled back to near control levels by 3 hours.
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Fig. 3.9: Recovery of DMTl at the M embrane Plasma Following Exposure to 
Iron. Cells were treated for 3 hours with . 100 pM FeCls (protein samples were 
isolated before ( - 3 h) and after iron treatment (0 h). After 3 hours iron pre­
treatment, cells were placed in iron free medium for 24 hours. Membrane protein 
samples were taken and subject to Western blotting at every time points up to 24 
hours. The line refers to the DMTl levels over 24 hours iron exposure. Band 
density was measured using Scion Image software. Values were expressed as 
Mean ± SEM of three independent biological determinations.
3.9 Investigating the Effects of Dietary Components on Cell Viability in Uptake 
Buffer 
Rationale:
Various dietary components will have different effects on Caco-2 cell viability. 
This is the first step in looking at the suitability of the components for further use in iron 
uptake study. The effects on cell viability can be seen through colour changes in the
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formazan added to the medium. Cells with active mitochondria will react with the 
formazan, changing it to a blue colour after several hours of incubation.
Result:
The selected dietary components used for this study had no significant effect on 
cell viability compared to the control, which contained all the chemical components 
except the test compounds (Fig. 3.10). All the components showed less than 15% cell 
death compared to the control after 24 hours incubation times.
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Fig 3.10: The Effects of Dietary Components on Cell Viability. This cell 
viability analysis was measured by MTT assay 24 hours after adding up to 1000 
pM of selected compounds in uptake buffer. Results are expressed as Mean ± 
SEM for at least four independent biological determinations.
3.10 Investigating the Effect of Amino Acids on Iron Uptake
The solubility of iron in intestinal cells is affected by the ingredients in foods or 
meals. (Lynch, 1997). Meat, fish, and poultry have been demonstrated many times to 
enhance non-haem iron absorption, especially from cereal- and legume-based meals 
(Hurrell et al., 2006). Hence, proteins are of considerable interest in studies of iron
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uptake in intestinal cells. Since Caco-2 cell monolayers exhibit transport properties 
similar to intestinal epithelia (Cattoor et aL, 2010), the effects o f amino acids and 
dipeptides on iron uptake by these cells provides a good model system for intestinal 
epithelium cells.
Amino acids can be divided into several groups and each group exhibits different 
reactions in iron uptake. Depending on its polarity, amino acids can be categorized as 
hydrophilic or hydrophobic.
Result:
Non-polar amino acids (alanine and proline) were found to increase iron uptake 
in Caco-2 cells from the medium (Fig. 3.11). At 20 pM concentration of alanine, and 
proline in the medium, iron uptake was significantly higher (p<0.05) than the controls, 
with the effect of proline on iron uptake was the most profound. At the lowest 
concentration of alanine and proline tested, which was 20 pM, iron uptake was 1.6-fold 
and 1.9-fold higher compared to control, respectively.
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Fig. 3.11: Alanine, Arginine, Asparagine, Cysteine, Histidine, Lysine and 
Proline Enhance Iron Uptake in Caco-2 TC7 cells in a Dose-dependent 
Manner. Cells were incubated with different concentrations of amino acids and 
FeCls exposed to ^^FeCls for 15 minutes just prior to the uptake study. Iron taken 
into the cell was measured by scintillation counting. Iron uptake was measured 
after removing loosely bound ^^Fe from the cell surface by multiple washings 
with ice-cold buffer.
The polar amino acids arginine, asparagine, cysteine and histidine also increased 
iron uptake into Caco-2 cells (Fig. 3.11). All of the three tested amino acids significantly 
increased iron uptake in the medium compared to the control (p<0.05). The effect of 
cysteine was the most profound than the others. At the lowest concentration of argine, 
asparagine, cysteine and histidine tested, which was 20 pM, iron uptake was increased 
by 1.9-fold, 2.0-fold, 2.7-fold and 1.8-fold higher compared to the control, respectively.
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3.11 Investigating the Effect of Organic Acids on Iron Uptake 
Rationale:
Iron in the unchelated form of Fe(III) is only soluble at acidic pH (pH < 4) and 
will precipitate out of solution at higher pH levels unless it can form a complex with 
other compounds to remain in a dissolved state. Compounds that can form soluble 
complexes with Fe(III) include organic acids (Hazel 1 & Johnson, 1987), which was 
investigated in further detail here by determining the dose-dependent effect of selected 
organic acids on iron uptake in Caco-2 cells, based on their chemical structural 
classifications. Organic acids can be divided into four groups. Group A consists o f three 
carboxyl groups such as citric acid. Group B consists of monocarboxylic acids such as 
propionic acid. Group C consists of four carbon dicarboxylic acids with hydroxyl groups 
such as tartaric acid. And Group D consists of four dicarboxylic acids with no hydroxyl 
groups such as succinic acid (Ryan & Delhaize, 2001; Chen et ah, 2008).
Result:
In this study, the lowest concentration of organic acids used was at 10 pM based 
on the finding by other researchers which found organic acids displayed a moderate 
effect on iron uptake at the concentration below 1 mM (1000 pM) (Salovaara et ah, 
2003, Ren et aL, 2009). At the lowest citric acid concentration tested (10 pM), iron 
uptake was 2.6-fold higher compared to the control (Fig. 3.12).
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Fig. 3.12: Citric Acid, Propionic Acid, Tartaric Acid and Succinic Acid 
Enhance Iron Uptake in Caco-2 TC7 Cells in a Dose-dependent M anner.
Cells were incubated with different concentrations of organic acid and FeClg 
exposed to ^^FeClg for 15 minutes just prior to the uptake study. Iron taken into 
the cell was measured by scintillation counting. Iron uptake was measured after 
removing loosely bound ^^Fe from the cell surface by multiple washings with 
ice-cold buffer.
There was a significant increase in iron uptake with added propionic acid in the 
medium compared to the control (p<0.05) (Fig. 3.12). At 10 pM concentration tested, 
iron uptake was 130 pmol/h compared to the control at just under 80 pmol/h.
The effect of tartaric acid on iron uptake was noteworthy. There was a threefold 
increase when lOpM concentration of tartaric acid was added to the medium. At 100 pM 
concentration, the uptake was increased eightfold compared to the control (Fig. 3.12).
At 10 pM concentration of succinic acid tested, there was a 2 fold increase in 
iron uptake compared to the control (75 pmol/h to 160 pmol/h) (Fig. 3.12). Increasing
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concentration of succinic acid in the medium significantly augmented iron uptake in 
Caco-2 TC7 cells.
Furthermore, the source of organic acids did not affect pH of the medium (Table
3.1).
Table 3.1: Changes in pH with time after adding different types of organic acids 
at lOOpM concentration in the medium.
Types of 
organic acid
Time (min)
0 5 10 15
Citric 6 6 6 6
Propionic 6 6 6 6
Tartaric 6 6 6 6
Succinic 6 6 6 6
3.12 Investigating the Effect of Aseorbate on Iron Uptake 
Result:
At 10 pM concentration of aseorbate, there was more than 2-fold increase in iron 
uptake compared to the control (Fig. 3.13). At the highest aseorbate concentration used 
(100 pM) hiThe study, there was 14-fold increase in iron uptake compared to the control.
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Fig. 3.13: Aseorbate Enhances Iron Uptake in Caco-2 TC7 Cells in a Dose- 
dependent M anner. Cells were incubated with different concentrations of 
aseorbate and FeCl] exposed to ^^FeClg for 15 minutes just prior to the uptake 
study. Iron taken into the cell was measured by scintillation counting. Iron uptake 
was measured after removing loosely bound ^^Fe from the cell surface by multiple 
washings with ice-cold buffer. Means without common letters in their
superscript are significantly different (p<0.05).
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3.13 Investigating the Effect of p-carotene on Iron Uptake
Result:
Fig. 3,14 shows the influence of p-carotene on iron uptake in Caco-2 cells. There 
was an increase in iron uptake following the addition of p-carotene up to 30 pM 
concentration (p<0.05). However, p-carotene at higher concentrations appeared to have 
an inhibitory effect (Fig. 3.14).
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Fig. 3.14: p-Carotene Enhances Iron Uptake by Caco-2 TC7 Cells. Cells were 
incubated with different concentrations o f p-carotene and FeClg exposed to ^^FeCb 
for 15 minutes just prior to the uptake study. Iron taken into the cell was measured 
by scintillation counting. Iron uptake was measured after removing loosely bound 
 ^ Fe from the cell surface by multiple washings with ice-cold buffer. ®
Means without common letters in their superscript are significantly different (p < 
0.05).
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3,14 Investigating the Effect of Phytate on Iron Uptake
Result:
Fig. 3.15 shows the influence of phytate on iron uptake in Caco-2 cells. 
Increasing phytate concentration significantly decreases iron uptake by up to 80% when 
compared to the control (p<0.05).
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Fig. 3.15: Phytate Inhibits Iron Uptake in Caco-2 TC7 Cells in a Dose- 
dependent M anner. Cells were incubated with different concentrations of 
phytate and FeClg exposed to ^^FeCb for 15 minutes just prior to the uptake study. 
Iron taken into the cell was measured by scintillation counting. Iron uptake was 
measured after removing loosely bound ^^Fe from the cell surface by multiple 
washings with ice-cold buffer. ® Means without common letters in their
superscript are significantly different (p<0.05).
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3.15 Investigating the Effect of Vitamin E on Iron Uptake
Result:
Fig. 3.16 shows the influence of vitamin E on iron uptake in Caco-2 cells. Five 
difference concentrations of vitamin E were used but none of the concentration added 
into the uptake media showed any significant effect on iron uptake (p>0.05).
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Fig. 3.16: Vitamin E Enhances Iron Uptake in Caco-2 TC7 Cells. Cells were 
incubated with different concentrations of vitamin E and FeCl] exposed to 
^^FeCl) for 15 minutes just prior to the uptake study. Iron taken into the cell was 
measured by scintillation counting. Iron uptake was measured after removing 
loosely bound ^^Fe from the cell surface by multiple washings with ice-cold 
buffer.
65
3.16 Investigating the Effect of Polyphenols on Iron Uptake
Result:
Only two types of polyphenols were used in this study, rutin and catechin. 
Contrary to what one might expect, both compounds showed slightly higher uptake of 
iron in Caco-2 TC7 cells (p<0.05). At the lowest concentration used (10 pM), uptake 
increased by more than 50% relative to the control and further increases were observed 
at higher levels (Fig. 3.17A & Fig. 3.17B).
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Fig. 3.17A: Catechin Enhances Iron Uptake in Caco-2 TC7 Cells. Cells were 
incubated with different concentrations of catechin dihydrate and FeCb exposed 
to ^^FeCls for 15 minutes just prior to the uptake study. Iron taken into the cell 
was measured by scintillation counting. Iron uptake was measured after removing 
loosely bound ^^Fe from the cell surface by multiple washings with ice-cold 
buffer.  ^Means without common letters in their superscript are significantly 
different (p<0.05).
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Fig. 3.17B: Rutin Enhances Iron Uptake in Caco-2 TC7 Cells. Cells were 
incubated with different concentrations of rutin and FeCb exposed to ^^FeCb 
for 15 minutes just prior to the uptake study. Iron taken into the cell was 
measured by scintillation counting. Iron uptake was measured after removing 
loosely bound ^^Fe from the cell surface by multiple washing with ice-cold 
buffer.  ^ Means without common letters in their superscript are
significantly different (p<0.05).
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3.17 Investigating the Effect of Amino Acids, Organic Acids and Polyphenols on 
the Expression of Membrane DMTl Levels 
Rationale:
DMTl is a divalent cation transporter that plays a key role in iron metabolism by 
mediating Fe(III) uptake across the small intestine. In addition to uptake study, using the 
same model system, the ability of the amino acids, organic acids and polyphenols on the 
expression of membrane DMTl were studied.
Result:
The concentrations of all amino acids are quantitatively identical to avoid bias in 
these studies. All the tested amino acids, with the exception of asparigine, significantly 
reduced (p<0.05) the expression of DMTl in plasma membranes of Caco-2 TC7 cells 
(Fig. 3.18). Cysteine was found to be the most effective amino acid with a greater than 
50% reduction in membrane DMTl levels, whereas alanine, arginine, histidine, lysine 
and proline reduced membrane DMTl levels by almost 30% as compared to the 
controls.
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Fig. 3.18: The Effect of Added Amino Acids on M embrane D M Tl Levels. 
Cells were treated for 24 hours with 2 pM amino acid. Membrane protein 
samples were taken and subjected to Western blotting. Band density was 
measured using Scion Image software. Values are expressed as Mean ± SEM 
of 3 independent biological experiments. *Significantly different from control 
(p<0.05).
Fig. 3.19 shows the effect of organic acids added to the medium on membrane 
DMTl levels. Tartaric acid, succinic acid, and citric acid were found to be significantly 
effective in decreasing the membrane DMTl expression in Caco-2 TC7 cells (p<0.05).
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DMTl levels was reduced almost 50% when tartaric acid was added into the medium. 
Addition of propionic acid into the medium had no effect on membrane DMTl levels.
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Fig. 3.19: The Effect of Added Organic Acids on M embrane DM Tl Levels.
Cells were treated for 24 hours with 100 pM organic acids. Membrane protein 
samples were taken and subject to Western blotting. Band density was measured 
using Scion Image software. Values were expressed as Mean ± SEM of 3 
independent biological experiments. ^Significant difference from control 
(p<0.05).
Fig. 3.20 shows the effect of added polyphenols, namely catechin and rutin, on 
membrane DMTl levels. Both polyphenols tested had a significant reduction effect on 
membrane DMTl levels in Caco-2 TC7 cells. The expression of membrane DMTl in
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Caco2 TC7 cells was significantly decreased by 2.6-fold and 2.8-fold with catechin and 
rutin, respectively.
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Fig. 3.20: The Effect of Added Catechin and Rutin on M em brane D M Tl 
Levels. Cells were treated for 24 hours with 100 pM catechin dihydrate or rutin 
dihydrate. Membrane protein samples were taken and subject to Western blotting. 
Band density was measured using Scion Image software. Values were expressed 
as Mean ± SEM of 3 independent biological experiments. * Significant difference 
from control (p<0.05).
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3.18 Discussion
Absorption of iron into the body is a complex process that involves three 
important steps: (i) digestion and release of available iron from the diet into the digestive 
system, (ii) uptake of iron into the enterocytes, and (iii) release and transportation of iron 
into the circulation system (Fleming & Bacon, 2005). Although knowledge about the 
mechanism of iron absorption has increased, the effects of dietary components on iron 
uptake are still not fully understood. Iron is an essential mineral that is required by all 
types o f cells and is vital for multiple metabolic processes (Hower et aL, 2009). In these 
studies Caco-2 TC7 cells were used as an in vitro model system for the intestinal 
epithelium (Yun et ah, 2004).
Before any dietary components are investigated for their effects on iron uptake in 
Caco-2 TC7 cells. It is prudent to evaluate cell viability under incubation conditions and 
the reduction of tétrazolium salts, as part of the MTT assay, is now recognized as a safe 
and accurate test for cell viability (Mirhosseini et aL, 2007). This conversion is thought 
to be accomplished by NADPH and NADH produced by dehydrogenase enzymes in 
metabolically active cells (Foresti et aL, 1999). This study showed no effect of any of 
the dietary components on cell viability at concentrations up to 1000 pM.
By using this culture system as an in vitro model, it was found that iron uptake 
was increased by Fe(III) in a linear manner with respect to time for up to 2 hours 
(Fig 3.2). Iron uptake in Caco-2 TC7 cells was maximal at 500 pM. Nevertheless, all 
subsequent experiments were performed with less than or equal to 100 pM concentration 
of FeClg as this concentration is within the range of the normal iron status in the human 
body (Longo, 2010)
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In addition, Caco2 cells also express transporter proteins (Cammisotto et aL, 
2010). The apical surface of the polarized Caco-2 cell monolayer has been 
demonstrated to express villin and divalent metal transporter 1 (DMTl) protein (Johnson 
et aL 2005). Villin is an actin-binding protein localized in intestinal and kidney brush 
borders (George et aL, 2007). Iron absorption across the brush-border membrane 
requires DMTl. However, in interpreting these data, it is important to remember that 
Caco-2 cells are derived from colorectal adenocarcinoma cells and, as such, are not 
identical to normal duodenal enterocytes. Characterization of the Caco-2 TC7 subclone 
during the transition from a proliferative to a fully differentiated phenotype has been 
performed extensively by others (Mahraoui et al. 1994; Sharp et a l, 2002), and is 
associated with an increase in the expression of the brush border membrane structural 
protein villin (Fig.3.4). A similar increase in DMTl protein was expressed in Caco-2 
TC7 cells at all stages of differentiation, reaching maximal levels at day 21 (Fig. 3.5). 
Caco-2 cells can spontaneously undergo differentiation between a range of 0-21 days 
(Mariadason et aL, 2000). To confirm this process, transepithelial resistance values 
(TEER) and dome formation can be monitored because fully differentiated polarized 
Caco-2 cells have tight junctions with a TEER o f >200 Q cm^ (MacCallum et aL, 2005).
To further investigate the relationship between non-haem iron and the expression
of the apical membrane transporters, we exposed the cells with different strength of iron
into the media. There is evidence that DMTl expression can respond to iron availability
in cells in animals and humans (Sharp et a l, 2002; Collard, 2009). Only 10% of the
normal lO-to-20 mg o f dietary iron is absorbed each day, and this is sufficient to balance
the 1-2 mg daily losses from desquamation of epithelia. The biological importance of
this transporter is shown by its involvement in two naturally occurring animal mutants o f
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iron metabolism. Homozygous mutation of DMTl in mice is responsible for microcytic 
anaemia, and in rats, the Belgrade phenotype of microcytic is linked to hypochromic 
anaemia, with severe defects in intestinal and reticulocyte iron absorption (Fleming et 
a l, 1998). The Belgrade reticulocyte defect seems to be a failure to transport iron out of 
the transferrin cycle endosomes.
High iron concentration in the medium had no effect on whole cell DMTl levels 
(Fig. 3.6). In contrast, increasing concentration of Fe(III) was found to decrease the 
expression of membrane protein DMTl levels (Fig. 3.7). DMTl protein expression was 
significantly lower than the respective controls at iron concentrations greater than 10 pM 
(Fig. 3.7). This means that the DMTl expression and transport function can be regulated 
by physiologically relevant levels of iron found in the diet. Johnson et al. (2005) showed 
that both acute administration of iron and prolonged feeding of an iron-loaded diet leads 
to decreased DMTl expression and to changes in the cellular localisation of the protein. 
The data for whole cell and membrane DMTl levels suggest that the high levels of iron 
presented to the apical surface of intestinal epithelial cells induce trafficking of DMTl 
transporter protein away from the apical membrane. This is the reason why membrane 
DMTl levels were low even though total cellular DMTl protein levels remained 
unchanged.
Normally, the changes in iron body stores and the demands of the developing
erythroid mass will regulate iron absorption, influencing absorption in two-to-three days.
In addition to regulation of iron uptake by signals from the body stores, there is also a
more rapid response to dietary iron (Sharp et a l, 2002). The only phenomenon that does
not conform to the two-to-three day lag period for absorption is the mucosal block
phenomenon, in which the intestine becomes resistant to iron absorption immediately
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after a large dose o f dietary iron (Sharp et a l, 2002). This phenomenon was proposed to
describe the diminished absorption of iron following an oral administered iron dose, and
mucosal ferritin synthesis as a result of a bolus of iron was postulated to serve as a block
to the absorption o f excess iron (Ma et al., 2006). When the mechanism of mucosal
block was investigated in rats, a reduction in iron uptake within 3 h of iron exposure was
reported to be associated with a reduction in DMTl mRNA and protein (Frazer et a l,
2003). Sharp et a l  (2002) also reported a dramatic down-regulation of DMTl
transporter protein and iron uptake in Caco-2 cells. In this study, the time course for
these iron-mediated events was also determined since these changes might be
physiologically relevant in regulating iron absorption during the digestive period. This
response was performed by investigating changes in DMTl proteins following iron
treatment at specific time intervals. A significant decrease in DMTl protein was
observed in the membrane between one and three hours (Fig. 3.9), matching the
response seen in rats in previous studies (Frazer et al., 2003). Despite the dramatic
decrease in membrane DMTl levels, total transporter protein expression was unaltered
over the 24 hour incubation period (Fig. 3.8). One explanation for this data is the
internalization of DMTl from plasma membrane following iron exposure. Trinder et a l
(2000) and Kwo-Yih et al. (2003) reported that changes in the cellular localization of
DMTl have been noted in duodenal enterocytes from control and iron-loaded animals
and that this may involve rapid internalization of DMTl into cytosolic vesicles.
Although hepcidin is also responsible for regulating iron absorption, some researchers
found that the effects of hepcidin are cell-type specific and enterocytes are less sensitive
to hepcidin than macrophages (Mena et al., 2008; Chung et al., 2009). Hence, there
seems to be no reasonable doubt that the control of iron absorption, particularly in the
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Caco-2 cells study, resides predominantly in the mucosa of the gastrointestinal tract even 
though it has been shown that iron absorption may be increased in certain types of 
anaemia without iron deficiency and also by dietary factors under certain extreme 
conditions.
Despite the dramatic decrease in the expression of DMTl following iron 
exposure, the prospect that DMTl protein might be recycled back to the cell surface 
when the iron levels in the apical medium drop was also of interest. Cells were exposed 
to iron for 3 hours and washed off after that period; later, they were placed in an iron- 
free medium for up to 24 hours, during which time changes in membrane DMTl protein 
levels were monitored. The expression of DMTl was recycled back to the baseline when 
the iron levels in the apical medium dropped. Johnson et ah (2005) suggested that this 
mechanism of restoration was post-transcriptional because there were no changes in 
DMTl mRNA over this time period. This recovery effect was later confirmed by adding 
cycloheximide to the cells. After 24 hours in an iron-free medium (following pre­
incubation with iron for four hours), the expression of DMTl in the cycloheximide- 
treated group was no different from the control group (Johnson et ah, 2005).
Many factors condition iron uptake in the human body. Among them includes
the individual’s body iron stores and dietary components. Some animal tissues usually
referred to as “meat factor(s)” have been reported to enhance non-haem iron absorption
in humans. Not all animal proteins have the same enhancing effect. For example, beef,
pork, and fish have been reported to enhance iron uptake, but eggs, cheese, and milk do
not (Swain et ah, 2002). Increasing interest in Caco-2 TC7 cells in nutritional studies
prompted many researchers to use this model in characterizing the effect of animal
proteins responsible for iron absorption. Non-polar amino acids, especially cysteine,
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were found to be the most effective amino acids for increasing iron uptake in Caco-2 
TC7 cells. Up to 1600 pmol/h iron were taken up by Caco-2 TC7 cells at 1000 pM 
concentration of cysteine. The normal percentage of iron taken up in a Caco-2 cells 
model study system is between 0.005% - 0.01% (100% uptake is equivalent to 20,000 
pmol iron) (Fig. 3.11). However, by introducing cysteine into the medium, the 
percentage of iron uptake was more than 0.08%, a significant increase from the control 
(Fig. 3.11). This finding is in contrast with Swain et aL (2002), which found no 
significant effect of cysteine on iron uptake, although previous work done by Garcia- 
Casal et al. (1996) found that cysteine did increase iron uptake in human subjects. Swain 
and colleagues (2002) studied the effect of beef muscle protein on non-haem iron 
bioavailability and found that histidine had pronounced enhancing effect on iron uptake 
whereas no relationship was found with iron uptake and cysteine content. However, 
Garcia-Casal and colleagues (1996) conducted a study on the effect o f iron-containing 
proteins of rabbit meat on human subjects and found the enhancing effect of cysteine on 
iron uptake. Another study conducted by Glahn & Van Campen (1997) reported that 
cysteine had no effect on iron uptake from Fe(ll)-ascorbate media, but did increase iron 
uptake from Fe(lll) complexes. Their findings also noted that cysteine was a more 
effective amino acid than methionine, alanine, glutamine, histidine, and lysine in 
promoting iron uptake. Glahn & Van Campen (1997) observed that the effect of 
glutathione in enhancing iron uptake in Caco-2 cells was recorded only when glutathione 
was cleaved into its peptide components, resulting in the formation of cysteine and 
cysteinyl glycine. If so, then these observations suggest that the enhancing effect was 
most likely because of the reduced sulfhydryl of cysteine and that the amine groups are
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necessary for the enhancing effect on iron uptake by increasing iron solubility when 
added to a solution containing soluble and insoluble Fe(III).
Other non-polar amino acids (proline and alanine) were the least effective of 
amino acids tested at increasing iron uptake in Caco-2 TC7 cells. Another group of polar 
amino acids were found to be significant in enhancing iron uptake when compared to the 
control. It is likely that these amino acids either maintain iron in the soluble form or 
cause reduction of some of the Fe(III), making the iron easier to absorb. In a separate 
study, Swain et a l  (2002) reported that histidine was effective in increasing iron uptake. 
In this study, high concentrations of histidine in the medium was found to decrease iron 
uptake in Caco-2 cells. In this case, the carboxyl group may be responsible for the shift 
of pH in the medium and may have had an impact on iron uptake. Decarboxylation of 
histidine, removal of the epsilon(e)-amino group of lysine, and substitution of the 
hydrogen of hydroxyl group for the sulfhydryl group of cysteine, all resulted in a loss of 
ability to enhance iron uptake (Glahn & Van Campen, 1997).
Organic acids had been reported to influence iron uptake (Salovaara et,al, 2002). 
Organic acids can be categorized into several groups: (i) containing four-carbon
dicarboxylic acids with one or two hydroxyl groups, (ii) containing four-carbon
dicarboxylic acids with no hydroxyl groups, (iii) a structurally heterogenous group 
containing one, two, or three carboxyl groups, respectively, and (iv) monocarboxylic 
acids with either a methyl or ethyl group attached. The chemical structures of these
groups are shown in Fig. 3.21:
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Fig. 3.21:Chemical Structures of Organic Acid Groups, (a) Containing four- 
carbon dicarboxylic acids with one or two hydroxyl groups; (b) Containing four- 
carbon dicarboxylic acids with no hydroxyl groups; (c) A structurally 
heterogenous group containing one, two, or three carboxyl groups, respectively, 
and (d) Monocarboxylic acids with either a methyl or ethyl group attached.
Tartaric acid was found to be the most effective organic acid for increasing iron 
uptake in Caco-2 TC7 cells. Tartaric acid, which consists of four-carbon dicarboxylic 
acids with two hydroxyl groups, had a very significant effect on iron uptake. Although 
some people may claim reduction in pH might account for this effect, in actuality the pH 
changes were very small as to be negligible when compared to the pH of the medium at 
the beginning o f the experiment (pH 6.0±0.1) (Table 3.1). Another factor that could have 
contributed is the solubility of iron in the medium because solubility is frequently used 
as an estimation of iron availability. Certain organic acids would probably be more 
effective than others in keeping iron in its soluble form. In addition, the formation of 
iron-acid complexes or other biological factors such as the expression of iron transporter 
in the presence of organic acids may contribute to this enhancing effect. Upon making a
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comparison, it was found that organic acids in the fourth category were the least 
effective at enhancing iron uptake. Even though propionic acid had a significant impact 
on iron uptake, its effect was not as remarkable as the other groups o f organic acids.
Aseorbate is the most powerful known intensifier of iron uptake. It was first 
purified by Szent-Gyorgyi in 1928 (Toth & Bridges, 1995). Aseorbate serves as a 
cofactor in numerous enzymatic reactions and affects the turnover of an array of proteins 
(Toth & Bridges, 1994). For a normal individual, the body’s iron level is sufficient to 
meet our daily physiological requirements. The iron is present at birth and after the first 
six months, the estimated average daily requirement is 0.69 mg (Dube et ah, 2010). 
Moore and Dubach were among the earliest investigators to use radioisotopes to study 
iron uptake. In 1951, they first demonstrated the enhancing effect o f aseorbate on iron 
uptake (Fairweather-Tait, 1992). Aseorbate acts as a common non-haem pool ligand, 
increasing the absorption of iron from meals that are soluble in the gastric juice (Lynch 
& Cook, 1980). This study showed a marked increase on iron uptake in the presence of 
aseorbate. At as low as 10 pM concentration, aseorbate tested remarkably effective in 
increasing iron uptake in the medium. Because of this, and because no specific study has 
been conducted on its kinetic mechanism on iron uptake, this efficient dietary 
component was selected for further investigation. A more detailed discussion of the 
effect of aseorbate on iron uptake will be presented in a separate chapter.
Carotene is another important dietary component that may have beneficial effects
on iron uptake. There are two primary isomers of carotene, a-carotene and p-carotene,
which differ in the position of the double bonds in the cyclic group at the end. Between
these two carotenes, p-carotene is the most common form found in yellow, orange, and
green leafy fruits and vegetables (Evans & Johnson, 2010). This study found that p-
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carotene increased iron uptake in Caco-2 TC7 cells at lower levels o f concentration, but 
at concentrations above 30 pM, iron uptake was decreased. A study done by Williams et 
a l (2000) found that p-carotene was able to inhibit human prostate cancer cell growth. 
This effect may also apply to Caco2 TC7 cells, which are reduced in number at certain 
concentrations of p-carotene. This retardation effect on cell growth may indirectly 
reduce the amount of iron taken up by the cells. This interesting effect of p-carotene 
will be discussed in a separate chapter.
According to several studies, phytate is one of the most potent inhibitors of iron 
uptake in both infants and adults (Hurrel et a l, 2003; Perlas & Gibson, 2005; Trinidad et 
a l, 2008). Phytate is the principle storage form of phosphorus in many plant tissues. 
High levels of phytate can inhibit the absorption o f several trace elements and minerals 
in the human body such as calcium, iron, zinc, and magnesium by chelating the minerals 
to become insoluble complexes (Kumar et a l, 2010). This study shows that at a ratio of 
1:1 (phytate: iron), almost half of the iron available in the medium became insoluble for 
cell uptake. Phytate causes a substantial shift in the redox potential of iron, ensuring the 
rapid removal of Fe(II) without the concomitant production of lipid peroxide (Kumar et 
a l, 2010). A study done by Hurrell (2003) found that whole-grain cereals and legumes 
(phytate ~1 g/100 g) decreases iron absorption from porridge by as much as 2-3% even 
in iron-deficient subjects. Decreasing phytate in the meals by 90% (^100 mg/100 g dried 
product) would be expected to increase absorption about 2-fold and complete 
degradation perhaps 5-fold or more. This interesting effect of phytate on iron uptake will 
be discussed in a separate chapter.
In contrast to the other dietary components above, this study showed no evidence
for vitamin E to affect iron uptake (p>0.05). Although there was a slight increase in iron
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uptake, it was not significant enough to validate the effect of vitamin E in the medium. 
There has been no publication on the effect of vitamin E on iron uptake, however, a 
study done by Link et a l (1999) found that alpha-tocopherol at 0.023 mmol/L 
completely inhibited mitochondrial iron toxicity without affecting iron uptake or release, 
irrespective of whether it was used before, during, or after in vitro iron loading. Most of 
the other studies on vitamin E and iron focused more on the effect of vitamin E in 
inhibiting the formation of oxidative stress.
Polyphenols are known to have antioxidant properties (Scalbert et aL, 2005). In 
this study, two types of polyphenols were randomly selected, which are rutin dihydrate 
and catechin dihydrate. Although most researchers have found polyphenols inhibit iron 
uptake because they can easily form a complex with Fe(II) to prevent radical oxygen 
formation, this data showed the reverse effect when the concentration of iron in the 
medium was low, causing hardly any harmful effect on the cells. A study done by Cook 
-6i aL, (1995) found that the inhibitory effect o f phenolic compounds in red and white 
wine is unlikely to affect iron balance significantly. However, this finding is supported 
by another study done by Kim and colleagues (2011) which found polyphenols are 
capable to enhance the apical iron uptake but not on transepithelial iron transport 
partially by reducing the conversion of Fe(III) to Fe(II) and possibly by increasing the 
uptake of polyphenol-iron complexes via the energy-independent pathway. Even 
though many studies have reported that some plant polyphenols possess a remarkable 
transition metal chelating activity and form redox stable complexes with transition metal 
ions to prevent free radicals formation by means of scavenging them (Brown et aL, 
1998; Hider et aL, 2001), low levels of soluble iron available in the medium do not
seemed to be affected by these polyphenols.
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After completing iron uptake study in Caco-2 TC7 cells by using ^^Fe, the effect 
of the respective dietary components on the expression of membrane DMTl levels was 
determined in Caco-2 TC7 cells. Most of the amino acids and organic acids tested were 
able to reduce the expression of membrane DMTl levels. The entry of amino acids into 
the cells from the extracellular medium may regulate its expression. It is suggested that 
DMTl plays a role in cellular protection from excess iron in Caco-2 cells thereby 
providing protection against iron overload and iron-dependant tissue damage.
83
4.0 Kinetic Effect of Ascorbate on Iron Uptake and Iron 
Transport in Caco-2 TC7 Cells
4.1 Introduction
One of the most prominent dietary components in iron uptake studies is vitamin 
C. Ascorbate, or vitamin C, is chemically written as L-ascorbic acid (CôHsOô). It exists 
in two chemically distinct forms: ascorbate and dehydroascorbate. Most plants and 
animals can synthesise ascorbate from D-glucose or D-galactose. However, humans and 
several other animals are deficient in the enzyme L- gulonolactone oxidase, which is the 
final enzyme for ascorbate synthesis and is crucial in the process. Hence for humans, 
ascorbate has to be taken through diet or supplementation tablets.
Ascorbate is known to enhance the availability of iron from non-haem iron 
sources (Cook & Reddy, 2001) although Hunt et al. (1994) reported no significant effect 
of ascorbate on serum ferritin levels. However, the effect of ascorbate on iron absorption 
from a complete diet is far less pronounced than it is from single meals. In one of the 
studies conducted by Cook et a/., (1991), when iron absorption from a complete diet was 
measured over several days by having subjects consume a labelled bread roll with each 
meal of the day, the extremes in mean iron absorption between diets differing maximally 
in iron bioavailability ranged from only 3.2% to 8.0% compared with a significantly 
wider range of 2,3-13.5% when iron absorption was measured with single meals (Cook 
et al., 1991).
In respect o f this, Hallberg and Hulthen (2000) have reviewed these dietary 
interactions and proposed an algorithm for estimating dietary iron absorption, and the 
enhancing or inhibiting effects of other dietary components consumed concurrently. For
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most vegetarian diets, the enhancing effect of ascorbate (Gillooly et al., 1983; Hallberg 
et al., 1987) on non-haem iron absorption is most likely to counteract the presence 
inhibitors o f iron absorption in the diets.
4.2 Aims and objectives
The purpose of this experiment was to evaluate the effects of ascorbate on iron 
uptake and non-haem iron transporters.
The specific objectives were:
i) to investigate the kinetic mechanism of ascorbate on iron uptake.
ii) to study the effect of ascorbate on iron reduction activity in Caco-2 TC7 cells.
iii) to study the effect of ascorbate on the apical transporter, D M Tl.
iv) to investigate the effect o f ascorbate on the basolateral transporter, Iregl.
4.3 The Effect of Ascorbate on Caco-2 TC7 Cell Viability 
Rationale:
Ascorbate can influence cell proliferation (Chepda et al., 2000). However, by 
adding high concentration of ascorbate in the culture media may perhaps give rise to an 
autoxidation. This phenomenon is particularly pronounced in the presence of 
uncomplexed transition metal ions like copper or iron ions (Buttner, 1986). Hence, it is 
necessary to expose the Caco-2 TC7 cell to the highest concentration of ascorbate used 
in this study to assess the impact of ascorbate on cell growth.
Result:
Fig. 4.1 shows the effect of ascorbate at 10 pM and 30 pM concentrations on 
Caco-2 TC7 cell viability in uptake buffer (PBS buffer), which represents the conditions 
for the iron uptake study. There was no significant effect of ascorbate on cell viability in 
uptake buffer (p>0.05).
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Fig. 4.2 shows the effects o f ascorbate on Caco-2 TC7 cell viability in serum-free 
media at 24 hours incubation time, which represents the conditions for protein analysis. 
There was no significant difference between the control and the treatments on cell 
viability (p>0.05).
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Fig. 4,1: The Effect of Ascorbate on Caco-2 TC7 Cell Viability in Uptake
Buffer. The percentage of cell viability was evaluated in the presence of 
ascorbate at 0, 10 and 30 pM concentrations. The effect o f ascorbate on cell 
viability was measured by MTT assay 15 minutes after giving the treatments in 
uptake buffer. Statistical analysis was performed using Student’s unpaired t-test. 
Results were expressed as Mean ± SEM for at least four independent biological 
determinations.
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Fig. 4.2: The Effects of Ascorbate on Caco-2 TC7 Cell Viability in Serum- 
free Media. The percentage of cell viability was evaluated in the presence of 
ascorbate at 0, 10 and 30 pM concentrations. The efleet of ascorbate on cell 
viability was measured by MTT assay 24 hours after giving the treatment in 
serum-free media. Statistical analysis was performed using Student’s unpaired t- 
test. Results were expressed as Mean ± SEM for at least four independent 
biological determinations.
4.4 Ascorbate Enhances the Reduction of Fe(III)
Rationale:
Caco-2 TC7 cells were used to explore the impact of added ascorbate on iron
reduction because brush border membrane vesicles isolated from Caco-2 TC7 cells
possess a ferric reductase that reduces Fe(IIl) to Fe(II) before the iron is transported
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through the microvillous membrane (Han & Wessling-Resnick, 2002; Pullakhandam et 
a l,  2008).
Result:
Fig. 4.3 shows the formation of Fe(II) increased in a linear manner with 
increasing concentrations of Fe(III) in Caco-2 TC7 cells after 15 minutes incubation at 
37®C. Maximal levels of Fe(II) formation were present in the mixture solutions 
containing 30 pM Fe(III) and 10 pM ascorbate, where the reduction of Fe(III) to Fe(II) 
was 1.8-fold compared to the control.
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Fig. 4.3: Fe(II) Formation from Fe(III) in Uptake Buffer. Comparison of Fe(II) 
formation in the presence of ascorbate at 0 (♦), 0.5 (■), 1.0 (À ), 5.0 (•)  and 10.0 
(□) pM concentration. Cells were incubated for 15 minutes with different 
concentrations of ascorbate and FeClg, respectively. Cell-mediated reduction of 
Fe(III) was assessed by measuring the concentration of Fe(II)-BPDS complex as 
described previously. Values are Mean ± SEM for at least four independent 
biological determinations.
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In terms of percentage, the maximal percentage was 38% in the mixture solutions 
containing 30 pM Fe(III) and 10 pM ascorbate. Fig. 4.4 shows that the formation of 
Fe(II) increased in a linear manner with increasing concentrations of Fe(III) in Caco-2 
TC7 cells after 15 minutes incubation at 37°C.
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Fig. 4.4: Percentage Formation of Fe(II) from Fe(III) in Uptake Buffer.
Comparison of Fe(III) uptake in the presence of ascorbate at 0 (0), 0.5 (■), 1.0 
(A), 5.0 (• )  and 10.0 (□) pM concentration. Cells were incubated with different 
concentrations of ascorbate and different concentrations of FeCls for 15 
minutes. Cell-mediated reduction of Fe(III) was assessed by measuring the 
concentration o f Fe(II)-BPDS complex as described previously. Values are 
Mean ± SEM for at least four independent biological determinations.
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4.5 Influence of Ascorbate Concentration on Iron Uptake in Caco-2 TC7 Cells 
Rationale:
This investigation examines the influence o f ascorbate status on iron uptake by 
utilising the human intestinal Caco-2 TC7 cell line as a model system to study this 
process.
Result:
Under these conditions, increased levels of ascorbate and Fe(III) were observed. 
The concentration of ascorbate used for this study ranged from 0.5 pM up to 10 pM and 
the concentration of Fe(III) ranged from 2 pM up to 30 pM. Each concentration was 
studied in duplicate, several experiments were performed, and a typical experiment is 
shown in Fig. 4.5.
There was significant improvement in iron uptake when ascorbate was added to 
the incubation media. The addition of 0.5 pM ascorbate significantly increased uptake 
compared to the control (p<0.05). Further increases in ascorbate resulted in significant 
increases in iron uptake compared to the control (p<0.05). Differences were also 
significant for 1.0, 5.0, and 10.0 pM ascorbate on 30 pM Fe(III) compared to 0.5 pM 
ascorbate tested (Fig. 4.5).
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The Lineweaver-Burk plot is widely used to present kinetics data, such as Km 
and Vmax. Fig. 4.6 shows that the reciprocal plot reached linearity with increasing 
concentrations o f ascorbate.
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0.010
Si
&  0.008
cu
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- 1.0 0-0.5 0.5 2.01.0 1.5 2.5
l/[Fe] (hM ')
♦ + Asc (lO.O i^M) 0 + Asc (5.0^M) A+Asc (l.OpM) # + Asc (0.5pM)
Fig. 4.6: Effect of Ascorbate on the Uptake of ^^Fe into Caco-2 TC7 cells. Data 
from the same experiment as in Fig. 4.5 are plotted as \ N  vs. l/[Fe] at 0 (O), 0.5 
(•), 1.0 (A), 5.0 (□) and 10.0 (♦) pM FeClg. The data were fitted to a hyperbolic 
equation (v =[S] x Vmax/(Km + [S]), as indicated by the solid lines.
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Table 4.1 shows the influence of ascorbate on Vmax and Km values of iron uptake.
Table 4.1: Kinetic param eters for ^^Fe uptake into Caco-2 cells in the presence of 
0,0.5,1.0, 5.0 and 10.0 pM ascorbate.
[Ascorbate] pM Vmax value (pmol/h) Km value (pM)
0 304 ±1.6 13.2 ± 1.6
0.5 1242 ±75 6.4 ± 1.0
1.0 1546 ±77 7.1 ±0.8
5.0 1820 ±91 7.4 ±0.9
10.0 2044± 123 7.3 ± 1.1
The data were fitted separately for every ascorbate concentration to a hyperbolic 
equation: rate of Fe(III) uptake (v) = [S] x VmaxXKm + [S]), where [S] is the 
concentration of FeClg substrate, Vmax (pmol/h) is the calculated maximum rate of ^ ^Fe 
uptake and Km (pM) is the calculated Michaelis constant at every ascorbate 
concentration, r  ^ > 0.985 for all fitted data. Two-way ANOVA indicated a significant 
effect of ascorbate concentration on Km and Vmax (p < 0.001).
4.6 Investigating the Effect of Ascorbate on Iron Availability and Fe(II)
Formation in Uptake Medium 
Rationale:
Iron absorption is fully regulated by the human body because the body does not 
possess a physiological mechanism for significant iron secretion. The Caco-2 TC7 cell 
model was used to evaluate the effect of ascorbate on iron uptake as well as iron 
availability in the medium.
Result:
Fig. 4.7 shows the effect of adding ascorbate on iron availability and Fe(II) 
formation in the system. Ascorbate helped to reduce Fe(III) to Fe(II) significantly more 
than the medium without ascorbate. Uptake of iron from the medium with added 
ascorbate was 16 times higher than without added ascorbate.
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Fig. 4.7: Iron Availability and Fe(II) in the Medium. Effect o f ascorbate on 
the uptake of ^^Fe or the reduction of Fe(III) to Fe(II) into Caco-2 TC7 cells. 
Uptake o f^F e  (4, A) and reduction of Fe(III) to Fe(II) (A,d) was measured in 
the presence or absence of 10 pM ascorbate. Cells were incubated with and 
without ascorbate at 10 pM concentration and different concentrations o f FeCls, 
exposed to ^^FeCls up to 60 minutes just prior to the uptake study. Iron 
available in the medium was measured by scintillation counting as previously 
described in materials and methods. Cell-mediated reduction o f Fe(III) was 
assessed by measuring the concentration of Fe(II)-BPDS complex as described 
previously. Data were analysed by two-way ANOVA.
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4.7 Effect of Ascorbate on Membrane DMTl Levels 
Rationale:
Iron is thought to be transported into the cell through an active transport process 
involving the protein DMTl. Ascorbate may influence this active process. In this 
experiment, we used ascorbate to investigate the subcellular localisation and trafficking 
properties of D M Tl.
Result:
The amount of DMTl decreased by almost 50% following exposure to iron and 
was reversed by adding ascorbate to the media (Fig. 4.8).
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Fig. 4.8: The Effect of Added Ascorbate on M embrane D M Tl Levels. Cells were 
treated for 24 hours with 10 p.M ascorbate. Membrane protein samples were taken 
and subjected to Western blot analysis. Band density was measured using Scion 
Image software. Values were expressed as Mean ± SEM of three independent 
biological experiments. *Significant difference from control p<0.05 (one way 
ANOVA).
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4.8 Effect of Ascorbate on Whole Cell DMTl Levels
Result:
Whole cell DMTl levels were unchanged following exposure to iron and there 
was no significant effect on whole cell DMTl levels in the presence of ascorbate in the 
media (Fig. 4.9).
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Fig. 4.9: The Effect of Added Ascorbate on Whole Cell D M Tl Levels. Cells 
were treated for 24 hours with lOpM ascorbate. Whole cell protein samples were 
taken and subject to Western blot analysis. Band density was measured using Scion 
Image software. Values were expressed as Mean ± SEM of three independent 
biological experiments.
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4.9 Investigating the Effect of Added Ascorbate on Iregl 
Rationale:
Dietary iron enters the intestinal epithelium via the brush-border transporter 
DMTl and exits through the basolateral membranes. The basolateral transfer of iron 
requires two components: a copper-containing iron oxidase known as hephaestin and a 
membrane transport protein Iregl. Iregl plays a role to transport iron crosses the 
basolateral membrane and ascorbate might have some effects on this activity. In this 
experiment, a Western blot analysis was used to investigate the effect of ascorbate on 
Iregl.
Result:
Fig. 4.10 shows no significant difference between the control and the medium 
with ascorbate on Iregl expression in Caco-2 TC7 cells.
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Fig. 4.10: The Effect of Added Ascorbate on Iregl. Cells were treated for 24 
hours with or without 30 ascorbate. Whole cell protein samples were taken and 
subjected to Western blotting. Band density was measured using Scion Image 
software. Values were expressed as Mean ± SEM of three independent biological 
experiments.
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4.10 Discussion
Firstly, we investigated the effect of ascorbate on cell viability to elucidate its 
effect on cell death. As a well-known dietary antioxidant, ascorbate can decrease the 
adverse effect o f reactive species that can cause damage to macromolecules such as 
lipids, DNA, and proteins (Gutteridge & Halliwell, 2000). However, there is concern 
that elevated Fe(II) may lead to the generation of reactive oxygen and nitrogen species 
(RONS). The proposed mechanism of oxidation of ascorbate is as shown in Fig. 4.11 
and this mechanism will be discussed later in the chapter.
OH
COOH
Hot OH
HO, .COOH
Fig. 4.11: Proposed Mechanism for the Generation of H2O2 via the 
Oxidation of Ascorbate. (Martell and Taqui Khan, 1973)
Ascorbate is purported to have a pronounced enhancing effect on the absorption
of dietary non-haem iron in in vitro studies due to the capacity o f ascorbate to reduce 
Fe(III) to Fe(II) (Kim et aL, 2011). Recently, theories about the effects o f ascorbate on 
the cellular metabolism of iron have been proposed. These effects should be investigated 
for several reasons. One important aspect is whether ascorbate has any effects on iron 
transporters in the absence and presence of extracellular iron in the intestinal lumen. For
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that purpose, Caco-2 TC7 cells have been used as the in vitro model system to 
investigate ascorbate-iron and ascorbate-metal transporter relationships.
Furthermore, the mechanism of non-haem iron uptake is different from haem
iron uptake. Some studies reported that before reaching the intestinal brush border,
Fe(III) must be reduced by surface ferrireductases to be transported via DMTl into the
enterocyte (Dhungana et aL, 2004; Ohgami et aL, 2005). This study showed that
ascorbate in enterocytes mediated the reduction of Fe(III) to Fe(II) (Fig. 4.3) and may
also serve as an electron donor to duodenal cytochrome B (DcytB), a candidate
ferrireductase at this apical membrane (Turi et aL, 2006). The corresponding
transmembrane ferrireductase identified so far are duodenal cytochrome b561 (Dcytb),
in the brush border membrane of duodenal enterocytes (McKie et aL, 2001), and Steap3
(Six-transmembrane epithelialantigen of the prostate 3) in the endosomes of erythroid
cells (Ohgami et aL, 2005). Increasing the concentration of ascorbate was found to
significantly increase the reduction of Fe(III) to Fe(II) (p<0.05). Interestingly, Atanasova
et aL (2004) found that lowering tissue ascorbate levels by incubation in oxygenated
(95% 0 2 :5 % CO2) incubation buffer (pH = 7.4; 125 mmol/L NaCl, 3.5 mmol/L KCl,
1 mmol/L CaCl2, 10 mmol/L MgS0 4 , 16 mmol/L Na-HEPES, and 10 mmol/L
D-glucose) at 37°C for five minutes also decreased ferrireductase activity in hypoxic
mouse duodenal tissue, which indirectly supports this finding of the effect of ascorbate
concentration on ferrireductase activity after 15 minutes incubation in uptake buffer.
Studies conducted on mice (which can produce their own ascorbate) also found that
Dcytb activity was partly dependent on the concentration of its intracellular substrate,
ascorbate (McKie et aL, 2001; Latunde-Dada et aL, 2002), and the concentrations of
duodenal ascorbate were found to be higher in mice with iron deficiency than in those
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that are iron replete (Atanasova et aL, 2004). These present findings can provide 
additional information supporting the theory that ascorbate has a direct impact on 
ferrireductase activity. To conduct further investigations in humans would require strict 
control of dietary ascorbate intake as well as other factors that may influence ascorbate 
concentrations, such as smoking (Schectman et aL, 1989).
As one o f the vitamins that is fundamental to human physiology, ascorbate is
present in human blood at an average concentration of about 50-75 pM, and at least 95%
is in the reduced form with the remaining 5% in the oxidised form (dehydroascorbate)
(Rose, 1988; Wechtersbach & Cigic, 2007). The observation that cells and tissues
accumulate characteristic intracellular concentrations of the ascorbate, both in vivo and
in vitro, suggests that the transport and cellular accumulation of ascorbate is a highly
regulated process (Savini et aL, 2007). The saturable, low-affinity uptake process of iron
can be remedied by the presence of ascorbate, resulting in an excellent fit of velocity
data to the kinetic equation describing high-affinity iron uptake (Fig. 4.5). The best way
to analyse these kinetic data was to fit the data directly to the Michaelis-Menten
equation using nonlinear regression. Plots of ^^Fe uptake rates (1/V vs. l/[^^Fe]) in the
presence of ascorbate display mixed-type activation kinetics (Fig. 4.6) (Segel, 1975),
with activation o f ^^Fe uptake by ascorbate being saturable, as indicated by the finite
Vmax obtained (Fig. 4.5). These observations are characteristic o f a non-essential
activator process (Segel, 1975) and indicate that ascorbate forms a complex with Fe(III)
that is then taken up into the Caco-2 TC7 cells. This finding implies that ascorbate
functions as a chelating agent of Fe(III) and suggests that an iron-ascorbate complex
enters the cells directly, although this study cannot determine whether the iron in this
complex is in the Fe(III) or Fe(II) form. The assumption that the ascorbate-iron complex
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is present in the gastrointestinal tract as an intact chelate complex is shared by others 
(Lynch & Stoltzfus, 2003; Miccichè et aL, 2005). Based on this relationship (Fig. 4.5), at 
very low iron concentrations, the concentration of available ascorbate is much larger 
than the concentration of iron molecules. Therefore, when the concentration of iron is 
increased, the rate of uptake will increase until it reaches a saturation point. Under this 
condition, all of the ascorbate will be saturated with iron molecules, and when the 
concentration is increased further, there will be no change in the rate of the reaction. In 
other words, the maximum rate of reaction (Vmax) has been achieved (Segel, 1975). 
When the Michaelis-Menten relationship does apply, the influence may be accurately 
estimated. Although the kinetic models can accurately predict rates of product 
formation, they do not directly address the specific mechanistic aspects of multiple 
ligand binding. Where Vmax is the maximum rate of reaction, Km is the Michaelis-Menten 
constant of an enzyme/activator/inhibitor or the substrate concentration at which the 
reaction occurs at half of the maximum rate (Vmax/2). In physical terms, this means that 
Km is an indicator o f the affinity that an ascorbate has for iron molecules, and hence the 
stability of the ascorbate-iron complex (Fig. 4.6). This novel finding of kinetic analysis 
enabled us to describe the actual ascorbate-iron interaction occurring at the mucosa level 
which has been ignored by previous researchers.
The interactions of ascorbate with iron in the medium will determine the
efficiency with which the iron can be absorbed in Caco-2 TC7 cells. To further
investigate the interaction, a simultaneous study of the effect of ascorbate on iron uptake
and Fe(II) formation was conducted in Caco-2 TC7 cells. The main reason was to
investigate whether all insoluble Fe(III) will be reduced to soluble Fe(II) by adding
ascorbate in the uptake medium. This study found that the reduction of Fe(III) was 2-
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fold higher with added ascorbate compared to the control. A study done by Lane & 
Lawen (2008) found that cancer cells preloaded with ascorbate by incubation with DHA 
showed a more than 1 2 -fold stimulation of ferrireductase activity and a 2 -fold 
stimulation o f iron uptake from ^^Fe. This study also showed that the reduction of 
Fe(III) with added ascorbate was almost 25,000 pmol compared to the medium without 
added ascorbate, which was just above 10,000 pmol reduction (Fig. 4.7). A study done 
by Hsieh and Hsieh (1997) observed that 1 mol of ascorbate was able to reduce 2 mol of 
Fe(III) in the range of pH 2.6 -  6 , which was similar to the pH of this study. They also 
found that Fe(III) can be reduced by ascorbate only when the pH is below a certain limit, 
somewhere between pH 6.0 and 6 .8 . Above that pH limit, ascorbate is no longer an 
effective reducing agent for Fe(III). A similar study conducted by May (1999) found that 
the addition of ascorbate oxidase in the medium almost reversed the effects of ascorbate 
on both ^^Fe uptake and Fe(III) reduction. Thus, it is likely that extracellular ascorbate 
reduced Fe(III) to Fe(II), which was then taken up by the cells. The absorption of the 
Fe(III) is influenced by various food components including ascorbate (Sandberg, 2002). 
Due to the importance of ascorbate on iron uptake, this discovery is expected to have 
profound ramifications for the understanding of the iron uptake mechanism in both 
human health and disease.
Another possibility for the effect of adding ascorbate to the uptake medium is the
modulation of the main iron transporter at the brush border membrane, DMTl. DMTl
has two major isoforms (isoform 1 and isoform 11) which are generated by alternative
splicing at 3' exons. Isoform 1 is predominantly expressed in epithelial cells, whereas
isoform 11 is predominantly expressed in erythroid cells (Paradkar & Roth, 2007). The
involvement of ascorbate on DMTl was examined by analysing the expression of this
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transporter in Caco-2 TC7 cells. To determine whether ascorbate influences DMTl 
levels, cells were incubated in an iron-free medium (control) and an iron-treated medium 
and ascorbate added to the iron-treated medium for 24 hours prior to plasma membrane 
isolation and Western blotting. This study showed that membrane levels o f DMTl were 
significantly decreased in iron-treated cells compared to the control, but the effect of 
iron was reversed by adding ascorbate, which increased the expression of DMTl back to 
basal (Fig. 4.8). Interestingly, whole cell DMTl levels were not affected by high iron 
concentration or by ascorbate added to the media (Fig. 4.9). This phenomenon may be 
due to the redistribution of DMTl between the plasma membrane and some intracellular 
location (Sharp et ah, 2002; Courville et aL, 2006). This finding suggests that the effects 
of ascorbate are not simply on the reduction and chelating of iron, but also on the 
transporter protein DMTl itself. When iron is low in the system, DMTl is dramatically 
upregulated in the intestine by dietary iron restriction or increased demand for iron 
(Zoller et aL, 2001).
While influx of dietary non-haem iron from the intestinal lumen into the
enterocyte is mediated by the specific brush border membrane iron transporter DMTl at
the apical membrane, Iregl is a candidate at the basolateral membrane (Martini et aL,
2002). This study has found that ascorbate slightly reduces the expression of Iregl with
added iron in the medium, but with no significant effect (p>0.05). It is thought that the
action of ascorbate on iron transporters (DMTl and Iregl) is probably a mucosal block
phenomenon (Frazer et aL, 2003). Due to the short time interval between doses, the
initial dose must have a direct effect on the mature enterocytes rather than on the cells of
the crypts (Frazer et aL, 2003). Many researchers suggested that this phenomenon is
merely the ability of DMTl itself to be localised or internalised to another part o f the
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cells in a way that protects the overloading of iron in the cells, as has been documented 
by many researchers (Roth et a l, 2000; Tabuchi et ah, 2002; Johnson et al., 2005). One 
study done by Ma et al. (2006) reported that this mucosal block phenomenon only 
happens at the uptake step.
As mentioned earlier in the first part of the discussion on the possibility of
ascorbate to act as a pro-oxidant with excess iron in the medium, the viability results
showed that there was no effect of ascorbate on cell viability within 15 minutes and at
24 hours incubation times in uptake buffer and serum-free media (Fig. 4.1 and Fig. 4.2).
Besides, ascorbate has been found to have a stimulatory effect on iron uptake and on
incorporation of this element into ferritin. This is a natural way o f reducing the impact of
iron-generating reactive oxygen in the system (Goralska et al., 1998). Although
ascorbate has been reported to have cytotoxic and antimetastatic actions on malignant
cell lines (Roomi et al., 1998; Naidu et al., 2003), this individual nutrient may not be as
powerful as in synergy, especially when the concentration is low enough and longer
incubation times are not permitted where it can cause damage to the cells’ integrity.
Ascorbate, in fact, has an antioxidant effect in the absence of metals, while it becomes a
pro-oxidant when they are present with prolonged exposure of ascorbate only after
oxidative and thermic stress (Zanatta et al., 2003). Furthermore, high concentrations of
ascorbate alone were unable to increase the oxidative stress induced by dietary iron in
C3H mice (Premkumar & Bowlus, 2004). A study done by Chen et al. (2005) found that
ascorbate killed cancer cells selectively and the effectiveness depended on the ascorbate
EC50 values, which is less than 4 mM. Taking this into consideration, the concentration
of ascorbate and iron used in this study was too low to cause any significant harmful
effect on Caco-2 TC7 cells. Only at very high concentrations were exogenous iron (200
106
mg/day) and ascorbate (75 mg/day) reported to promote release of iron from iron- 
binding proteins and enhance in vitro lipid peroxidation in the serum of guinea pigs 
(Naidu, 2003).
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5.0 Kinetic Effect of p-carotene on Iron Uptake and Iron
Transport in Caco-2 TC7 Cells
5.1 Introduction
p-carotene is an antioxidant and precursor of vitamin A. p-carotene can be 
converted into two molecules of retinal by cleavage, catalysed by P-carotene 15, 15’- 
dioxygenase (Raju et aL, 2006; Takitani et ah, 2006). The retinal formed will be further 
metabolised to retinoic acid or retinol. There are over 600 known carotenoids in nature, 
and approximately 50-60 display provitamin A activity. Among these, p-carotene is the 
most important for animal and human nutrition. However, there are marked species 
differences in carotenoid absorption and/or metabolism. In humans, around 60-70% of 
P-carotene is believed to be converted directly to retinal after absorption (Nagao, 2004), 
while the remainder is absorbed intact and deposited in the liver and adipose tissues. In 
rodents, p-carotene is entirely cleaved to retinal, leaving no intact P-carotene in 
circulation (Raju et al. 2006).
Some studies have reported the beneficial effect of P-carotene on iron uptake. It 
was thought that p-carotene was able to maintain iron in the soluble form. In the case of 
rice meals, it was shown that 0.95 pmol (558 lU) of P-carotene increases iron absorption 
more than 3 fold compared to a meal given alone. Absorption from the other two cereals 
showed similar behaviour (Datta & Datta, 2006). It seems that p-carotene also prevents 
the inhibitory effect of polyphenols on iron absorption. When coffee was administered 
with the test meals containing P-carotene, iron absorption did not show a significant 
decrease as expected. On the contrary, it increased from up to 2-fold compared to the
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meal without P-carotene or coffee (Layrisse et aL, 2000). Why P-carotene reacts this 
way is something that is not fully understood.
Meanwhile, vitamin A shows no effect on iron absorption in human subjects. In 
fact, one study found that a small addition of vitamin A led to a small but significant 
(5%) decrease in iron absorption (Walczyk et aL, 2003). Interestingly, vitamin A 
deficiency can also lead to low iron intake (Dreyfuss & Fawzi, 2002). Although many 
studies found a positive effect of vitamin A supplementation on iron status in humans 
and animal models (Muslimatun et aL, 2001; Roodenburg et aL, 1996), their interaction 
is complex. Multiple anomalies such as reduced incorporation o f iron into erythrocytes, 
altered red blood cell morphology, mild anaemia, lower plasma total iron-binding 
capacity, increased iron absorption, and iron accumulation in spleen and bone were 
related to vitamin A deficiency (Kelleher & Lonnerdal, 2005). The mechanisms through 
which vitamin A deficiency affects whole-body iron homeostasis are unknown; 
however, retinoic acid redistributes intracellular iron pool(s), resulting in decreased 
transferrin receptor (TfR) expression in promonocytic U937 cells (Iturralde et aL, 1992) 
and increased ferritin expression in rodent brain and neuronal cells in culture 
(VanLandingham & Levenson, 2003). Conversely, retinoic acid exposure increases TfR 
mRNA levels in kératinocytes (Kelleher & Lonnerdal 2005), indicating that the effects 
of retinoic acid on the iron transport machinery are cell specific.
Since p-carotene is the main precursor that can be enzymatically converted into 
vitamin A, which plays many roles in humans as well as in most animals, it is well worth 
studying its direct and indirect effect on iron uptake by using the Caco2 TC7 cells model 
system, p-carotene is insoluble in water and can be dissolved in DMSO before diluting 
with the aqueous buffer of choice.
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5.2 Aims and objectives
The purpose o f this experiment was to evaluate the effect of P-carotene on iron 
uptake and non-haem iron transporters.
The specific objectives were:
i) to investigate the kinetic mechanism of p-carotene on iron uptake,
ii) to study the effect of P-carotene on iron reduction activity in Caco-2 TC7 cells,
iii) to study the effect of P-carotene on the apical transporter, DMTl
iv) to investigate the effect of p-carotene on the basolateral transporter, Iregl.
5.3 The Effect of p-carotene on Caco-2 TC7 Cell Viability 
Rationale:
It will be necessary first to establish cell viability exposed to the highest 
concentration of p-carotene used in this study versus viability of cells not exposed to the 
compound.
Result:
Fig. 5.1 shows the effect of p-carotene at 30 pM concentration on Caco-2 TC7 
cell viability in uptake buffer for a 15 minute incubation period, which represents the 
conditions in the iron uptake study. There was no significant difference between control 
and treatment on cell viability (p>0.05).
Fig 5.2 shows the effects of P-carotene on Caco-2 TC7 cell viability in serum- 
free media, which represents the conditions for protein analysis, p-carotene had no 
significant effect on cell viability at 24 hours incubation in a serum-free media (p>0.05).
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Fig. 5.1: The Effect of p-carotene on Caco-2 TC7 Cell Viability in Uptake 
Buffer. The effect of p-carotene on cell viability was measured by MTT assay 15 
minutes after giving 30 pM treatments in uptake buffer. Statistical analysis was 
performed using Student’s unpaired t-test. Results were expressed as Mean ± SEM 
for at least four determinations.
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Fig. 5.2: The Effect of p-carotene on Caco-2 TC7 Cell Viability in Serum-free 
Media. The effect of P-carotene on cell viability was measured by MTT assay 24 
hours after giving 30 pM treatments in serum-free media. Statistical analysis was 
performed using Student’s unpaired t-test. Results were expressed as Mean ± SEM 
for at least four determinations.
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5.4 p-carotene Enhances the Reduction of Fe(III)
Rationale:
In the previous chapter, we found that ascorbate influenced the reduction of 
Fe(III) to Fe(II). In the case of rice meals, it was shown that 0.95 pmol (558 lU) of p- 
carotene increases iron absorption more than 3-fold compared with the meal given alone 
(Garcia-Casal et aL, 1998). Hence, in order to understand the effect of p-carotene on 
Fe(III) in Caco-2 TC7 cells, the reduction assay is one of the essential aspects that needs 
to be monitored.
Result:
In this study, p-carotene was found to facilitate reduction o f Fe(III) into Fe(II) in 
the medium containing Caco-2 TC7 cells (Fig. 5.3). The concentration of Fe(II) formed 
was in excess of 57 ± 4 pmol compared to the control. There was no effect of P-carotene 
on Fe(III) reduction in a plate containing cell-free medium (Table 5.1).
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Table 5.1: Fe(II) Formation from Fe(III) Reduction in cell-free Medium. Blank 
plates were incubated for 15 minutes with different concentrations of P-carotene and 
FeCl]. The reduction of Fe(III) was assessed by measuring the concentration of Fe(II)- 
BPDS complex as described previously. Values are Mean ± SEM for at least four 
determinations.
FeCla Concentration (pM)
[p-carotene]
(HM)
0 2 4 .6 10 30
0 0 ± 0 pmol 0 ± 0 pmol 0 ± 0 pmol 0 ± 0 pmol 0 ± 0 pmol 0 ± 0 pmol
0.5 0 ± 0 pmol 2 ±  0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol
1 0 ± 0 pmol 2 ±  0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol
2 0 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol
4 0 ± 0 pmol 2 ± 0 pmol 2 ±  0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol
6 0 ±  0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol
10 0 ± 0 pmol 2 ± 0 pmol 2 ± 2 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol
30 0 ± 0 pmol 2 ± 0 pmol 2 ± 2 pmol 2 ± 0 pmol 2 ± 0 pmol 2 ± 0 pmol
5.5 Influence of p-carotene Concentration on Iron Uptake in Caco-2 TC7 Cells 
Rationale:
Identification the effect of p-carotene on iron uptake will allow the exploration of 
the kinetic mechanism of p-carotene on iron uptake in Caco-2 TC7 cells.
Result:
The concentration of P-carotene used for this study ranged from 0.5 pM up to 
30 pM, and the concentration of Fe(lll) ranged from 2 pM up to 30 pM respectively. 
Each concentration was studied in duplicate; several experiments were performed, and a 
typical experiment is shown in Fig. 5.4A. This study demonstrates that increasing the 
concentration of p-carotene increased iron uptake in the Caco-2 TC7 cells. There was a 
2-fold increase in iron uptake at 30 pM concentration o f p-carotene compared to the 
control. Nevertheless, the Vmax and Km values for this uptake study were not consistent 
(Fig. 5.4B). At this point, this data does not fit into the Michaelis-Menten equation.
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Fig. 5.4B: Variable Values of Vmax (pmol/h) and Km (jiM) for Iron Uptake 
Study Mediated by p-carotene. Cells were incubated with different 
concentrations of P-carotene and FeCls and exposed to ^^FeCb for 15 minutes 
just prior to the uptake study. Iron taken into the cell was measured by 
scintillation counting. Iron uptake was measured after removing loosely bound 
^^Fe from the cell surface by multiple washings with ice-buffer. The line shows 
that Km points and Vmax points were not constant and fluctuated when different 
concentrations of p-carotene were added into the media.
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5.6 Effect of p-carotene on Whole Cell DMTl Levels 
Rationale:
Marginal vitamin A deficiency can result in a secondary iron deficiency. Since 
p-carotene is a precursor o f vitamin A, it presence in the media may influence the main 
iron transporter, DMTl. In this experiment, we used p-carotene to investigate the 
subcellular localisation and trafficking properties of D M Tl.
Result:
Fig. 5.5 shows there was no significant effect on whole cell DMTl levels 
following the exposure of p-carotene to Fe(III) at lOpM concentration in the medium.
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Control p-carotene (10 |iM ) P-carotene (30fj.M)
Fig. 5.5: The Effect of Added p-carotene on Whole Cell DM Tl Levels. Cells 
were treated for 24 hours with 10 pM and 30 pM p-carotene. Whole cell protein 
samples were taken and subjected to Western blotting. Band density was measured 
using Scion Image software. Values were expressed as Mean ± SEM of three 
experiments.
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5.7 Effect of p-carotene on Membrane DMTl Levels
Result:
Following the exposure of P-carotene to Fe(III) at lOpM concentration in the 
medium, there was a significant decrease in the expression o f membrane DMTl 
(p<0.05) (Fig. 5.6).
^  î- I  ^ * bctâ &ctiri
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P-carotene (lOjiM) P-carotene (SO^iM)FeClj
Fig. 5.6: The Effect of Added p-carotene on M embrane D M Tl Levels. Cells 
were treated for 24 hours with 10 pM and 30 pM p-carotene. Membrane protein 
samples were taken and subjected to Western blotting. Band density was measured 
using Scion Image software. Values were expressed as Mean ± SEM of three 
experiments. ^Significant difference from control p<0.05 (Student’s t-test).
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5.8 Investigating the Effect o f Added p-carotene on Iregl 
Rationale:
The iron may be stored within the enterocyte (in the iron storage protein, 
ferritin) or transferred across the basolateral membrane to the plasma by the basolateral 
membrane, Iregl. Hence, p-carotene might have some effects on Iregl activity. In this 
experiment, a Western blot analysis was used to investigate the effect of P-carotene on 
Iregl at lOpM concentration of Fe(III).
Result:
There was no significant effect on the expression of Iregl either in the medium 
with added p-carotene or without added p-carotene (Fig. 5.7).
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Fig. 5.7: The Effect of Added p-carotene oh Ireg l. Cells were treated for 24 
hours with 30 P-carotene. Membrane protein samples were taken and subjected 
to Western blotting. Band density was measured using Scion Image software. 
Values were expressed as Mean ± SEM of three experiments.
122
5.9 Discussion
Evaluating cell viability is a key step in uptake studies. It was found that g- 
carotene at the concentration used in the iron uptake study and DMTl expression 
determination tended to reduce cell viability, but the reduction was less than 15% 
compared to the control after 24 hours exposure time, meaning p-carotene is non-toxic 
to the cells because any test material that reduces cell viability <15% after 24 hours 
exposure is classified as non-corrosive (Fig. 5.1 and Fig. 5.2). However, William et al. 
(2000) found that p-carotene at certain concentrations inhibits the growth of several 
culture cells such as PC-3, prostate cancer cell lines DU 145 (an androgen-independent 
prostate cancer cell line) and LNCaP (an androgen-dependent prostate cancer cell line). 
They found that significant growth inhibition was observed at medium concentrations 
of 40 pmol p-carotene/L in the PC-3 cell line, and >10 pmol p-carotene /L for the DU- 
145 and LNCaP cell lines. However, the possible degradation effects of P-carotene may 
influence the molecular and biological events in cell culture media. Hence, additional 
studies are necessary to define the actual biological mechanism o f actions of p-carotene 
in vitro.
In this study, the formation of Fe(II) was measured in the uptake buffer with
and without added p-carotene. The metabolic process o f P-carotene is still
controversial. However, in Caco-2 TC7 cells, it was found that the reduction step is
essential for transport o f non-haem iron. Out of several subclones o f Caco-2 cells, two
subclones of Caco-2 cells (PFll and TC7) have been detected to contain p-carotene
15,15’-dioxygenase (p-CD) (Quick & Ong, 1990), the enzymes that catalyse the
conversion of p-carotene to retinal (Fig. 5.8). In humans, only a portion of ingested p-
carotene is converted to vitamin A, so that 15-30% of absorbed P-carotene remains
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intact (Lemke et al., 2003; Burri & Clifford, 2004) and is delivered to tissues. In 
rodents, contrastingly, almost all p-carotene is converted to retinal in the intestine 
except at very high doses (Gong et aL, 2006). The conversion of p-carotene to retinal in 
Caco-2 cells may have an indirect effect on its ability to reduce Fe(III) in the medium 
up to a certain amount, although the findings were not conclusive (Fig. 5.3) and may 
require a more in-depth and thorough analysis for understanding because Caco-2 TC7 
cells have been proven to have many additional advantages over normal Caco-2 cells. 
However, knowledge about the regulation of the responsible enzyme by p-carotene is 
still limited.
C H
ÇHCH CH
CH
CH
HC3 HC3
O H
CH3
Fig. 5.8: p-carotene Conversion to Retinal by p-carotene 15,15-dioxygenase.
Arrows indicate the cleaved double bond {Source: Redmond et a l, 2000).
The effect of different concentrations of p-carotene on iron uptake is shown in 
Fig. 5.4A. At 37°C, there was a rapid radio-iron accumulation by the cells. However, it 
is evident that some experiments do not follow the Michaelis-Menten equation, and
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these kinetic profiles are better described by a non-Michaelis-Menten or an atypical 
kinetic model. Atypical kinetic profiles are characterised into five categories: 
activation, autoactivation, substrate inhibition, partial inhibition, and biphasic 
metabolism (Korzekwa et aL, 1998). Activation occurs when Vmax increases in the 
presence of an activator, which may or may not affect Km- For example, 7,8- 
benzoflavone (a-naphthoflavone) was shown to activate the progesterone 6p- 
hydroxylation and 17p-estradiol 2-hydroxylation in humans and rabbits based on the 
observation that the apparent Km of these reactions decreased and the Vmax increased. 
Similarly, another study by Shou et a l (1994) demonstrated that 7,8-benzofiavone 
activates phenanthrene metabolism by increasing Vmax, although the apparent Km was 
unaffected. Even though much evidence exists for the preceding mechanism of atypical 
kinetics, no one theory has been proven conclusively. The effect of P-carotene on iron 
uptake was very similar to biphasic kinetics. A biphasic-kinetic profile is characterised 
by an initial Michaelis-Menten-like increase in velocity with increasing substrate 
concentration. However, the profile eventually becomes linear as the substrate 
concentration continues to increase and does not become asymptotic. This is the first 
study to show the kinetic mechanism of p-carotene on iron uptake. There have been 
studies reporting biphasic kinetic behaviour including 7-ethoxycoumin O-deethylation 
and aminopyrine V-demethylation in recombinant yeast microsomes expressing rat 
CYPlAl and yeast NADPH-P450 reductase (Inouye et a l, 2000), and a study done by 
Miller & Guengerich (2001) which discovered the rates o f 4-nitrophenol and 
formaldehyde production from 0-demethylation o f l-methoxy-4-nitrobenzene by 
CYP1A2 isolated from rabbit liver. All other findings suggest that examples of
biphasic kinetics are becoming more prevalent and more may be determined in future.
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The capability o f Caco-2 TC7 cells to convert almost half of the available P-carotene 
and to retain certain amounts of p-carotene in the system may have an indirect 
influence on this mechanism. To confirm this phenomenon, other studies performed by 
Chen et aL (1996) and Dueker et aL (2000) have reported the disappearance of P- 
carotene and retinal from human plasma following a biphasic kinetics pattern.
Another useful aspect in understanding iron uptake is investigating the effect of 
p-carotene on the expression of DMTl. This study showed that membrane levels of 
DMTl were significantly decreased in iron-treated cells with p-carotene compared to 
the control. The addition of p-carotene to the medium probably facilitates endocytosis 
of DMTl. This phenomenon occurs rapidly, and within 10 minutes o f exposure of the 
brush-border membrane of Caco-2 cells to iron, more than 30% of the DMTl are 
internalised. With the continued presence of the iron that bathes the Caco-2 TC7 cells, 
it is most likely that internalisation continues until equilibrium is reached with some 
return of DMTl to the brush-border membrane (Ma et aL, 2006). Functionally, this is 
like a defensive or regulatory mechanism to prevent iron overloading which is toxic to 
the cells, especially if the ferritin levels cannot accommodate the influx of too much 
iron into the cells.
Interestingly, although membrane DMTl levels responded to the addition of 
P-carotene in the medium, there was no effect on Iregl expression. This experiment 
further confirmed that the effect of dietary components on iron transporters is merely a 
mucosal block phenomenon, where the first step of iron uptake is regulated by DMTl. 
The marginal concentration of P-carotene may not be able to influence hepcidin, which 
is one of the main regulators that regulate the expression of Iregl (McKie et aL, 2000).
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This study model sheds some light on the potential mechanism involved in 
these processes including the capability of p-carotene to reduce Fe(III) before Fe(II) is 
taken up by the cells. In a study done by Layrisse et al. (2000), P-carotene was found to 
increase iron absorption almost 3 times for three cereals tested (rice, wheat and com), 
showing that the compound was capable of preventing the inhibitory effect of phytates 
on iron absorption. They also suggested that P-carotene forms a complex with iron 
keeping it soluble in the intestinal lumen and preventing the inhibitory effect of 
phytates and polyphenols on iron absorption (Layrisse et aL, 2000). Nevertheless, in a 
study done by Palozza et al. (2001), by using the WiDr human adenocarcinoma cancer 
cell line at doses o f p-carotene that exceed the normal dietary intake and in conditions 
of enhanced oxidative stress, P-carotene may act as a propagator of free-radical 
formation which can be harmful to humans.
For the purpose of further investigation, a condition of several in vitro systems 
such as the effect o f added p-carotene alone, pre-incubation of cell culture with p- 
carotene or dietary vitamin A will provide more conclusive data for characterizing how 
p-carotene may influence non-haem iron uptake.
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6.0 Kinetic Effect of Zinc on Iron Uptake and Iron 
Transport in Caco-2 TC7 Cells
6.1 Introduction
Iron deficiency is often accompanied by insufficient dietary intake of other 
micronutrients, especially zinc and copper. This is prevalent in most developing 
countries because of the low consumption of meat and fortified foods. The diets of 
infants and children, especially during the weaning period, do not contain adequate 
amounts o f animal foods, which are good sources of iron and zinc; thus, over time, 
deficiencies of both iron and zinc develop (Baqui et aL, 2005). Both zinc and iron are 
essential micronutrients required for a number of physiological and biochemical 
functions in the body (Wasantwisut et aL, 2006). The body’s total zinc content ranges 
from about 1.5 g in women to 2.5 g in men. Skeletal muscle accounts for approximately 
60% of the total body content and bone mass for approximately 30%. Just like iron, 
zinc is an essential component of a large number of enzymes and plays a central role in 
the immune system (Wintergerst et aL, 2007). However, zinc can be excreted from the 
body through the intestines and urine by desquamation of epithelial cells, and in sweat 
(Huang et aL, 2006). In the conventional sense, unlike iron, the body has no zinc stores. 
However, in the case of bone resorption and tissue catabolism, zinc is released and may 
be re-utilised to some extent (Hunt, 2003).
There is a strategy to improve the iron and zinc status of a population by giving
combined supplementation of both micronutrients, but there is concern about the
interactions between these minerals (Baqui et al., 2005). Supplements containing iron
and multiple trace elements and minerals are used by millions of people worldwide
(Troost et aL, 2003). However, it is widely recognised that there are interactions
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between these minerals in the intestinal lumen, affecting their dietary bioavailability. 
Several studies have reported their direct interference reaction. Zinc absorption can be 
inhibited by high iron concentration and vice versa (Yamaji et aL, 2001). For example, 
when given to adults in solution in ratios > 2:1, inorganic iron was found to compete for 
absorption with zinc (Yamaji et al., 2001). A study conducted by Wasantwisut and co­
workers (2005) found that iron supplementation alone increased haemoglobin and 
ferritin concentrations more than iron and zinc combined in Thai infants aged 4-6 
months supplemented daily with 10 mg of iron and/or 10 mg of zinc for 6 months. 
Also, anaemia prevalence was significantly lower in infants receiving only iron than in 
infants receiving iron and zinc combined.
Although iron was found to significantly inhibit the uptake of zinc, the reverse 
was not true. A study conducted by Kordas & Stoltzfus (2004) reported that zinc 
uptake may be independent of the DMTl mechanism. They found that the reduction in 
zinc uptake did not occur in the absence of serum, which is important because only in 
its absence was DMTl expression downregulated. If zinc relied on the DMTl to enter 
the cell, its absorption should have decreased in the absence of serum, along with the 
decline in DMTl expression. However, negative effects of zinc supplementation on 
iron absorption was recorded in suckling rat pups associated with increased small 
intestine iron retention, decreased hephaestin, and increased Iregl expression (Kelleher 
& Lonnerdal, 2005).
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6.2 Aims and objectives
The purpose of this experiment was to evaluate the effects of zinc on iron 
uptake in the absence and presence o f ascorbate, and to evaluate the effect of zinc on 
non-haem iron transporters.
The specific objectives were:
i) to investigate the kinetic mechanism of iron with added zinc in the 
absence and presence of ascorbate in the uptake medium,
ii) to study the effect of zinc on cell viability of Caco-2 TC7 cells, and
iii) to investigate the effect of zinc on the expression of apical transporter,
DMTl and basolateral transporter, Iregl.
6.3 The Effect of Zinc on Caco-2 TC7 Cell Viability 
Rationale:
To better understand the consequences of addition of zinc on Caco-2 TC7 cell 
viability, the cells were treated with the high concentration o f zinc and a viable cell 
number was assessed after 24 hours.
Result:
There was no significant difference between the control and the treatment with 
ZnCh on cell viability (p>0.05) in both mediums. Less than 15% cell death was 
observed (Fig. 6.1 and Fig. 6.2).
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Fig. 6.1: The Effect of Zinc on Caco-2 TC7 Cell Viability in Uptake Buffer. The
effect of ZnCb on cell viability was measured by MTT assay 15 minutes after giving 
1000 |iM treatments in uptake buffer. Results were expressed as Mean ± SEM for at 
least four determinations.
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Fig. 6.2; The Effect of Zinc on Caco-2 TC7 Cell Viability in Serum-free Media.
The effect of ZnCL on cell viability was measured by MTT assay 24 hours after 
giving 1000 pM treatments in serum-free media. Results were expressed as Mean ± 
SEM for at least four determinations.
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6.4 Effect of Increasing Intracellular Zinc Concentration over Iron Uptake in
Caco-2 TC7 cells 
Rationale;
Studies performed in humans have shown an inhibitory effect of zinc on iron 
absorption, but it is has not been well established whether this interaction depends on 
the absolute amount o f iron and zinc in the supplement and/or on the molar ratio 
between these two minerals. Hence, this study will provide better understanding of the 
competition effect between both minerals.
Result:
When intracellular zinc concentration increased in the buffer, iron uptake 
decreased in the cells (Fig.6.3). A ratio of 1:100 of Fe:Zn inhibited more than 80% of 
iron uptake.
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Fig. 6.3: Competition Studies between Fe and Zn in Caco-2 TC7 Cells. Cells were 
incubated with different concentrations of ZnCl: and FeCb exposed to ^^FeCb for 15 
minutes just prior to the uptake study. Iron taken into the cell was measured by 
scintillation counting. Iron uptake was measured after removing loosely bound ^^Fe 
from the cell surface by multiple washings with ice-cold buffer.
6.5 Influence of Zinc Concentration on Iron Uptake in Caco-2 TC7 Cells 
Rationale:
The purpose o f this experiment was to investigate the effect of added zinc and 
ascorbate on iron uptake in Caco-2 TC7 cells.
Result:
The concentration of zinc used in this study ranged from 100 pM up to 1000 
pM. The concentration of ascorbate was 10 pM and the concentration of Fe(III) ranged
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from 2 pM to 30 pM. Caco-2 cells attached to transwell accumulated ~ 200 pmol 
Fe/well during a 1 hour incubation period in a medium containing 30 pM Fe(III) 
without zinc. Zinc reduced iron uptake in a dose-dependent manner (Fig. 6.4A). 
Cellular uptake of iron was reduced by half (p<0.05) when 100 pM zinc was added to 
the uptake buffer. To examine whether the decrease in cellular acquisition of iron 
uptake from an uptake buffer containing both iron and zinc followed a Michaelis- 
Menten equation, the levels of Vmax values and Km values were calculated. Table 6.1 
shows the influence o f zinc on Vmax and Km values of iron uptake from Fig. 6.4A.
Table 6.1: Kinetic Param eters for ^^Fe uptake into Caco-2 TC7 cells in^ the 
Absence of Ascorbate
[Zinc] pM Vmax values (pmol/h) K m  values (pM)
0 283.70 ±11.97 12.05 ± 1.08
100 146.20 ±6.72 12.47 ± 1.20
200 123.20 ±5.05 13.00 ± 1.11
400 111.60 ±4.79 13.03 ± 1.16
800 86.21 ±3.43 12.02 ± 1.01
1000 73.31 ±3.15 11.53 ±1.06
To determine whether the decreased uptake of iron from solutions with zinc was 
associated with a change in the ratio of Fe(IlI) to Fe(II), ascorbate was added to uptake 
solutions containing different concentrations of zinc and iron. Maximal levels o f uptake 
were present in solutions containing 100 pM zinc and 10 pM ascorbate. These data 
suggest that ascorbate can partly offset the inhibitory effect of zinc on iron uptake. Our 
observation suggests that concentrations of zinc in excess of 200 pM further reduce the 
uptake of iron by Caco-2 TC7 cells at a constant concentration of ascorbate at 10 pM 
by increasing the probability that iron is in its oxidised state at any time (Fig. 6.5A). To
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examine whether the increase in cellular acquisition of iron uptake from an uptake 
buffer containing both iron and zinc in the presence of ascorbate followed a Michaelis- 
Menten equation, the levels of V^ax values and Km values were calculated (Table 6.2).
Table 6.2: Kinetic Param eters for ^^Fe uptake into Caco-2 TC7 cells in the 
Presence of Ascorbate
Ascorbate 10 pM  + [Zinc] pM Vmax values (pmol/h) Km (pM)
0 2398.00 ±90.79 13.24 ± 1.03
100 1642.00 ±49.59 13.14 ±0.82
200 1236.00 ±40.63 12.43 ± 0.86
400 963.10 ±33.88 13.52 ±0.98
800 555.60 ±18.05 13.29 ±0.89
1000 428.90 ± 19.16 14.08 ± 1.28
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Fig. 6.4B and 6.5B show that the reciprocal plot reached linearity with increasing 
concentrations o f zinc in the absence and presence of ascorbate.
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Fig. 6.4B: Effect of Added Zinc on the Uptake of ^^Fe into Caco-2 TC7 Cells.
Data from the same experiment as in Fig. 6.4B are plotted as I/V vs. l/[Fe] at 100 
(■), 200 (A), 400 (À ), 800 (□) and 1000 (♦) pM ZnC^. The data were fitted to a 
hyperbolic equation (v=[S] x Vmax/(Km + [S]), as indicated by the solid lines.
139
0.02 1
0.015 -
o>
CS
a . 0.005 -
- 0.2
-0.005 J
—4 - -+Zn (1000pM) +
Asc(lOpM)
—S -- +Zn (SOOpM) +
Asc(lOpM)
- A - -+Zn(400pM ) +
Asc(lOpM)
—6 --+Zn(200pM ) +
Asc(lOpM)
-+Zn(100pM ) +
Asc(lOgM)
Fig. 6.5B: Effect of Added Zinc and Ascorbate on the Uptake of ^^Fe into Caco-2 
TC7 Cells. Data from the same experiment as in Fig. 6.5B are plotted as lA^ vs. 
l/[Fe] at 100 (■), 200 (A), 400 (À ), 800 (□) and 1000 (♦) pM ZnClz. The data were 
fitted to a hyperbolic equation (v =[S] x Vmax/(Km + [S]), as indicated by the solid 
lines.
6.6 Effect of Zinc on Whole Cell and M embrane DM Tl Levels 
Rationale:
In the present of enhancers or inhibitors or iron in the medium, there is a 
possibility that different regulatory signals might act through different mechanisms to 
alter intestinal iron absorption. If so, some might involve changes in the level of DMTl 
expression, whereas others might affect other iron transport steps, such as basolateral 
transfer, Iregl.
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Result:
Zinc was able to significantly increase DMTl levels for the whole cells and 
membrane levels (p<0.05) (Fig. 6.6 & Fig. 6.7).
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Fig. 6.6: The Effect of Added Zinc on Whole Cell DM Tl Levels. Cells were 
treated for 24 hours with 1000 ZnCl]. Whole cell protein samples were taken and 
subjected to Western blotting. Band density was measured using Scion Image 
software. Values were expressed as Mean ± SEM of three experiments. * Significant 
difference from control p<0.05 (Student’s t-test).
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Fig 6.7: The Effect of Added Zinc on M embrane D M Tl Levels. Cells were treated 
for 24 hours with 1000 pM ZnCl]. Membrane protein samples were taken and 
subjected to Western blotting. Band density was measured using Scion Image 
software. Values were expressed as Mean ± SEM of three experiments. * Significant 
difference from control p<0.05 (Student’s t-test).
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6.7 Investigating the Effect of Added Zinc on Iregl
Result:
Zinc had no effect on the expression of Iregl in Caco2 TC7 cells because the 
slight increase was not significant compared to the control (p>0.05) (Fig. 6.8).
beta actin 
Iregl
a 40
Contro
Fig. 6.8: The Effect of Added Zinc on Ireg l. Cells were treated for 24 hours with 
1000 pM ZnCb. Membrane protein samples were taken and subjected to Western 
blotting. Band density was measured using Scion Image software. Values were 
expressed as Mean ± SEM of three experiments.
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6.8 Discussion
Zinc is critical for the functional and structural integrity of cells. In this work, a 
zinc-supplemented medium containing either an uptake buffer or serum-free media up to 
1000 pM Zn^^ was found to be a non-toxic dose for Caco-2 TC7 cells (Fig. 6.1 and Fig. 
6.2). Although at high concentrations zinc can be toxic for cells (Kim et aL, 2000) and 
can cause a significant reduction in cell viability as early as 4 hours in neuroblastoma 
cells (Daniels et aL, 2004), the high zinc content in the experimental buffer is unlikely to 
interfere with the Caco-2 TC7 cell viability. It was found that less than 10% cell death 
occurred in both experimental buffers. Vega-Robledo et ah (2007) conducted a study on 
the effects of zinc in different cell lines (U-937, human monocytes, and murine bone 
marrow cells). They found that the viability of all cells cultivated with 0.05 and 0.1 mM 
of zinc was similar to that of the controls without zinc (90%). The advantages of the 
MTT procedure are accuracy, reliability and the fact that it saves time (Freimoser et aL, 
1999) in determining cell viability.
The body maintains iron homeostasis principally by inversely regulating iron
absorption relative to liver iron stores. However, adverse effects of zinc supplementation
on iron status have been demonstrated, such as decreased iron absorption, haemoglobin,
and serum ferritin levels in adults (Donangelo et aL, 2002; Lind et aL, 2003; Dekker &
Villamor, 2010). Interaction between iron and zinc have been reported in many studies
and the physiological basis is the competition of these chemically similar ions for some
portions of a common absorptive pathway shared between inorganic (non-haem) iron
and zinc (Chang et aL, 2010); this has been demonstrated in animal experiments and in
zinc absorption studies in human volunteers (Brewer et aL, 1985; Hambridge & Krebs,
2007). In this study, we investigated the effect of zinc and iron combinations in different
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ratios on iron uptake. A molar ratio of 1:100 of FeiZn managed to decrease iron uptake
by more than 80%. This study was conducted to investigate the actual effect of zinc on
iron uptake. High concentration of zinc significantly inhibited iron uptake (Fig. 6.4A).
However, this effect was found to be a non-competitive inhibition because the extent of
inhibition depends only on the concentration of inhibitor (Table 6.1). Specifically, Vmax
will decrease due to the inability for the reaction to proceed as efficiently, but Km will
remain the same as the actual binding o f the substrate. The analysis of the Km value of
iron uptake at different zinc concentrations should allow us to differentiate the modes of
inhibition. Thus, the non-competitive binding means zinc is binding to another
transporter spatially distinct from the active site regardless of the presence of iron. Zinc
is not competing with iron for the same transporter. This means increasing the
concentration of iron still does not allow the maximum Vmax value to be reached and the
reduction in Vmax values was not followed by changes in Km values. Some studies
reported that zinc has its own transporters, hZIPl and hZIP2, that are expressed in
various tissues of the body, whereas~hZIP4 is expressed on the apical membrane of
enterocytes and regulated by dietary zinc (Dufner-Beattie et aL, 2003; Kim et al., 2004)
(Fig. 6.9). Recent findings suggest that a shared absorption pathway for iron and zinc is
distinct from DMTl (Arredondo et aL, 2006). It seems like iron-zinc interactions depend
on their ratio and the wide and unknown variations that were likely to occur between
them. Moreover, a study performed by Santon et al. (2008) suggested that zinc affects
the cellular levels of iron by competition with the same ligand sites and/or by coordinate
regulation of metallothionein and glutathione content. A study performed by Stumiolo et
al. (1999) found a significant correlation between metallothionein and duodenal zinc
concentrations in Wilson's disease patients. Metallothionein may therefore prevent
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oxidative damage caused by metal toxicity. It is unclear how the rapid flux of zinc into 
the body during absorption can be modulated by the synthesis of intestinal 
metallothionein, which requires some time to become maximally active (Webb & Cain,
1982X
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Fig. 6.9: Proposed Mechanism Involved in Iron and Zinc Uptake by the 
Enterocytes. Two concepts must be distinguished when interpreting intestinal 
absorption studies. Apical uptake refers to the shuttling of metals across the apical 
membrane of the enterocyte from the intestinal lumen to the cytoplasm. In the case of 
iron, these is accomplished by the DMTl. A family of human intestinal Zn 
transporters (ZIP) was identified recently, suggesting separate mechanisms for iron 
and zinc absorption. Two such zinc transporters, hZIPl and hZIP2 are expressed in 
various tissues o f the body but are not thought to participate in iron transport. 
Another ZIP protein, hZIP4, expressed on the apical membrane o f enterocytes, is 
defective in acrodermatitis enteropathica and regulated by dietary zinc but, again, is 
not involved in iron uptake {Source: Kordas & Stoltzfus, 2004).
By adding substantial concentrations of ascorbate in the medium, however, there 
was increased iron uptake in Caco-2 TC7 cells. Ascorbate was expected to make iron 
more available in its soluble form [Fe(II)]. Ascorbate would likely help the reduction o f 
Fe(III) to Fe(II) by ferrireductase and overcome the inhibitory effect o f zinc. For 
example, at 1000 pM zinc concentration, iron uptake was less than 50 pmol and added 
ascorbate was able to increase the uptake more than 6-fold to almost 300 pmol.
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To determine whether considerable differences in uptake medium zinc levels in 
Caco-2 TC7 cells could have affected the expression of iron transporters (DMTl and 
Iregl), western blotting analysis was performed. The effect o f zinc on DMTl was 
intriguing. We found that zinc significantly increases DMTl expression in whole cell 
and membrane proteins. New evidence suggests that zinc can indirectly interact with 
DMTl by binding and inducing a proton conductance through the transporter (Sacher et 
aL, 2001). Increasing zinc concentration will probably lead to the cells becoming 
depleted in iron and will indirectly increase expression of DM Tl. This finding does 
support the previous experiment on iron uptake, which found that the effect of zinc on 
iron uptake is non-competitive, meaning zinc and iron use different active sites on 
DMTl when taken up by the cells. This activity will be impeded when saturated with 
either iron or zinc in the cells. Several reports suggested that the zinc transporter is 
distinct from the iron transporter, but the 5’ promoter region of DMTl contains several 
metal responsive element consensus sequences which are similar to the promoter of the 
metallothionein 11a gene (Yamaji et aL, 2001) and are implicated in increased 
metallothionein production upon exposure to high zinc levels (Yamaji et al., 2001). If 
zinc was transported the same way as iron, there should be a decline in DMTl 
expression. Just why zinc reacts this way is not fully understood. Niles et aL (2008) 
conducted a study to examine the effect of zinc deficiency on tissue iron concentrations 
by using Swiss 3T3 cells and concluded that zinc deficiency can result in alterations in 
iron transporter, storage, and regulatory proteins, which facilitate iron accumulation. In 
this study, however, did not manipulate DMTl directly. Either a knockout or 
overexpression of the transporter would provide more direct evidence concerning
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whether zinc enters the cell via DMTl or competes with iron for absorption (Kordas & 
Stoltzfus, 2004).
A slight decrease of Iregl expression was recorded with added zinc in uptake 
medium, although it was not significant (p>0.05). This study also showed that Iregl is 
not only affected by iron, but also by other metals in the medium. In humans, there is a 
variety o f mechanisms that control metal concentrations to be below a nontoxic level 
sufficient for growth, which includes the control of translation and RNA stability by 
iron-regulatory proteins and the metal-dependent trafficking or degradation of metal 
transporters (Theil & Eisenstein, 2000; Eide, 2003). Yamaji et al. (2001) suggested that 
although the mechanisms involved in zinc-dependent regulation are unclear, metal 
responsive elements in the promoter regions of these key iron transport proteins (Iregl) 
could play this role.
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7.0 Kinetic Effect of Phytate on Iron Uptake and Iron 
Transport in Caco-2 TC7 Cells
7.1 Introduction
Phytate, also known as inositol hexakisphosphate (IP6), is found in many foods, 
in particular in cereals with high bran content, nuts, beans, and fruits (Oomah et aL,
2008). Inositol is not considered a vitamin itself because it can be synthesised by the 
body. Phytate is a chelator that comprises 1-3% by weight of all seeds that have the 
protective function against oxidative damage (Bowen et aL, 2006; Campos-Vega et aL, 
2010). In general, many scientists agree that vegan and vegetarian diets which are high 
in phytate contribute to widespread mineral deficiencies in third world countries 
(Gargari et aL, 2007). Phytate has long been recognised as an antinutrient because of its 
ability to bind to, precipitate, and decrease the availability of divalent and trivalent 
cationic minerals. For example, low iron absorption from cereal-based foods contributes 
to the high prevalence of iron deficiency in infants from developing countries and 
degradation of phytate in cereal porridges improves iron absorption by human subjects 
(Hurrell et aL, 2003). Phytate is also thought to regulate the process of digestion by 
binding to some digestion products, thereby delaying the onset of diabetes and 
hyperlipidemia (Okazaki & Katayama, 2008), thus helping in blood glucose control (Lee 
et al., 2006). Besides, phytate may directly bind to some metabolic by-products and even 
some enzymes, thus directly affecting the activities of those enzymes (Liu et aL, 2010), 
playing a role in reducing the in vitro rate of starch digestibility and, possibly, blood 
glucose response (Lee et aL, 2006). In addition, studies carried out by Thompson and 
Yoon (2006) also show that phytate may affect starch digestibility through interaction
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with amylase and protein and/or binding with salivary minerals such as zinc and 
calcium. It was thought that phytate and iron form insoluble complexes which are not 
available for absorption under the pH conditions of the small intestine (Anne & Gerald, 
2002).
7.2 Aims and objectives
The purpose of this experiment was to evaluate the effect of phytate in the 
absence and presence of ascorbate on iron uptake, and to evaluate the effect o f phytate 
on non-haem iron transporters.
The specific objectives were:
i) to investigate the kinetic mechanism of phytate inhibitory effect on iron 
uptake in the absence and presence of ascorbate,
ii) to study the effect of phytate in iron Caco-2 TC7 cells, and
iii) to investigate the effect of phytate on iron transporters DMTl and Iregl
7.3 The Effect of Phytate on Caco-2 TC7 Cell Viability 
Rationale:
Cell viability assessment is an important parameter for evaluating cell responses 
to endogenous factors before the respective compounds can be investigated for further in 
vitro work by using a cell culture model system.
Result:
Fig. 7.1 and Fig. 7.2 show the effect of phytate at 50 pM concentration on cell 
viability in serum-free media and uptake buffer, respectively. There was no significant 
difference between the treatment and the control on cell viability (p>0.05).
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Fig. 7.1: The Effect of Phytate on Caco-2 TC7 Cell Viability in Uptake Buffer.
The effect of phytate on cell viability was measured by MTT assay 15 minutes after 
giving 50 pM treatments in uptake buffer. Results were expressed as Mean ± SEM 
for at least four determinations.
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Fig. 7.2: The Effect of Phytate on Caco-2 TC7 Cell Viability in Serum-free 
Media. The effect of phytate on cell viability was measured by MTT assay 24 hours 
after giving 50 pM treatments in serum-free media. Results were expressed as Mean ± 
SEM for at least four determinations.
7.4 Phytate Decreases the Reduction of Fe(III)
Rationale:
Phytate is a known antioxidant and probably served as a potent inhibitor of iron- 
mediated hydroxyl radical (OH ) formation. In this regard, phytate will probably perturb 
the reduction of Fe(III) to Fe(II).
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Result:
The effects of phytate on Fe(lll) reduction are summarised in Fig. 7.3. In the 
absence of phytate, the plot shows straight lines of increasing slope with increasing 
Fe(III) concentration. However, in the presence of phytate, the increase was much 
smaller than the control. Phytate at a concentration of 10 pM caused a 30% reduction o f 
Fe(II) formation from 10 pM concentration of Fe(III).
7000i
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Q. 4000
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FeCb Concentration (pM)
♦  FeCls (Control)
O + Phytate (20 pM)
□ + Phytate (5pM) 
0 +  Phytate (30|iM )
A +  Phytate ( 1 OpM) 
■ +  Phytate (SO^iM)
Fig. 7.3: Fe(II) Formation from Fe(III) in Uptake Buffer. Cells were incubated 
with different concentrations of phytate and different concentrations of FeCl] for 15 
minutes. Cell-mediated reduction of Fe(lll) was assessed by measuring the 
concentration o f Fe(ll)-BPDS complex as described previously. Values are Mean ± 
SEM for at least four determinations.
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7.5 Influence of Phytate Concentration on Iron Uptake in Caco-2 TC7 Cells 
Rationale:
The rationale o f this experiment is to provide information on the effects of 
known inhibitors of iron uptake in this model system and their relative potency in the 
absence of other ingredients present in a food or meal matrix.
Result:
Fig. 7.4 shows the inhibitory effect of phytate on iron uptake. The concentration 
of phytate used in this study ranged from 5 pM up to 50 pM. Phytate at a concentration 
of 50 pM caused a 65% reduction of Fe(II) formation from 10 pM concentration of 
Fe(lll) (Fig. 7.4). Table 7.1 shows the influence of phytate on Vmax and Km values of 
iron uptake from Fig. 7.4 in the absence of ascorbate.
Table 7.1: Kinetic Param eters for ^^Fe uptake into Caco-2 TC7 cells in the Absence 
of Ascorbate
[Phytate] pM Vmax (pmol/h) K m  value (pM)
0 329.8 ± 11.08 15.43 ± 1.03
5 274.4 ± 9.62 13.55 ±0.97
10 278.0 ±7.19 17.03 ±0.85
20 218.2 ±8.60 12.90 ± 1.06
30 180.4 ±8.89 10.84±1.17
50 172.2 ±5.85 18.93 ±1.21
Fig. 7.5 shows that ascorbate was able to partially eliminate the effect o f phytate 
on iron uptake in Caco-2 TC7. The concentration of phytate used in this study ranged 
from 5 pM up to 50 pM, the concentration of ascorbate was 10 pM and the 
concentration o f Fe (III) ranged from 2 pM up to 10 pM, respectively.
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Table 7.2 shows the influence of added ascorbate on the Vmax and Km values of 
iron uptake from Fig. 7.5 in the presence of ascorbate.
Table 7.2: Kinetic Param eters for ^Fe uptake into Caco-2 TC7 cells in the 
Presence of Ascorbate
Ascorbate 10 pM  + [Phytate] pM V m a x  (pmol/h) Km value (pM)
0 7341 ± 343.5 46.04 ±3.18
5 2022 ± 46.86 12.46 ±0.61
10 1309 ± 135.5 20.76 ± 3.92
20 885.5 ± 57.34 34.16 ±3.52
30 512.4 ±62.33 37.89 ±7.15
50 276.9 ±20.70 26.52 ± 3.39
To determine whether the decreased uptake of iron from solutions with phytate 
was associated with a change in the ratio of Fe(IIl) to Fe(II), ascorbate was added to 
uptake solutions containing different concentrations of phytate and iron. Maximal levels 
of uptake were present in solutions containing 5 pM phytate and 10 pM ascorbate (Fig.
7.4 and Fig. 7.5).
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Fig. 7.4B and 7.5B show that the reciprocal plot reached linearity with increasing 
concentrations of phytate in the absence and presence o f ascorbate.
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Fig. 7.4B: Effect of Added Phytate on the Uptake of ^^ Fe into Caco-2 TC7 Cells.
Data from the same experiment as in Fig. 6.4A are plotted as 1/V vs. l/[Fe] at 5(d), 10 
(■), 201(A), 40 (À ), 50 (o) pM ZnCb- The data were fitted to a hyperbolic equation (v 
=[S] X Vmax/(Km + [S]), as indicated by the solid lines.
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Fig. 7.5B: Effect of Added Phytate and Ascorbate on the Uptake of ^^Fe into 
Caco-2 TC7 Cells. Data from the same experiment as in Fig. 7.5A are plotted as 
1/V vs. l/[Fe] at 5(d), 10 (■), 20 (A), 40 (A), 50 (o) pM phytate. The data were 
fitted to a hyperbolic equation (v =[S] x Vmax/(Km + [S]), as indicated by the solid 
lines.
7.6 Effect of Phytate on Whole Cell and Membrane DM Tl Levels 
Rationale:
One approach of examining the function of transporter is to investigate the effect 
of the selected compounds on the transporter expression. Expression studies allow 
investigators to ask what happens when DMTl activity is increased or made available 
where there was no such activity initially.
Result:
Phytate was able to significantly increase DMTl levels for the whole cells and 
membrane levels (p<0.05) (Fig. 7.6 & Fig. 7.7).
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Fig. 7.6: The Effect of Added Phytate on Whole Cell DM Tl Levels. Cells were 
treated for 24 hours with 50 phytate. Whole cell protein samples were taken and 
subject to Western blotting. Band density was measured using Scion Image software. 
Values were expressed as Mean ± SEM of three experiments. * Significant difference 
from control p<0.05 (Student’s t-test).
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Fig. 7.7: The Effect of Added Phytate on M embrane DM Tl Levels. Cells were 
treated for 24 hours with 50 pM phytate. Membrane protein samples were taken and 
subject to Western blotting. Band density was measured using Scion Image 
software. Values were expressed as Mean ± SEM of three experiments. ^Significant 
difference from control p<0.05 (Student’s t-test).
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7.7 Investigating the Effect of Added Phytate on Iregl 
Rationale:
Preliminary experiments indicated that the expression o f apical membrane 
transporter of iron (DMTl) increased in the presence of phytate, so the experiments 
were designed to elucidate the role of phytate on the expression o f Iregl.
Result:
Fig. 7.8 shows that the expression of Iregl significantly increased in the presence 
of phytate in the medium (p<0.05).
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Fig. 7.8: The Effect of Added Phytate on Ireg l. Cells were treated for 24 hours 
with 50 pM phytate. Membrane protein samples were taken and subject to Western 
blotting. Band density was measured using Scion Image software. Values were 
expressed as Mean ± SEM of three experiments. * Significant difference from 
control p<0.05 (Student’s t-test).
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7.8 Discussion
In this study, phytate at a concentration of 50 pM had no effect on cell viability 
in uptake buffer or serum-free medium at 24 hours and 15 minutes incubation times, 
respectively (Fig. 7.1 and Fig. 7.2). This finding shows a similar pattern to that seen in a 
study done by Dorsey and colleagues (2005) which reported that treated Hep-2 cells had 
no effect on cell proliferation at 50 pM concentration for 24- or 48-hour groups, 
although there was a decrease in cell numbers with the 72-hour group (Dorsey et aL, 
2005). Another MTT assay study performed by Wei and colleagues (2008) found that 
the growth of human gastric carcinoma cells (SGC-7901) was inhibited by phytate in a 
dose- and time-dependent fashion. The morphological observation by reverse 
discrepancy microscope indicated that the growth of cells exposed to phytate was not 
good. This finding is important to illustrate the usefulness of the Caco-2 TC7 cell model 
for a wide variety of uptake studies.
Traditionally, phytate has been linked to mineral deficiency because o f its 
affinity with minerals, mainly iron, zinc, calcium, and magnesium. However, recent 
studies show that phytate, even when dosed at normal levels, does not cause deficiencies 
or toxic effects (Fox & Eberl, 2002). Phytate seems only to affect cancer cells and not 
normal cells. Phyate and inositol appear to improve the effectiveness of chemotherapy 
(Vucenik & Shamsuddin, 2003). Phytate tends to reduce cell proliferation and increase 
the differentiation of malignant cells, resulting in a reversion to normal phenotype. 
Vucenik and Shamsuddin (2003) reported that exogenously administered phytate is 
rapidly taken into the cells and dephosphorylated to lower-phosphate inositol 
phosphates, which further interfere with signal transduction pathways and cell cycle 
arrest. However, the molecular mechanisms underlying this anticancer action are not
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fully understood (Vucenik & Shamsuddin, 2003) arid more studies are required to 
determirie optimal dosage, effectiveness, and safety of phytate.
This study has documented an inhibitory effect o f phytate on iron uptake and was 
similar to what has been previously reported (Glahn et aL, 2002). Phytate, a major 
constituent of cereals, pulses and seeds, is thought to be responsible in part for the low 
absorption efficiency and high incidence of iron deficiency anaemia evident in most 
developing countries, where largely vegetarian diets are consumed (Kristensen et aL, 
2005). For instance, Mendoza et al. (1998) observed that the absorption of iron from a 
tortilla-based test meal was 49% greater when the tortillas were manufactured from 
genetically modified low-phytate (368mg per lOOg) maize relative to the native maize 
(847 mg phytate/lOOg). Therefore, the effect of phytate on iron uptake was decided to be 
investigated in a pure and well defined system, varying only its concentration. The 
concentration range was chosen to match levels that might be found in meals with 
cereals, pulses and seeds. Naturally occurring levels of phytate are, for example, 7.48-
8.00 g/kg for chickpea {Cicer arietinum) and 8.47 g/kg for maize (Minihane & Rimbach, 
2002). These findings suggest that iron is poorly absorbed in the presence of phytate in 
the medium. It was found that the effect of phytate on iron is a competitive inhibition 
and is dose-dependent because phytate does affect the V^ax and Km values. Phytate 
presumably blocks the active sites or forms a complex with iron, making it insoluble, 
thereby preventing the iron from binding until the complex dissociates. Raising iron 
concentration can eventually overcome the effect of phytate, and Vmax can be achieved. 
Although Vmax can be reached. Km values will be raised, indicating that the affinity of 
the transporter for iron is lower in the presence of phytate. Iron uptake from the medium 
containing a ratio o f 5:1 [e.g. 50 pM of phytate: 10 pM of Fe(III)] was 35% compared to
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the control. Thus, the reduction in absorption was 65% in the presence of phytate. This 
suggests that phytate is a strong inhibitor for iron uptake in Caco-2 TC7 cells.
The inhibitory effect of phytate was markedly counteracted by ascorbate. This 
neutralising effect of ascorbate was related to the amount of ascorbate given and the 
amount of phytate present. The effect of ascorbate on increasing absolute absorption was 
significantly higher when 5 pM concentration of phytate was present in the medium and 
was significantly lower at 50 pM concentration of phytate in the medium. The relative 
effect of ascorbate, however, was more marked the more the absorption of iron was 
inhibited by phytate.
For non-haem iron to be absorbed by the enterocyte, it must first be soluble at the 
luminal pH of the intestine. Thus, the primary factors affecting iron solubility are pH 
and complexation by compounds such as organic acids, polyphenolic compounds, and 
proteins. Phytate has been known to inhibit iron absorption in humans for more than six 
decades (Reddy et aL, 2000). Under conditions such as in the present study, in which no 
foods were present in the in vitro digests, phytate was proposed to primarily inhibit non- 
haem iron absorption by binding the iron and thereby restricting exchange or interaction 
of iron with the brush border surface and the DM Tl. The observation that ascorbate only 
partially reversed the inhibitory effect of phytate, even at molar excess to phytate, can 
also be explained by a complexation mechanism of inhibition. Ascorbate is known to 
reduce Fe(III) to Fe(II) at low pH and only complexes iron weakly. Under the conditions 
of the present study, more Fe(II) was formed by ascorbate reduction of Fe(III). 
However, the 50 pM concentration o f phytate relative to Fe(III) was likely the dominant 
factor binding iron, thereby reducing access of free iron to interaction with the DMTl or 
membrane Dcytb. Human studies have also provided evidence that reasonable amounts
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of dietary ascorbate could partially overcome inhibition of iron absorption by phytate; 
however, it should also be noted that the concentration ratio of phytate to Fe(III) and 
ascorbate studied was somewhat lower (Hallberg et aL, 1989; Siegenberg et aL, 1991). 
For example, Siegenberg and colleagues found that iron absorption from a bread meal 
containing 3 mg o f Fe and 58 mg of phytate doubled when 30 mg of ascorbate was 
added (Siegenberg et aL, 1991). This corresponds roughly to a final molar ratio of 
1:1.6:3.2 (iron: phytate: ascorbate). The interaction observed between ascorbate and 
phytate has wide nutritional implications (Fuxia et aL, 2009). In diets with high phytate 
content, the desired levels of ascorbate should also be high. While phytate is responsible 
to inhibit iron uptake, the presence of ascorbate is critical for effective digestion of 
dietary iron. Ascorbate may alters the physiochemical characteristic of phytate-iron 
complex and the enhancing effect of ascorbate on iron uptake is believed to be due to its 
ability to reduce Fe(lII) to Fe(II) which binds less strongly with phytate to form 
insoluble complexes (Fairweather-Tait & Hurrell, 1996). The most feasible way to 
improve iron nutrition in populations where the traditional diet has high phytate content 
would probably be to increase the ascorbate content. More studies are needed on the 
interaction of factors inhibiting and enhancing iron absorption. These may lead to a 
better understanding of the causes of the variation of the bioavailability of iron from 
different meals and diets, to a better ability to predict the absorption from various meals 
and diets, and to the development of new, effective and realistic ways to improve iron 
nutrition in different populations.
Phytate has been thought to be responsible in part for the low absorption 
efficiency o f iron and high incidence of IDA in developing countries (Khan et aL, 2007). 
These findings suggest that phytate is responsible as it affects the formation of Fe(II).
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The inhibition of Fe(III) reduction by phytate is likely due to the formation of 
interactions in the phytate-iron complex that are not available for absorption under the 
pH conditions of the small intestine (Rimbach & Pallauf, 1998; Engle-Stone et ah, 
2005), thus making iron unavailable for absorption. However, not all studies have 
demonstrated the negative effects of phytate on nutrient availability, particularly iron. 
For an in vitro study, differences in experimental data may be attributed to factors such 
as the methodology used to study iron absorption, the chemical form, the concentration 
of iron in the diets, other components of the test meal, and species differences when 
comparing human and animal cells (Schricker & Miller, 1983; Derman et aL, 1987). In 
contrast to its anti-nutritive effects, the potential benefits of phytate include delayed 
postprandial glucose absorption (Paulauf & Rimbach, 1997; Farhat et aL, 2010), a 
decrease in plasma cholesterol and triglycerides (Lee et aL, 2005), as well as a change in 
the bioavailability and toxicity of heavy metals such as cadmium (Turecki et aL, 1995) 
and lead (Cuneo et aL, 2006).
Dietary phytate has often been noted for its strong iron ion-chelating ability, 
which possibly suppresses iron ion-induced oxidative damage in the gastrointestinal 
tract. A function of phytate as a natural antioxidant was first postulated by Graf et aL 
(1984). Studies done by Miyamoto et aL (2006) using liposomal membranes 
demonstrated that hydrolysis products containing three or more phosphate groups are 
able to inhibit iron ion-induced lipid peroxidation, although their effectiveness decreased 
with dephosphorylation. However, a research to confirm these antioxidant properties of 
phytate was not conducted in this study.
In this study, both DMTl and Iregl were found to increase with the addition of 
phytate in the uptake buffer. DMTl is dramatically upregulated in Caco-2 cells by
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dietary iron restriction or increased demand for iron expression. As previously described, 
DMTl expression is regulated by the amount of iron available in the system and low 
availability of iron will help to increase the expression of DMTl. The proteins involved 
in iron metabolism at the basolateral surface not only function in iron transport, but also 
serve as sensors of body iron stores (Leong et a l, 2003). Within the last eight years, a 
number of studies have cloned and characterised a putative basolateral transporter 
referred to as Iregl. Its location in cells and its trans-membrane configuration is 
consistent with its proposed role in exporting iron from the enterocytes. A study done by 
Thomas and Oates (2004) using bicameral inserts showed that Iregl was found to 
modulate iron uptake at the apical membrane of enterocytes. It is unlikely that Iregl 
reacts as the uptake transporter because there is convincing evidence that this occurs via 
DMTl (Gunshin et aL, 1997). However, it is possible that Iregl modulates the 
expression and/or activity of DMTl at the apical surface and that this, in turn, leads to 
altered iron uptake. In this study, the effect of phytate was found to have a similarity 
with another iron inhibitor (zinc) on the expression of Iregl, where both inhibitors were 
able to increase the expression o f Iregl in Caco-2 TC7 cells. Although the effect of 
phytate is presumably related to metal-responsive elements (Yamaji et aL, 2001) in the 
promoter regions of Iregl, the mechanisms responsible for the enhancing effect on Iregl 
are still unknown. Thus, DMTl is hypothesised to interact with Iregl, resulting in 
increased expression of Iregl when DMTl is increased. This finding suggests that if 
phytate interferes with iron uptake, this raises the possibility that iron will be released 
from the cytosol ferritin and will be likely to increase Iregl to mediate iron export from 
the cells.
169
8.0 Conclusions
Iron deficiency anaemia has been recognised as the most prevalent nutritional 
deficiency state on a worldwide (Yasuji et aL, 2002). Internationally, where plants are 
the major component of the diet, iron deficiency anaemia is six to eight times more 
prevalent than in the countries that depend on meat as an iron source (WHO, 2001). The 
complexity o f iron (with low molecular weight and high molecular weight ligands) in 
plants is not the only factor that influences iron absorption. Some components in plants 
such as phytate and polyphenols also interfere with iron absorption. There are two types 
of iron: haem iron, the easily absorbable form that accounts for 20-30% of the iron in 
meats, and non-haem iron, the low bioavailability form of iron present in vegetables. 
The majority of dietary non-haem iron enters the gastrointestinal tract in the Fe(III) 
form. Before Fe(III) can cross the cell membrane, it must be reduced to Fe(II) for 
handling by the apical membrane protein, DMTl, which is not selective for iron (a 
radiotracer assays in Caco-2 cells have established that DMTl is also capable o f 
transporting manganese, cobalt and cadmium) (Miret et aL, 2003) and basolateral 
membrane transporter, Iregl (Anderson et aL, 2002).
Previously, the effects of dietary components on iron uptake were identified 
mainly by the radiolabelled iron studies in humans and the enhancing or inhibiting effect 
mostly on the single dietary components and some in combinations. Nowadays, Caco-2 
cells are widely used to replace human studies and animal studies for several reasons 
such as risk of radioactivity exposure, cost and complexity. Caco-2 cells have been 
utilised for mechanistic studies to identify the transport pathways of drugs, but studies 
on nutrition and mineral uptake are limited. Although many researchers have determined
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various inhibitors and enhancers on iron uptake, kinetic studies of their effect have been 
left untouched by many. It is important to determine the actual Vmax, Km or Ki for the 
reactions if they are to be used most efficiently. Clearly, Vmax and Km values can be used 
to decide whether the inhibition is competitive, non-competitive, or uncompetitive (Tan 
et a l.,2 0 \\) .
8.1 Role of DM Tl and Iregl
DMTl is a key component of the complex physiological process regulating the 
body’s iron levels at the apical membrane duodenal enterocytes, while iron regulated 
gene 1 (Iregl) is a second transmembrane protein that is the exporter of iron through the 
basolateral membrane to plasma (Abboud & Haile, 2000; Donovan et aL, 2005). Iregl 
mediates the transport of iron from the intestinal epithelial cells to the rest of the body. 
Iron that is not exported into the plasma is lost with exfoliation of the intestinal 
epithelium (Lombard et aL, 1997). Unlike DMTl, Iregl is down-regulated under 
condition of low intracellular iron (Hentze & Kuhn, 1996). Between DMTl and Iregl, 
however, considerable evidence shows that the movement of iron through enterocytes 
involves interactions with various organelles before it exits at the basolateral membrane. 
Using high-resolution autoradiography following an intragastric dose of radiolabelled 
iron, the radiolabel was found in the rough endoplasmic reticulum (Bedard et aL, 1971; 
Humphrys et aL, 1977). Other proteins that are present within enterocytes are transferrin 
and TfR, and they may play a direct role in iron absorption as well (Trinder et aL, 2002).
To combat iron deficiency, dietary iron uptake needs to be estimated by taking 
into account the form of iron (haem or non-haem), the presence o f dietary components 
(enhancers or inhibitors), and the iron status of the individual. FAO/WHO suggested the
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following practical ways of classification of usual diets for the purpose of estimating 
iron bioavailability in developing countries:
a) Low bioavailability diet (iron absorption around 5%): a simple, monotonous diet 
containing cereals, roots and/or tubers, and negligible quantities o f meat, fish or 
ascorbate rich foods. This diet containing a high proportion of inhibitors of iron 
absorption (maize, beans, whole wheat flour, sorghum, etc) is dominant in many 
developing countries, particularly among lower socioeconomic groups.
b) Intermediate bioavailability diet (iron absorption about 10%): consists of mainly 
cereals, roots and/or tubers and negligible quantities of food of animal origin 
and/or ascorbate, both o f which promote iron absorption. A low bioavailability 
diet can be raised to this group by adding ascorbate-rich foods, meat and fish. 
Similarly, a high bioavailability diet can be reduced to this group by consuming 
more meals containing higher amounts of inhibitors of iron absorption, such as 
tea or coffee.
c) High bioavailability diet (iron absorption about 15%): diversified diet with 
generous quantities of meat, poultry, fish and/or foods containing a high amount 
of enhancers.
These classifications include the presence of enhancers and inhibitors available 
in meals and refer to non-anaemic individuals with non-iron stores. For individuals 
suffering from iron deficiency, each value is assumed to be increased by 50% (i.e., to 
7.5, 15, and 22.5 % absorption for low, intermediate and high bioavailability diets, 
respectively) (WHO 2001).
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8.2 Impact of Ascorbate on Iron Uptake
In Chapter 4, this study shows that ascorbate is a strong enhancer of non-haem 
iron uptake and absorption. In humans, ascorbate may exert its enhancing effect by 
increasing acidity within the stomach to maintain the solubility of dietary iron, by 
reducing Fe(III) to its soluble Fe(II) form, and/or by forming chelates with iron in the 
stomach. Adding 100 mg ascorbate on a semisynthetic meal increased iron absorption as 
much as 4-fold (Cook & Reddy, 1991). In fact, ascorbate was found to improve iron 
absorption even in the presence of inhibitors such as phytates in cereals and soy and 
tannins in tea and calcium (Jyothi et aL, 2006). This study found that ascorbate increased 
iron uptake as much as 19-fold in Caco-2 TC7 cells compared to the control (Fig. 4.5).
This study has shown that iron uptake will increase significantly (p<0.05) in 
uptake buffer containing ascorbate compared to the control in Caco-2 TC7 cells. 
Ascorbate was found to help in reducing Fe (III) to the more soluble form, Fe(II), 
compared to the medium without added ascorbate. By adding ascorbate to the medium, 
the apical membrane transporter (DMTl) was increased back to basal levels, but no 
significant increase was recorded for Iregl. In conclusion, ascorbate is an important 
dietary component that helps to increase iron uptake in this Caco-2 TC7 cells model 
system primarily by reducing Fe(III) into Fe(II) form.
8.3 Impact of p-carotene on Iron Uptake
Red palm oil, used as a nutritious source of oil for thousands of years in Asia and 
Africa (Cottrell, 1991), naturally contains tocopherols and tocotrienols (vitamin E), and 
carotenoids (vitamin A), which gives the oil its red color. It comes from the fruit o f the 
tropical palm tree. Elaeis guineensis. The most widely studied and well understood
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nutritional role for carotenoids is their pro-vitamin A activity. Vitamin A can be 
produced within the body from certain carotenoids, notably p-carotene. Scientists 
believe that because of its high carotenoid content, red palm oil may enhance the 
immune system’s function and protect against vitamin A deficiency and certain forms of 
cancer (Edem, 2002). In Venezuela, P-carotene is included in their food fortification 
programme. This study and others (Garcia-Casal et aL, 2000) found that p-carotene 
enhanced iron uptake. Interestingly, the effect of P-carotene on iron uptake did not 
follow the Michaelis-Menten equation. Rather, it likely follows biphasic kinetics. Also, 
p-carotene was found to be able to reduce Fe(III) to a more soluble form, Fe(II), though 
not to the degree of ascorbate. By adding p-carotene, the apical membrane transporter, 
DM Tl, was significantly reduced, but there was no effect on Iregl.
8.4 Im pact of Zinc on Iron Uptake
Iron deficiency is often accompanied by other micronutrient deficiencies. 
Combined iron-zinc supplementation regimens are employed with increasing frequency 
in field trials to combat co-occurring iron and zinc deficiencies; however, there is a 
growing concern for potential antagonism between these two metals (Kordas & 
Stoltzfus, 2004). Previously, DMTl was cited as a possible reason for the antagonism 
phenomenon because it is thought to be the transporter of a wide range of cations, 
including zinc. Yamaji et aL (2001) examined the absorption of iron (1 pM ^^Fe^"  ^in the 
presence of 100 pM excess zinc and the absorption of zinc (1 pM in the presence
of 100 pM iron. They found that iron loading decreased DMTl expression and reduced 
subsequent iron uptake, but did not affect zinc absorption. Conversely, cell loading with 
zinc increased DMTl mRNA levels and expression, increased iron absorption, increased 
Iregl expression, but did not change zinc absorption. This study also found similar
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results where the effects of zinc on iron is non-competitive, meaning they may not share 
the same active sites on DMTl or they may have their own specific transporter (Fig. 6.4 
and Fig. 6.7).
8.5 Impact of Phytate on Iron Uptake
Food products derived from plants contain high levels of potent inhibitors of 
non-haem iron such as phytate. Individuals who are dependent on vegetarian or plant- 
based foods are at risk of developing iron deficiency. For example, whole wheat and 
brown rice are staples consumed by lower socioeconomic status groups in Africa and 
Asia. Several strategies have been adopted to increase iron bioavailability derived from 
plants (i.e., milling, leavening, fermentation, germination and biofortification). Phytate 
in foods formed a complex with iron through its phosphate ester group and is considered 
to be a major inhibitor of iron bioavailability (Engle-Stone et aL, 2005). In this study 
and another study done by Engle-Stone et aL (2005) it was found that iron was 
maximally inhibited at a molar ratio of 1:5 (Fe: Phytate) when FeCE was used as an iron 
source. Nevertheless, the phytate inhibition effect was found to be competitive, meaning 
that high iron content in the medium will outperform the inhibition effect by phytate.
8.6 Summary of Findings and Recommendations for Future Work
This thesis has yielded some interesting results, especially on the kinetic 
mechanism of iron uptake. The results give a clear picture of the actual dietary 
components’ effects on iron uptake. Some things that seem certain today were merely 
conjecture a few years ago. Two reaction mechanisms, one involving non-competitive 
and the other competitive iron uptake, have been described. The effects o f ascorbate, p- 
carotene, and phytate on ferrireductase activity have been revealed. The effects of 
selected dietary components on apical membrane and basolateral membrane transporters
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have been determined. Data from these studies have highlighted numerous other
approaches which may provide useful information for further investigation:
a) This report demonstrated the effect of specific dietary components on iron uptake 
mostly available in plants. It would be useful to investigate the effects of proteins 
and carbohydrates, as well as other minerals such as calcium, on the mechanisms 
by which iron absorption is enhanced or inhibited. This information may provide 
additional clues as to how our bodies cope to improve iron absorption from diets 
high in specific inhibitors or enhancers.
b) There is another important indicator of iron uptake that has not been investigated 
in this study: ferritin. It would be interesting to study the effect of iron uptake on 
ferritin formation in the presence or absence of dietary components in the 
system. The use of recombinant proteins and site-directed variants, high 
resolution crystallography, and various rapid spectroscopic methods will provide 
definitive answers to many of these remaining questions.
c) These studies have used Caco-2 TC7 cells for predicting the effect o f various 
dietary components on iron uptake in the medium. This model system can also 
be used as a tool to predict human iron absorption both in vitro and in vivo with 
human trials simultaneously. This can be used both for comparing single meals 
and multiple meal or diet regimes with known enhancers and inhibitors.
d) Few studies have been conducted to study the effect of iron deficiency and 
overload on various organelles in the enterocytes. It would be useful to 
investigate important roles played by various organelles in the enterocytes and 
how they interact with the transporters when availability of iron has been 
disturbed.
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Taking into consideration the results obtained in this study, one can conclude that
i) ascorbate and (Tcarotene are enhancers of iron uptake in Caco-2 
TC7 cells.
ii) zinc and phytate are inhibitors of iron uptake in Caco-2 TC7 cells.
iii) ascorbate is able to diminish the inhibiting effect o f zinc and phytate on 
iron uptake in Caco-2 TC7 cells.
iv) DMTl expression is reduced in the presence of p-carotene and is 
augmented in the presence of ascorbate, zinc and phytate in the media.
v) Iregl expression is increased in the presence of zinc and phytate in the 
media and is decreased in the presence of ascorbate and p-carotene in the 
media.
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